Transplant Surgery — MCQs

Q: After the first postoperative year of cardiac transplantation, what is the most common cause of death?

Accelerated graft arteriosclerosis. **Explanation:** The survival of cardiac transplant recipients is divided into two distinct phases: the early postoperative period (within the first year) and the late postoperative period (after one year). **Why 'Accelerated Graft Arteriosclerosis' is correct:** Also known as **Cardiac Allograft Vasculopathy (CAV)**, this is a unique, progressive form of chronic rejection. Unlike typical atherosclerosis, CAV is characterized by diffuse, concentric intimal proliferation affecting the entire length of the coronary arteries. It remains the leading cause of late mortality (after 1 year) because the denervated heart does not experience typical angina, often leading to silent myocardial infarction, heart failure, or sudden death. **Why the other options are incorrect:** * **Infection:** This is the **most common cause of death within the first year** (specifically the first 30 days to 6 months) due to intense induction immunosuppression. * **Acute Rejection:** This typically occurs within the first 3–6 months. While it remains a risk, its incidence decreases significantly after the first year due to maintenance therapy. * **Arrhythmia:** While arrhythmias can occur due to surgical trauma or acute rejection in the early phase, they are rarely the primary cause of late-term mortality unless secondary to CAV. **High-Yield Clinical Pearls for NEET-PG:** 1. **Most common cause of death ( 1 year):** Cardiac Allograft Vasculopathy (CAV) / Graft Arteriosclerosis. 3. **Gold Standard for CAV diagnosis:** Annual coronary angiography with **Intravascular Ultrasound (IVUS)**, as angiography alone may underestimate the diffuse narrowing. 4. **Malignancy:** The risk of lymphomas (PTLD) and skin cancers increases significantly in the late phase due to long-term immunosuppression.

Q: Which of the following should be avoided in the long-term follow-up of a renal transplant recipient on ciclosporin?

All of the above. In renal transplant recipients on long-term immunosuppression with Ciclosporin, management focuses on preventing graft rejection, avoiding nephrotoxicity, and managing drug-drug interactions. **Explanation of Options:** * **A. Live Vaccines:** Immunosuppressed patients (on Ciclosporin, Tacrolimus, or Mycophenolate) have a diminished immune response. Administering live-attenuated vaccines (e.g., BCG, MMR, Yellow Fever) carries a significant risk of causing disseminated infection from the vaccine strain itself. * **B. Cytochrome P450 (CYP3A4) Inhibitors:** Ciclosporin is extensively metabolized by the hepatic CYP3A4 enzyme system. Drugs that inhibit this system (e.g., Erythromycin, Ketoconazole, Diltiazem) decrease Ciclosporin metabolism, leading to toxic blood levels. Conversely, CYP inducers (e.g., Rifampicin, Phenytoin) lower levels, risking graft rejection. * **C. NSAIDs:** Ciclosporin causes vasoconstriction of the afferent arterioles, reducing renal blood flow. NSAIDs inhibit prostaglandins, which are necessary to maintain afferent arteriolar vasodilation. Combining the two leads to synergistic pre-renal vasoconstriction and acute-on-chronic nephrotoxicity. **Clinical Pearls for NEET-PG:** * **Gingival Hyperplasia:** A classic side effect of Ciclosporin (also seen with Phenytoin and Nifedipine). * **Monitoring:** Therapeutic Drug Monitoring (TDM) is essential for Ciclosporin due to its narrow therapeutic index. * **Metabolic Profile:** Ciclosporin is associated with "H" side effects: **H**ypertension, **H**yperlipidemia, **H**yperglycemia, **H**irsutism, and **H**yperkalemia. * **Tacrolimus vs. Ciclosporin:** Tacrolimus is more potent and lacks hirsutism/gingival hyperplasia but has a higher incidence of New-Onset Diabetes After Transplantation (NODAT).

Q: Which type of transplant has the lowest chance of recipient failure?

Isograft. **Explanation:** The success of a transplant is primarily determined by the **Major Histocompatibility Complex (MHC)** or Human Leukocyte Antigen (HLA) compatibility between the donor and the recipient. **Why Isograft is correct:** An **Isograft** (also known as a syngeneic graft) is a transplant between genetically identical individuals, such as **monozygotic (identical) twins**. Because the donor and recipient share identical genetic material and HLA antigens, the recipient’s immune system recognizes the graft as "self." This results in a negligible risk of rejection, requiring little to no immunosuppression, and thus carries the lowest chance of failure. **Analysis of Incorrect Options:** * **Allograft:** This is a transplant between genetically different members of the same species (e.g., human to human). This is the most common clinical transplant type but carries a significant risk of rejection due to HLA mismatch. * **Xenograft:** This involves a transplant between different species (e.g., porcine heart valve to human). These carry the highest risk of hyperacute rejection due to pre-existing antibodies and significant genetic disparity. * **Heterotopic graft:** This refers to the **anatomical position** of the graft (placed in a different site than the original organ, like a kidney transplant in the iliac fossa) rather than the genetic relationship. It does not inherently determine the immunological failure rate. **High-Yield Clinical Pearls for NEET-PG:** * **Autograft:** Transplant within the same individual (e.g., skin graft, CABG). This has zero rejection risk and is technically the most successful, but among the options provided (comparing donor types), Isograft is the standard answer for "lowest failure." * **Hyperacute Rejection:** Occurs within minutes/hours; mediated by pre-formed Type II hypersensitivity antibodies. * **Order of Rejection Risk:** Autograft/Isograft < Allograft < Xenograft.

Q: Which of the following is considered an extended criteria donor for kidney transplantation?

All of the above. ### Explanation In kidney transplantation, an **Extended Criteria Donor (ECD)** refers to a deceased donor whose kidneys carry a higher risk of graft failure compared to "Standard Criteria Donors" (SCD). The definition was established to expand the donor pool while acknowledging that these organs have a 70% higher risk of graft loss. **The Criteria for ECD:** A donor is classified as ECD if they meet either of the following: 1. **Age ≥ 60 years.** 2. **Age 50–59 years** plus at least **two** of the following: * History of **Hypertension**. * Terminal serum **Creatinine > 1.5 mg/dL**. * Cause of death was a **Cerebrovascular Accident (CVA)**. **Analysis of Options:** * **Option A (Extreme Age):** Donors over 60 are automatically ECD due to age-related nephrosclerosis and reduced functional reserve. * **Option B (Hypertension):** Chronic hypertension causes vascular changes in the kidney, increasing the risk of delayed graft function. * **Option C (CVA):** Death by CVA often indicates underlying systemic vascular disease, which correlates with poorer long-term graft outcomes. Since all three factors are core components of the ECD definition, **Option D** is the correct answer. ### High-Yield Pearls for NEET-PG: * **Standard Criteria Donor (SCD):** A brain-dead donor under 50 years of age who does not meet ECD criteria. * **DCD (Donation after Circulatory Death):** These are donors who do not meet brain death criteria but have a non-survivable injury; they are distinct from ECD but also carry higher risks of primary non-function. * **Outcome:** While ECD kidneys have lower 5-year survival rates than SCD kidneys, they offer a significant survival advantage over remaining on long-term dialysis. * **Cold Ischemia Time:** For ECD kidneys, it is critical to keep cold ischemia time **< 12–15 hours** to minimize further damage.

Q: What type of graft is a graft from a sister to a brother?

Allograft. ### Explanation The correct answer is **Allograft (Option B)**. **1. Why Allograft is correct:** An **allograft** (or homograft) is a transplant between two genetically non-identical members of the same species. Since a brother and sister share approximately 50% of their genetic material (unless they are monozygotic twins), they are genetically distinct individuals. Therefore, any organ or tissue transfer between them is classified as an allograft. This requires immunosuppression to prevent T-cell mediated rejection. **2. Why other options are incorrect:** * **Isograft (Option A):** This is a graft between genetically identical individuals. In humans, this only occurs between **monozygotic (identical) twins**. Since the question specifies a brother and sister (who are dizygotic/siblings), they cannot be genetically identical. * **Autograft (Option C):** This involves a graft taken from one part of a patient's body and transferred to another part of the **same individual** (e.g., a skin graft from the thigh to the arm or a CABG using the radial artery). There is no risk of rejection. * **Heterograft (Option D):** Also known as a **Xenograft**, this is a transplant between members of **different species** (e.g., a porcine/pig heart valve transplanted into a human). **3. Clinical Pearls for NEET-PG:** * **Hyperacute Rejection:** Occurs within minutes to hours due to pre-formed antibodies (Type II Hypersensitivity). * **Acute Rejection:** Occurs within days to weeks; primarily T-cell mediated (Type IV Hypersensitivity). * **Chronic Rejection:** Occurs months to years later; characterized by fibrosis and vascular occlusion. * **Order of Immunogenicity:** Xenograft > Allograft > Isograft = Autograft. * **Graft-versus-Host Disease (GVHD):** Most common in bone marrow transplants where donor T-cells attack the recipient's tissues.

Q: Grafting done between genetically different individuals of the same species is termed as?

Allograft. **Explanation:** The classification of grafts is based on the genetic relationship between the donor and the recipient. **1. Why Allograft is correct:** An **Allograft** (also known as a homograft) refers to the transfer of tissue or organs between **genetically non-identical members of the same species** (e.g., human to human). This is the most common type of clinical transplant (e.g., a kidney transplant from a deceased donor). Because the MHC (Major Histocompatibility Complex) molecules differ, these grafts require immunosuppression to prevent rejection. **2. Analysis of Incorrect Options:** * **Autograft:** Tissue is transferred from one site to another on the **same individual** (e.g., Split-thickness skin graft or GSV harvest for CABG). There is no risk of rejection. * **Isograft (Syngeneic graft):** Grafting between **genetically identical individuals** of the same species, such as monozygotic (identical) twins. Like autografts, these do not trigger an immune response. * **Xenograft:** Tissue transfer between **different species** (e.g., porcine/pig heart valve used in a human). These carry the highest risk of hyperacute rejection. **High-Yield Clinical Pearls for NEET-PG:** * **Orthotopic Graft:** Placed in the normal anatomical position (e.g., Liver transplant). * **Heterotopic Graft:** Placed in a different anatomical location (e.g., Kidney transplant into the iliac fossa). * **Order of Immunogenicity:** Xenograft > Allograft > Isograft/Autograft. * **Split-thickness skin grafts (STSG)** are autografts that survive initially by *plasmatic imbibition* (first 24-48 hours), followed by *inosculation* and *neovascularization*.

Q: Following liver transplantation, recurrence of the primary disease in the liver most likely occurs in which of the following conditions?

Autoimmune hepatitis. **Explanation:** The recurrence of the primary disease post-liver transplantation depends on whether the underlying pathology is systemic (immunological or viral) or a localized genetic defect within the hepatocytes. **Why Autoimmune Hepatitis (AIH) is correct:** AIH is a systemic immune-mediated disorder. Even after the native liver is replaced, the recipient’s immune system remains predisposed to attacking liver tissue. Recurrence of AIH occurs in approximately **20–30%** of patients. Among the options provided, AIH (along with Hepatitis C and Primary Sclerosing Cholangitis) has a significantly higher clinical recurrence rate compared to metabolic disorders. **Analysis of Incorrect Options:** * **Wilson’s Disease (A) & Alpha-1 Antitrypsin Deficiency (C):** These are metabolic/genetic defects localized to the liver. Since the donor liver possesses the correct genetic machinery (normal ATP7B protein or normal alpha-1 antitrypsin production), the disease is effectively **cured** by the transplant. Recurrence is biologically impossible unless the donor also had the genetic trait. * **Primary Biliary Cirrhosis (D):** While PBC can recur (now termed Primary Biliary Cholangitis), the recurrence is often histological and slow-progressing. In the context of competitive exams, AIH is considered to have a more aggressive and likely clinical recurrence pattern. **High-Yield Clinical Pearls for NEET-PG:** * **Highest Recurrence:** Hepatitis C (almost 100% histological recurrence if viremic at the time of transplant). * **Zero Recurrence:** Wilson’s disease, Alpha-1 antitrypsin deficiency, and Budd-Chiari syndrome (if anticoagulated). * **Hepatocellular Carcinoma (HCC):** Recurrence depends on the **Milan Criteria** (Single lesion ≤5cm or up to 3 lesions ≤3cm). * **De Novo AIH:** Occasionally, patients transplanted for non-AIH reasons develop "De Novo" autoimmune hepatitis post-transplant.

Q: A parathyroid gland is implanted into the forearm muscle. What type of transplantation is this?

Heterotopic. ### Explanation The correct answer is **Heterotopic** transplantation. **1. Why Heterotopic is Correct:** In transplant surgery, the classification is based on the anatomical site of implantation. **Heterotopic transplantation** occurs when a tissue or organ is implanted into an anatomical location different from its original physiological position. * **Clinical Context:** In patients undergoing total parathyroidectomy (e.g., for secondary hyperparathyroidism), a portion of the parathyroid gland is often autotransplanted into the **brachioradialis muscle** of the forearm. This allows the gland to maintain endocrine function while being easily accessible for monitoring or partial resection if recurrence occurs. **2. Why Other Options are Incorrect:** * **Orthotopic (Option A):** This refers to placing the graft in its **normal anatomical position** after removing the diseased organ. A classic example is a Liver Transplant, where the donor liver replaces the recipient's liver in the right upper quadrant. * **Auxiliary (Option C):** This is a subtype of heterotopic transplant where the graft is placed in a different location **without removing the recipient's native organ**. The graft "assists" the failing organ. An example is an auxiliary liver transplant placed in the infra-mesocolic space. **3. High-Yield Clinical Pearls for NEET-PG:** * **Autograft:** Transfer of tissue within the same individual (e.g., the parathyroid forearm transplant mentioned above). * **Allograft:** Transfer between genetically different members of the same species (most cadaveric organ transplants). * **Isograft (Syngeneic):** Transfer between genetically identical individuals (monozygotic twins). * **Xenograft:** Transfer between different species (e.g., porcine heart valve). * **Renal Transplant:** Most kidney transplants are **Heterotopic** (placed in the iliac fossa), not orthotopic.

Transplant Surgery Indian Medical PG Practice Questions and MCQs

Question 1: After the first postoperative year of cardiac transplantation, what is the most common cause of death?

A. Infection
B. Arrhythmia
C. Accelerated graft arteriosclerosis (Correct Answer)
D. Acute rejection episode

Explanation: **Explanation:** The survival of cardiac transplant recipients is divided into two distinct phases: the early postoperative period (within the first year) and the late postoperative period (after one year). **Why 'Accelerated Graft Arteriosclerosis' is correct:** Also known as **Cardiac Allograft Vasculopathy (CAV)**, this is a unique, progressive form of chronic rejection. Unlike typical atherosclerosis, CAV is characterized by diffuse, concentric intimal proliferation affecting the entire length of the coronary arteries. It remains the leading cause of late mortality (after 1 year) because the denervated heart does not experience typical angina, often leading to silent myocardial infarction, heart failure, or sudden death. **Why the other options are incorrect:** * **Infection:** This is the **most common cause of death within the first year** (specifically the first 30 days to 6 months) due to intense induction immunosuppression. * **Acute Rejection:** This typically occurs within the first 3–6 months. While it remains a risk, its incidence decreases significantly after the first year due to maintenance therapy. * **Arrhythmia:** While arrhythmias can occur due to surgical trauma or acute rejection in the early phase, they are rarely the primary cause of late-term mortality unless secondary to CAV. **High-Yield Clinical Pearls for NEET-PG:** 1. **Most common cause of death (<1 year):** Infection. 2. **Most common cause of death (>1 year):** Cardiac Allograft Vasculopathy (CAV) / Graft Arteriosclerosis. 3. **Gold Standard for CAV diagnosis:** Annual coronary angiography with **Intravascular Ultrasound (IVUS)**, as angiography alone may underestimate the diffuse narrowing. 4. **Malignancy:** The risk of lymphomas (PTLD) and skin cancers increases significantly in the late phase due to long-term immunosuppression.

Question 2: Infection in a renal transplant patient is usually caused by which pathogen?

A. Cytomegalovirus (CMV) (Correct Answer)
B. Human Immunodeficiency Virus (HIV)
C. Herpes Simplex Virus (HSV)
D. Salmonella

Explanation: **Explanation:** **Cytomegalovirus (CMV)** is the most common clinically significant opportunistic viral pathogen in renal transplant recipients. It typically manifests between **1 to 6 months post-transplant**, coinciding with the period of maximal immunosuppression. The infection occurs due to primary infection (seronegative recipient receiving a seropositive organ), reactivation of latent virus, or superinfection. CMV is high-yield because it not only causes systemic symptoms (fever, leukopenia) and organ-specific disease (pneumonitis, hepatitis, colitis) but also acts as an immunomodulator, increasing the risk of graft rejection and other opportunistic infections. **Analysis of Incorrect Options:** * **HIV (Option B):** While HIV is a significant viral pathogen, it is not a common "post-transplant infection." In fact, HIV-positive status was previously a contraindication to transplant, though "HIV-to-HIV" transplants are now performed in specific protocols. * **HSV (Option C):** Herpes Simplex Virus can cause mucocutaneous lesions in the early post-operative period, but its incidence has significantly decreased due to routine prophylactic use of Acyclovir/Valacyclovir. It is less common and less severe than CMV. * **Salmonella (Option D):** While transplant patients are at higher risk for intracellular bacterial infections like Salmonella, it is far less frequent than viral pathogens like CMV. **High-Yield Clinical Pearls for NEET-PG:** * **Timeline of Infection:** * *<1 month:* Bacterial infections (UTI, wound infection) and donor-derived infections. * *1–6 months:* **CMV (Peak incidence)**, BK virus, and opportunistic infections (PJP). * *6+ months:* Community-acquired pneumonia or chronic viral infections (HCV, HBV). * **Diagnosis:** Quantitative PCR for CMV DNA is the gold standard. * **Treatment:** Intravenous **Ganciclovir** or oral Valganciclovir. * **Prophylaxis:** Most centers use Valganciclovir for 3–6 months post-transplant to prevent CMV.

Question 3: Which of the following should be avoided in the long-term follow-up of a renal transplant recipient on ciclosporin?

A. Administer live vaccines
B. Prescribe drugs that inhibit cytochrome P450 activity
C. Prescribe NSAIDs
D. All of the above (Correct Answer)

Explanation: In renal transplant recipients on long-term immunosuppression with Ciclosporin, management focuses on preventing graft rejection, avoiding nephrotoxicity, and managing drug-drug interactions. **Explanation of Options:** * **A. Live Vaccines:** Immunosuppressed patients (on Ciclosporin, Tacrolimus, or Mycophenolate) have a diminished immune response. Administering live-attenuated vaccines (e.g., BCG, MMR, Yellow Fever) carries a significant risk of causing disseminated infection from the vaccine strain itself. * **B. Cytochrome P450 (CYP3A4) Inhibitors:** Ciclosporin is extensively metabolized by the hepatic CYP3A4 enzyme system. Drugs that inhibit this system (e.g., Erythromycin, Ketoconazole, Diltiazem) decrease Ciclosporin metabolism, leading to toxic blood levels. Conversely, CYP inducers (e.g., Rifampicin, Phenytoin) lower levels, risking graft rejection. * **C. NSAIDs:** Ciclosporin causes vasoconstriction of the afferent arterioles, reducing renal blood flow. NSAIDs inhibit prostaglandins, which are necessary to maintain afferent arteriolar vasodilation. Combining the two leads to synergistic pre-renal vasoconstriction and acute-on-chronic nephrotoxicity. **Clinical Pearls for NEET-PG:** * **Gingival Hyperplasia:** A classic side effect of Ciclosporin (also seen with Phenytoin and Nifedipine). * **Monitoring:** Therapeutic Drug Monitoring (TDM) is essential for Ciclosporin due to its narrow therapeutic index. * **Metabolic Profile:** Ciclosporin is associated with "H" side effects: **H**ypertension, **H**yperlipidemia, **H**yperglycemia, **H**irsutism, and **H**yperkalemia. * **Tacrolimus vs. Ciclosporin:** Tacrolimus is more potent and lacks hirsutism/gingival hyperplasia but has a higher incidence of New-Onset Diabetes After Transplantation (NODAT).

Question 4: Which type of transplant has the lowest chance of recipient failure?

A. Allograft
B. Isograft (Correct Answer)
C. Xenograft
D. Heterotropic graft

Explanation: **Explanation:** The success of a transplant is primarily determined by the **Major Histocompatibility Complex (MHC)** or Human Leukocyte Antigen (HLA) compatibility between the donor and the recipient. **Why Isograft is correct:** An **Isograft** (also known as a syngeneic graft) is a transplant between genetically identical individuals, such as **monozygotic (identical) twins**. Because the donor and recipient share identical genetic material and HLA antigens, the recipient’s immune system recognizes the graft as "self." This results in a negligible risk of rejection, requiring little to no immunosuppression, and thus carries the lowest chance of failure. **Analysis of Incorrect Options:** * **Allograft:** This is a transplant between genetically different members of the same species (e.g., human to human). This is the most common clinical transplant type but carries a significant risk of rejection due to HLA mismatch. * **Xenograft:** This involves a transplant between different species (e.g., porcine heart valve to human). These carry the highest risk of hyperacute rejection due to pre-existing antibodies and significant genetic disparity. * **Heterotopic graft:** This refers to the **anatomical position** of the graft (placed in a different site than the original organ, like a kidney transplant in the iliac fossa) rather than the genetic relationship. It does not inherently determine the immunological failure rate. **High-Yield Clinical Pearls for NEET-PG:** * **Autograft:** Transplant within the same individual (e.g., skin graft, CABG). This has zero rejection risk and is technically the most successful, but among the options provided (comparing donor types), Isograft is the standard answer for "lowest failure." * **Hyperacute Rejection:** Occurs within minutes/hours; mediated by pre-formed Type II hypersensitivity antibodies. * **Order of Rejection Risk:** Autograft/Isograft < Allograft < Xenograft.

Question 5: Which of the following is considered an extended criteria donor for kidney transplantation?

A. Donor of extreme age
B. Donor with hypertension
C. Donor with cerebrovascular accident (CVA)
D. All of the above (Correct Answer)

Explanation: ### Explanation In kidney transplantation, an **Extended Criteria Donor (ECD)** refers to a deceased donor whose kidneys carry a higher risk of graft failure compared to "Standard Criteria Donors" (SCD). The definition was established to expand the donor pool while acknowledging that these organs have a 70% higher risk of graft loss. **The Criteria for ECD:** A donor is classified as ECD if they meet either of the following: 1. **Age ≥ 60 years.** 2. **Age 50–59 years** plus at least **two** of the following: * History of **Hypertension**. * Terminal serum **Creatinine > 1.5 mg/dL**. * Cause of death was a **Cerebrovascular Accident (CVA)**. **Analysis of Options:** * **Option A (Extreme Age):** Donors over 60 are automatically ECD due to age-related nephrosclerosis and reduced functional reserve. * **Option B (Hypertension):** Chronic hypertension causes vascular changes in the kidney, increasing the risk of delayed graft function. * **Option C (CVA):** Death by CVA often indicates underlying systemic vascular disease, which correlates with poorer long-term graft outcomes. Since all three factors are core components of the ECD definition, **Option D** is the correct answer. ### High-Yield Pearls for NEET-PG: * **Standard Criteria Donor (SCD):** A brain-dead donor under 50 years of age who does not meet ECD criteria. * **DCD (Donation after Circulatory Death):** These are donors who do not meet brain death criteria but have a non-survivable injury; they are distinct from ECD but also carry higher risks of primary non-function. * **Outcome:** While ECD kidneys have lower 5-year survival rates than SCD kidneys, they offer a significant survival advantage over remaining on long-term dialysis. * **Cold Ischemia Time:** For ECD kidneys, it is critical to keep cold ischemia time **< 12–15 hours** to minimize further damage.

Question 6: What type of graft is a graft from a sister to a brother?

A. Isograft
B. Allograft (Correct Answer)
C. Autograft
D. Heterograft

Explanation: ### Explanation The correct answer is **Allograft (Option B)**. **1. Why Allograft is correct:** An **allograft** (or homograft) is a transplant between two genetically non-identical members of the same species. Since a brother and sister share approximately 50% of their genetic material (unless they are monozygotic twins), they are genetically distinct individuals. Therefore, any organ or tissue transfer between them is classified as an allograft. This requires immunosuppression to prevent T-cell mediated rejection. **2. Why other options are incorrect:** * **Isograft (Option A):** This is a graft between genetically identical individuals. In humans, this only occurs between **monozygotic (identical) twins**. Since the question specifies a brother and sister (who are dizygotic/siblings), they cannot be genetically identical. * **Autograft (Option C):** This involves a graft taken from one part of a patient's body and transferred to another part of the **same individual** (e.g., a skin graft from the thigh to the arm or a CABG using the radial artery). There is no risk of rejection. * **Heterograft (Option D):** Also known as a **Xenograft**, this is a transplant between members of **different species** (e.g., a porcine/pig heart valve transplanted into a human). **3. Clinical Pearls for NEET-PG:** * **Hyperacute Rejection:** Occurs within minutes to hours due to pre-formed antibodies (Type II Hypersensitivity). * **Acute Rejection:** Occurs within days to weeks; primarily T-cell mediated (Type IV Hypersensitivity). * **Chronic Rejection:** Occurs months to years later; characterized by fibrosis and vascular occlusion. * **Order of Immunogenicity:** Xenograft > Allograft > Isograft = Autograft. * **Graft-versus-Host Disease (GVHD):** Most common in bone marrow transplants where donor T-cells attack the recipient's tissues.

Question 7: Grafting done between genetically different individuals of the same species is termed as?

A. Autograft
B. Allograft (Correct Answer)
C. Isograft
D. Xenograft

Explanation: **Explanation:** The classification of grafts is based on the genetic relationship between the donor and the recipient. **1. Why Allograft is correct:** An **Allograft** (also known as a homograft) refers to the transfer of tissue or organs between **genetically non-identical members of the same species** (e.g., human to human). This is the most common type of clinical transplant (e.g., a kidney transplant from a deceased donor). Because the MHC (Major Histocompatibility Complex) molecules differ, these grafts require immunosuppression to prevent rejection. **2. Analysis of Incorrect Options:** * **Autograft:** Tissue is transferred from one site to another on the **same individual** (e.g., Split-thickness skin graft or GSV harvest for CABG). There is no risk of rejection. * **Isograft (Syngeneic graft):** Grafting between **genetically identical individuals** of the same species, such as monozygotic (identical) twins. Like autografts, these do not trigger an immune response. * **Xenograft:** Tissue transfer between **different species** (e.g., porcine/pig heart valve used in a human). These carry the highest risk of hyperacute rejection. **High-Yield Clinical Pearls for NEET-PG:** * **Orthotopic Graft:** Placed in the normal anatomical position (e.g., Liver transplant). * **Heterotopic Graft:** Placed in a different anatomical location (e.g., Kidney transplant into the iliac fossa). * **Order of Immunogenicity:** Xenograft > Allograft > Isograft/Autograft. * **Split-thickness skin grafts (STSG)** are autografts that survive initially by *plasmatic imbibition* (first 24-48 hours), followed by *inosculation* and *neovascularization*.

Question 8: Following liver transplantation, recurrence of the primary disease in the liver most likely occurs in which of the following conditions?

A. Wilson's disease
B. Autoimmune hepatitis (Correct Answer)
C. Alpha-1 antitrypsin deficiency
D. Primary biliary cirrhosis

Explanation: **Explanation:** The recurrence of the primary disease post-liver transplantation depends on whether the underlying pathology is systemic (immunological or viral) or a localized genetic defect within the hepatocytes. **Why Autoimmune Hepatitis (AIH) is correct:** AIH is a systemic immune-mediated disorder. Even after the native liver is replaced, the recipient’s immune system remains predisposed to attacking liver tissue. Recurrence of AIH occurs in approximately **20–30%** of patients. Among the options provided, AIH (along with Hepatitis C and Primary Sclerosing Cholangitis) has a significantly higher clinical recurrence rate compared to metabolic disorders. **Analysis of Incorrect Options:** * **Wilson’s Disease (A) & Alpha-1 Antitrypsin Deficiency (C):** These are metabolic/genetic defects localized to the liver. Since the donor liver possesses the correct genetic machinery (normal ATP7B protein or normal alpha-1 antitrypsin production), the disease is effectively **cured** by the transplant. Recurrence is biologically impossible unless the donor also had the genetic trait. * **Primary Biliary Cirrhosis (D):** While PBC can recur (now termed Primary Biliary Cholangitis), the recurrence is often histological and slow-progressing. In the context of competitive exams, AIH is considered to have a more aggressive and likely clinical recurrence pattern. **High-Yield Clinical Pearls for NEET-PG:** * **Highest Recurrence:** Hepatitis C (almost 100% histological recurrence if viremic at the time of transplant). * **Zero Recurrence:** Wilson’s disease, Alpha-1 antitrypsin deficiency, and Budd-Chiari syndrome (if anticoagulated). * **Hepatocellular Carcinoma (HCC):** Recurrence depends on the **Milan Criteria** (Single lesion ≤5cm or up to 3 lesions ≤3cm). * **De Novo AIH:** Occasionally, patients transplanted for non-AIH reasons develop "De Novo" autoimmune hepatitis post-transplant.

Question 9: Compared to early immunosuppressive drugs such as azathioprine, steroids, and anti-lymphocyte serum, what specific advantages do newer immunosuppressive agents offer?

A. Cyclosporine interferes with lymphokine production and has neither bone marrow nor renal toxicity.
B. Monoclonal antibody (OKT3) is more available, more specific, and has fewer side effects than anti-lymphocyte serum.
C. Tacrolimus (FK506) shares properties with cyclosporine but is particularly useful for rescuing grafts failing under cyclosporine therapy. (Correct Answer)
D. None of the above.

Explanation: This question tests your knowledge of the evolution of immunosuppressive therapy in transplant surgery, specifically the transition from non-specific agents to targeted calcineurin inhibitors (CNIs). ### **Explanation of the Correct Option** **Option C** is correct because **Tacrolimus (FK506)** and Cyclosporine are both calcineurin inhibitors that inhibit IL-2 production. However, Tacrolimus is significantly more potent (10–100 times). Clinically, Tacrolimus is the preferred agent for **"rescue therapy"** in patients experiencing refractory acute rejection while on Cyclosporine-based regimens. It has superior efficacy in preventing and treating rejection episodes in kidney and liver transplants. ### **Analysis of Incorrect Options** * **Option A:** While Cyclosporine does interfere with lymphokine (IL-2) production and lacks significant bone marrow toxicity (unlike Azathioprine), it is notoriously **nephrotoxic**. Renal toxicity is its most significant dose-limiting side effect. * **Option B:** While **OKT3** (a murine monoclonal antibody against CD3) is more specific than polyclonal anti-lymphocyte serum (ALS), it is associated with severe side effects, most notably **Cytokine Release Syndrome (CRS)**. Furthermore, OKT3 has largely been phased out in modern practice due to the development of safer monoclonal antibodies like Basiliximab. ### **High-Yield NEET-PG Pearls** * **Mechanism of Action:** Both Tacrolimus and Cyclosporine inhibit **Calcineurin**, preventing the dephosphorylation of **NFAT** (Nuclear Factor of Activated T-cells), which stops IL-2 transcription. * **Binding Proteins:** Cyclosporine binds to **Cyclophilin**; Tacrolimus binds to **FK-binding protein (FKBP-12)**. * **Side Effect Profile:** * **Cyclosporine:** Gingival hyperplasia, hirsutism, and hyperlipidemia. * **Tacrolimus:** Post-transplant diabetes mellitus (PTDM/NODAT) and more significant neurotoxicity (tremors). * **Drug of Choice:** Tacrolimus is currently the mainstay of maintenance immunosuppression in most solid organ transplants.

Question 10: A parathyroid gland is implanted into the forearm muscle. What type of transplantation is this?

A. Orthotopic
B. Heterotopic (Correct Answer)
C. Auxiliary
D. None of the above

Explanation: ### Explanation The correct answer is **Heterotopic** transplantation. **1. Why Heterotopic is Correct:** In transplant surgery, the classification is based on the anatomical site of implantation. **Heterotopic transplantation** occurs when a tissue or organ is implanted into an anatomical location different from its original physiological position. * **Clinical Context:** In patients undergoing total parathyroidectomy (e.g., for secondary hyperparathyroidism), a portion of the parathyroid gland is often autotransplanted into the **brachioradialis muscle** of the forearm. This allows the gland to maintain endocrine function while being easily accessible for monitoring or partial resection if recurrence occurs. **2. Why Other Options are Incorrect:** * **Orthotopic (Option A):** This refers to placing the graft in its **normal anatomical position** after removing the diseased organ. A classic example is a Liver Transplant, where the donor liver replaces the recipient's liver in the right upper quadrant. * **Auxiliary (Option C):** This is a subtype of heterotopic transplant where the graft is placed in a different location **without removing the recipient's native organ**. The graft "assists" the failing organ. An example is an auxiliary liver transplant placed in the infra-mesocolic space. **3. High-Yield Clinical Pearls for NEET-PG:** * **Autograft:** Transfer of tissue within the same individual (e.g., the parathyroid forearm transplant mentioned above). * **Allograft:** Transfer between genetically different members of the same species (most cadaveric organ transplants). * **Isograft (Syngeneic):** Transfer between genetically identical individuals (monozygotic twins). * **Xenograft:** Transfer between different species (e.g., porcine heart valve). * **Renal Transplant:** Most kidney transplants are **Heterotopic** (placed in the iliac fossa), not orthotopic.

Question 11: Which of the following is not a component of the University of Wisconsin solution?

A. Adenosine
B. Glutathione
C. Allopurinol
D. Potassium citrate (Correct Answer)

Explanation: The **University of Wisconsin (UW) solution** is the "gold standard" for cold storage of intra-abdominal organs (liver, pancreas, and kidney). Its primary goal is to minimize cell swelling and prevent oxidative damage during ischemia. ### Why Potassium Citrate is the Correct Answer The UW solution is an **intracellular-type** solution, meaning it contains high concentrations of potassium and low concentrations of sodium to mimic the intracellular environment. However, the potassium source in UW solution is **Potassium Lactobionate**, not Potassium citrate. Potassium citrate is typically used in cardioplegic solutions (like St. Thomas solution) to induce cardiac arrest, but it is not a component of the UW formula. ### Explanation of Incorrect Options * **Adenosine (Option A):** Included as a precursor for ATP synthesis, helping the organ regain energy stores once reperfused. * **Glutathione (Option B):** Acts as a potent antioxidant to reduce oxidative stress and neutralize free radicals during the reperfusion phase. * **Allopurinol (Option C):** A xanthine oxidase inhibitor that prevents the formation of reactive oxygen species (ROS), protecting the graft from reperfusion injury. ### High-Yield Clinical Pearls for NEET-PG * **Key Components of UW Solution:** Lactobionate and Raffinose (prevent osmotic swelling), Hydroxyethyl starch (HES - prevents interstitial edema), and Magnesium sulfate. * **Mechanism:** It works by preventing the "sodium-potassium pump" failure that occurs during cold ischemia. * **Storage Time:** It allows for liver preservation for up to 12–18 hours and kidney preservation for up to 48–72 hours. * **Note:** Because of its high potassium content (120 mEq/L), the solution must be thoroughly flushed out of the organ before anastomosis to prevent **systemic hyperkalemia** and cardiac arrest in the recipient.

Question 12: Which immunosuppressive drug is commonly given after renal transplantation?

A. Cyclophosphamide
B. Corticosteroids (Correct Answer)
C. Interferon
D. All of the above

Explanation: **Explanation:** In renal transplantation, the primary goal of immunosuppression is to prevent graft rejection while minimizing systemic toxicity. **Corticosteroids** (such as Prednisolone) are a cornerstone of post-transplant maintenance therapy. They act by inhibiting the expression of multiple inflammatory cytokines (like IL-1, IL-2, and TNF-alpha) and suppressing T-cell activation. Most transplant protocols utilize a "triple drug regimen" consisting of a Calcineurin Inhibitor (e.g., Tacrolimus), an Antiproliferative agent (e.g., Mycophenolate Mofetil), and **Corticosteroids**. **Analysis of Options:** * **A. Cyclophosphamide:** While an immunosuppressant, it is primarily used in chemotherapy or for specific autoimmune conditions (like Wegener’s granulomatosis). It is rarely used in routine transplant maintenance due to its significant toxicity profile (e.g., hemorrhagic cystitis). * **C. Interferon:** This is an immunomodulator, not an immunosuppressant. In fact, interferons *stimulate* the immune system to fight viruses or tumors and could potentially trigger graft rejection if administered post-transplant. * **D. All of the above:** Incorrect, as only corticosteroids are standard post-transplant therapy among the choices. **High-Yield Clinical Pearls for NEET-PG:** * **Standard Triple Therapy:** Tacrolimus + Mycophenolate Mofetil (MMF) + Prednisolone. * **Drug of Choice for Induction:** Basiliximab (IL-2 receptor antagonist) or Antithymocyte Globulin (ATG). * **Side Effects of Steroids:** Hyperglycemia (Post-Transplant Diabetes Mellitus), osteoporosis, peptic ulcers, and impaired wound healing. * **Tacrolimus vs. Cyclosporine:** Tacrolimus is generally preferred due to a lower incidence of rejection and fewer cosmetic side effects (like gingival hyperplasia or hirsutism).

Question 13: What is the common site for islet cell transplantation in patients with diabetes mellitus?

A. Forearm muscles
B. Pelvis
C. Thigh
D. Injected into the portal vein (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Injected into the portal vein.** In islet cell transplantation, the goal is to deliver insulin-producing beta cells into a highly vascularized environment that allows for rapid engraftment and glucose sensing. The **portal vein** is the preferred site because it allows the islets to lodge in the **liver sinusoids**. This site is physiologically advantageous as it mimics the natural portal circulation, where insulin is secreted directly into the liver—the primary organ for glucose metabolism. The procedure is typically performed via percutaneous transhepatic catheterization under radiologic guidance. **Why other options are incorrect:** * **A. Forearm muscles:** While the forearm is a common site for **parathyroid autotransplantation**, it lacks the specific microenvironment and portal-venous drainage required for optimal islet cell function and metabolic regulation. * **B. Pelvis:** This is the standard anatomical site for **whole-organ kidney or pancreas transplantation** (specifically the iliac fossa), but it is not used for cellular islet infusion. * **C. Thigh:** Similar to the forearm, the intramuscular environment of the thigh does not provide the necessary vascular architecture or physiological feedback loops for islet survival. **Clinical Pearls for NEET-PG:** * **The Edmonton Protocol:** The landmark protocol for islet transplantation involving corticosteroid-free immunosuppression. * **Source:** Islets are isolated from a cadaveric donor pancreas using **Collagenase** digestion. * **Complications:** The most common immediate complication of portal vein infusion is **portal vein thrombosis** or transient elevation of liver enzymes. * **Success Metric:** The primary goal is achieving "insulin independence," though many patients eventually require supplemental insulin over time.

Question 14: Who performed the first autologous renal transplantation?

A. Higgins
B. Studor
C. Kavosis
D. Hardy (Correct Answer)

Explanation: **Explanation:** **1. Why the Correct Answer is Right:** The first **autologous renal transplantation** (autotransplantation) was performed by **James D. Hardy** in **1963**. In this procedure, the patient’s own kidney is removed and reimplanted into a different site (usually the iliac fossa) within the same individual. Hardy performed this to treat a patient with a high ureteral injury where primary repair was not feasible. James D. Hardy is a monumental figure in transplant history, also credited with performing the first human lung transplant (1963) and the first heart transplant (xenotransplant using a chimpanzee heart) in 1964. **2. Analysis of Incorrect Options:** * **Higgins (A):** While associated with urological surgery, Higgins is not credited with the first autotransplant. * **Studor (B):** Known for the **Studer Pouch**, an orthotopic urinary ileal neobladder construction following cystectomy. * **Kavosis (C):** Louis Kavoussi is a pioneer in **laparoscopic urology** and performed the first laparoscopic live donor nephrectomy in 1995, but not the first autotransplant. **3. Clinical Pearls for NEET-PG:** * **First Successful Human Kidney Transplant:** Performed by **Joseph Murray** in 1954 (between identical twins, the Herrick brothers). He received the Nobel Prize for this. * **Indications for Autotransplantation:** Complex ureteral injuries, renal artery aneurysms, "nutcracker syndrome," and extensive retroperitoneal fibrosis. * **Father of Modern Transplantation:** **Thomas Starzl** (performed the first human liver transplant in 1963). * **Alexis Carrel:** Developed the surgical techniques for vascular anastomosis (triangulation technique) used in transplants.

Question 15: What is the most common indication for heart transplant?

A. Dilated cardiomyopathy (Correct Answer)
B. Myocardial Infarction (MI)
C. Hypertrophic cardiomyopathy
D. Tetralogy of Fallot (TOF)

Explanation: **Explanation:** **Correct Answer: A. Dilated cardiomyopathy** Heart transplantation is the definitive treatment for end-stage heart failure that is refractory to medical management. Globally, the most common indication for heart transplantation in adults is **Dilated Cardiomyopathy (DCM)**, followed closely by Ischemic Cardiomyopathy. DCM leads to progressive ventricular enlargement and systolic dysfunction, eventually reaching a point where the heart can no longer maintain adequate cardiac output. **Analysis of Incorrect Options:** * **B. Myocardial Infarction (MI):** While acute MI is a leading cause of death, it is managed with reperfusion (PCI/CABG). It only leads to transplant if it results in chronic, end-stage **Ischemic Cardiomyopathy**. * **C. Hypertrophic cardiomyopathy (HCM):** Although HCM can lead to heart failure or sudden cardiac death, it is a much less frequent indication for transplant compared to the high prevalence of DCM. * **D. Tetralogy of Fallot (TOF):** This is a congenital cyanotic heart disease usually managed with surgical repair (Blalock-Taussig shunt or total correction) in infancy/childhood. Congenital heart diseases are the most common indication in the **pediatric** age group, but not the overall population. **High-Yield Clinical Pearls for NEET-PG:** * **Most common indication (Adults):** Dilated Cardiomyopathy. * **Most common indication (Pediatrics):** Congenital Heart Disease. * **Gold Standard for Diagnosis of Rejection:** Endomyocardial biopsy (usually taken from the right ventricle). * **Denervated Heart:** A transplanted heart lacks autonomic nerve supply; therefore, it does not respond to Atropine, and patients do not experience classic angina (silent ischemia). * **Most common cause of late death:** Cardiac Allograft Vasculopathy (CAV).

Question 16: Which of the following is considered an extended criteria donor for kidney transplantation?

A. Donors with extremes of age
B. Donors with excess alcohol intake
C. Donors having cerebrovascular accident
D. All the above (Correct Answer)

Explanation: **Explanation:** In kidney transplantation, an **Extended Criteria Donor (ECD)** refers to a deceased donor whose kidneys carry a higher risk of graft failure compared to standard criteria donors (SCD). The concept was developed to expand the donor pool due to the increasing organ shortage. The correct answer is **D (All the above)** because the definition of ECD is primarily based on age and specific clinical comorbidities that predict reduced graft survival: 1. **Extremes of Age (Option A):** By definition, any donor **≥ 60 years** is an ECD. Additionally, donors aged **50–59 years** are classified as ECD if they meet at least two of the following: history of hypertension, terminal serum creatinine >1.5 mg/dL, or cause of death being a cerebrovascular accident. 2. **Cerebrovascular Accident (Option C):** CVA as a cause of death is a core component of the ECD criteria (for the 50–59 age bracket) as it often indicates underlying systemic vascular disease, which may affect the microvasculature of the kidney. 3. **Excess Alcohol Intake (Option B):** While not part of the formal UNOS point-based definition, clinical practice and various transplant protocols categorize donors with significant lifestyle comorbidities (like chronic alcoholism or heavy smoking) as "marginal" or extended criteria due to the risk of associated systemic diseases. **High-Yield Facts for NEET-PG:** * **Standard Criteria Donor (SCD):** Ideally a young donor (<50 years) who died of trauma with no history of hypertension or renal dysfunction. * **ECD Outcomes:** These kidneys have a **1.7 times higher risk** of graft failure compared to SCD kidneys but are still preferred over remaining on long-term dialysis. * **Cold Ischemia Time:** For ECD kidneys, it is crucial to keep cold ischemia time **<24 hours** to minimize delayed graft function (DGF). * **Dual Kidney Transplant:** Sometimes, two ECD kidneys are transplanted into a single recipient if the nephron mass of one is deemed insufficient.

Question 17: In which of the following conditions is liver transplantation indicated?

A. Hemochromatosis
B. Primary biliary cirrhosis (Correct Answer)
C. Sclerosing cholangitis without ulcerative colitis
D. Sclerosing cholangitis with ulcerative colitis

Explanation: **Explanation:** Liver transplantation is the definitive treatment for end-stage liver disease (ESRD). Among the options provided, **Primary Biliary Cirrhosis (PBC)**—now often termed Primary Biliary Cholangitis—is a classic and well-established indication for transplantation. It is a chronic cholestatic disease where progressive destruction of small bile ducts leads to cirrhosis and liver failure. Transplantation is indicated when patients develop complications like intractable pruritus, bilirubin >6 mg/dL, or hepatic encephalopathy. **Analysis of Options:** * **Primary Biliary Cirrhosis (Correct):** It is one of the most common autoimmune indications for transplant. Survival rates post-transplant are excellent (80-90% at 5 years). * **Hemochromatosis (Incorrect):** While it can lead to cirrhosis, it is often considered a relative contraindication or a high-risk indication because these patients have significantly poorer outcomes post-transplant due to iron-related cardiac complications and increased risk of infections (e.g., *Listeria*, *Vibrio*). * **Sclerosing Cholangitis (Incorrect):** While Primary Sclerosing Cholangitis (PSC) is an indication for transplant, the presence of **Ulcerative Colitis (UC)** significantly complicates the prognosis. Patients with PSC and UC have a much higher risk of developing **cholangiocarcinoma** and colorectal cancer. In the context of this specific question, PBC is the more straightforward, "textbook" indication compared to the complexities of PSC management. **High-Yield Clinical Pearls for NEET-PG:** * **Most common indication (Adults):** Hepatitis C related cirrhosis (historically) and NASH/Alcoholic Liver Disease (currently). * **Most common indication (Children):** Biliary Atresia. * **MELD Score:** Used to prioritize patients on the transplant waiting list (based on Bilirubin, Creatinine, and INR). * **Absolute Contraindications:** Extrahepatic malignancy, active systemic infection, advanced cardiopulmonary disease, and active substance abuse.

Question 18: Which of the following is an absolute contraindication to liver transplantation?

A. Age >70
B. Portal vein thrombosis
C. Severe obesity
D. AIDS (Correct Answer)

Explanation: **Explanation:** In liver transplantation, contraindications are categorized into **absolute** (conditions where the risk of surgery or post-transplant failure is prohibitively high) and **relative** (conditions that increase risk but can be managed). **Why AIDS is the Correct Answer:** Historically, **AIDS** (defined by low CD4 counts and opportunistic infections) is considered an **absolute contraindication**. The primary concern is that the mandatory post-transplant immunosuppression will further deplete the immune system, leading to uncontrollable opportunistic infections and poor survival. While HIV-positive patients with well-controlled viral loads and high CD4 counts are now being transplanted in specialized centers, "AIDS" as a clinical stage remains a classic absolute contraindication in standard surgical textbooks and NEET-PG curricula. **Analysis of Incorrect Options:** * **Age >70 (Relative):** While advanced age increases the risk of cardiovascular complications, it is not an absolute cutoff. "Physiological age" is prioritized over "chronological age." * **Portal Vein Thrombosis (Relative):** Previously a contraindication, it is now managed using thrombectomy or venous bypass techniques during the transplant. * **Severe Obesity (Relative):** While BMI >35-40 increases the risk of wound infections and metabolic complications, it is a relative contraindication that requires pre-operative weight management. **High-Yield Clinical Pearls for NEET-PG:** * **Absolute Contraindications:** Extrahepatic malignancy, active extrahepatic sepsis, advanced cardiopulmonary disease, and active substance/alcohol abuse. * **MELD Score:** Used for prioritizing patients on the waiting list (based on Bilirubin, Creatinine, and INR). * **Milan Criteria:** Used to determine eligibility for patients with Hepatocellular Carcinoma (Single lesion ≤5cm or up to 3 lesions each ≤3cm).

Question 19: What is the safest transplantation approach in liver disease?

A. Directly transplanting embryonic stem cells into the liver
B. Transplanting donor hepatocytes into the liver
C. Transplanting mesenchymal stem cells from adipose tissue into the liver (Correct Answer)
D. Injecting erythropoietin into the body

Explanation: **Explanation:** The correct answer is **C: Transplanting mesenchymal stem cells (MSCs) from adipose tissue into the liver.** **Why it is correct:** Mesenchymal stem cells (MSCs) are multipotent cells that possess unique immunomodulatory and anti-inflammatory properties. Adipose tissue is considered the **safest and most practical source** because it is easily accessible via minimally invasive procedures (liposuction), yields a high concentration of MSCs, and avoids the ethical controversies associated with embryonic cells. Clinically, MSCs promote liver regeneration by secreting growth factors and reducing fibrosis without the high risk of malignant transformation or acute immune rejection. **Why other options are incorrect:** * **Option A:** Embryonic stem cells (ESCs) carry a significant risk of **teratoma formation** (tumorigenicity) and face major ethical and legal hurdles, making them unsafe for routine clinical transplantation. * **Option B:** Hepatocyte transplantation is limited by the poor survival of donor cells in a diseased environment, the requirement for high-quality donor livers (which are scarce), and the risk of **portal vein thrombosis** or embolic events during infusion. * **Option D:** Erythropoietin (EPO) is primarily used to treat anemia. While it may have minor cytoprotective effects, it is not a "transplantation approach" and does not address the underlying architectural loss of liver tissue. **Clinical Pearls for NEET-PG:** * **Source of MSCs:** Bone marrow and adipose tissue are the primary sources; however, adipose-derived MSCs (AD-MSCs) are often preferred due to higher cell yield. * **Immunomodulation:** MSCs are "immuno-privileged" (low MHC I, no MHC II expression), reducing the need for aggressive immunosuppression. * **Standard of Care:** While stem cell therapy is an emerging "bridge" or alternative, **Orthotopic Liver Transplantation (OLT)** remains the definitive gold standard for end-stage liver disease (ESLD).

Question 20: What is the most common malignancy observed after renal transplantation?

A. Lymphoma
B. Renal cell carcinoma
C. Skin cancer (Correct Answer)
D. Adrenal cancer

Explanation: **Explanation:** The correct answer is **Skin cancer**. Post-transplant patients are at a significantly higher risk of developing malignancies compared to the general population due to long-term **immunosuppressive therapy**, which impairs the body’s immune surveillance against oncogenic viruses and UV-damaged cells. **1. Why Skin Cancer is Correct:** Skin cancers, particularly **Squamous Cell Carcinoma (SCC)**, are the most common malignancies following renal transplantation. Unlike the general population where Basal Cell Carcinoma (BCC) is more frequent, in transplant recipients, SCC is more common (SCC:BCC ratio is reversed). Risk factors include prolonged immunosuppression, sun exposure, and infection with Human Papillomavirus (HPV). **2. Analysis of Incorrect Options:** * **Lymphoma (Option A):** While **Post-Transplant Lymphoproliferative Disorder (PTLD)** is a serious and well-known complication (often associated with Epstein-Barr Virus), it is less common than skin cancer. * **Renal Cell Carcinoma (Option B):** There is an increased risk of RCC in the native kidneys (especially in patients with acquired cystic kidney disease), but it does not surpass the incidence of skin malignancies. * **Adrenal Cancer (Option D):** This is a rare malignancy and is not specifically associated with the post-transplant immunosuppressed state. **Clinical Pearls for NEET-PG:** * **Most common malignancy overall:** Skin cancer (SCC > BCC). * **Most common non-skin malignancy:** Lymphoma (PTLD). * **Most common viral association:** EBV is linked to PTLD; HHV-8 is linked to Kaposi Sarcoma. * **Screening:** Transplant recipients require lifelong, annual dermatological evaluation. * **Management:** If malignancy occurs, the first step is often the reduction or modification of immunosuppressive agents (e.g., switching to mTOR inhibitors like Sirolimus, which have anti-tumor properties).

Question 21: What is a xenograft?

A. Graft from one twin to another twin
B. Graft from one species to another species (Correct Answer)
C. Graft from a father to his child
D. Graft from a sister to her brother

Explanation: ### Explanation **Correct Answer: B. Graft from one species to another species** **Understanding the Concept:** In transplant surgery, grafts are classified based on the genetic relationship between the donor and the recipient. A **Xenograft** (also known as a heterograft) involves the transplantation of cells, tissues, or organs between members of **different species**. A common clinical example is the use of porcine (pig) or bovine (cow) heart valves in humans. Because of the significant genetic disparity, xenografts are prone to **hyperacute rejection** mediated by pre-formed antibodies against alpha-galactosyl determinants. **Analysis of Incorrect Options:** * **Option A (One twin to another):** This is an **Isograft** (or Syngeneic graft). It occurs between genetically identical individuals (monozygotic twins). There is no risk of rejection. * **Option C & D (Father to child / Sister to brother):** These are examples of **Allografts** (or Homografts). An allograft is a transplant between genetically non-identical members of the **same species**. This is the most common type of clinical transplant (e.g., cadaveric or living-related kidney transplant). **NEET-PG Clinical Pearls:** 1. **Autograft:** Tissue moved from one site to another in the same individual (e.g., SSG, CABG using the saphenous vein). No immunosuppression is required. 2. **Hyperacute Rejection:** The primary barrier in xenotransplantation, occurring within minutes due to pre-existing antibodies. 3. **GalSafe Pigs:** Genetically modified pigs lacking the alpha-gal sugar are being developed to reduce xenograft rejection. 4. **Order of Rejection Risk:** Isograft (None) < Allograft (Variable) < Xenograft (Highest).

Question 22: A 55-year-old man with idiopathic dilated cardiomyopathy receives a heart transplant. Which of the following is the most likely cause of death in this patient 2 years after transplantation?

A. Acute cellular graft rejection
B. Aortic valve stenosis
C. Chronic vascular rejection (Correct Answer)
D. Hyperacute graft rejection

Explanation: ### Explanation The correct answer is **Chronic vascular rejection**, specifically known as **Cardiac Allograft Vasculopathy (CAV)**. #### 1. Why Chronic Vascular Rejection is Correct In heart transplantation, the timeline of complications is a critical high-yield concept. While infections and acute rejection dominate the first year, **Chronic Vascular Rejection** is the leading cause of late graft failure and death after the first post-transplant year. * **Mechanism:** It involves concentric, diffuse intimal hyperplasia of the coronary arteries. Unlike typical atherosclerosis, it affects the entire length of the vessel (both intramyocardial and epicardial). * **Clinical Presentation:** Because the donor heart is denervated, patients do not experience typical angina. Instead, they present with "silent" myocardial infarction, heart failure, or sudden cardiac death. #### 2. Why Other Options are Incorrect * **A. Acute Cellular Graft Rejection:** This typically occurs within the first few weeks to months (usually <6 months). While it can occur later if immunosuppression is tapered, it is not the most common cause of death at 2 years. * **B. Aortic Valve Stenosis:** This is a degenerative or congenital valvular pathology and is not a specific or common complication of heart transplantation. * **D. Hyperacute Graft Rejection:** This occurs within **minutes to hours** due to pre-formed ABO or HLA antibodies (Type II hypersensitivity). It is now rare due to mandatory cross-matching. #### 3. NEET-PG High-Yield Pearls * **Most common cause of death <1 year:** Infection or Acute Rejection. * **Most common cause of death >1 year:** Chronic Rejection (CAV) and Malignancy (especially Lymphoma/PTLD). * **Pathology of CAV:** Diffuse, concentric narrowing (vs. eccentric focal plaques in normal CAD). * **Diagnosis:** Annual coronary angiography or intravascular ultrasound (IVUS) is often required because the patient lacks sensation (denervated heart).

Question 23: Following liver transplantation, recurrence of primary disease in the liver most likely occurs in which of the following conditions?

A. Wilson disease
B. Autoimmune hepatitis (Correct Answer)
C. Alpha-1 antitrypsin deficiency
D. Primary biliary cirrhosis

Explanation: **Explanation:** Recurrence of the primary disease is a significant long-term complication of liver transplantation. Among the options provided, **Autoimmune Hepatitis (AIH)** has the highest rate of recurrence, affecting approximately **20–30%** of recipients within five years. The underlying medical concept is that the patient’s systemic immune dysregulation persists even after the native organ is replaced; the recipient's immune system continues to produce autoantibodies and T-cells that attack the new graft. **Analysis of Options:** * **Autoimmune Hepatitis (AIH):** Recurrence is common and often requires lifelong titration of immunosuppressants (corticosteroids and azathioprine). * **Wilson Disease:** This is a genetic defect in copper metabolism (ATP7B gene) localized in the liver. Since the donor liver has normal genetics, the disease **does not recur**. * **Alpha-1 Antitrypsin (A1AT) Deficiency:** Similar to Wilson’s, this is a genetic metabolic disorder. A transplant from a donor with normal alleles (PiMM) effectively cures the patient; the new liver produces normal A1AT protein. * **Primary Biliary Cirrhosis (PBC):** While PBC can recur (now termed Primary Biliary Cholangitis), its recurrence rate and clinical impact are generally lower and slower to manifest compared to the aggressive nature of recurrent AIH. **NEET-PG High-Yield Pearls:** * **Most common indication for liver transplant (Global):** Hepatitis C (though decreasing due to DAAs) and NASH/NAFLD. * **Most common indication (India):** Decompensated Cirrhosis due to Hepatitis B or NASH. * **Disease with 0% recurrence:** Genetic/Metabolic disorders like Wilson disease and A1AT deficiency. * **Hepatocellular Carcinoma (HCC):** Recurrence is strictly monitored using the **Milan Criteria** to minimize post-transplant relapse.

Question 24: In orthotopic liver transplant, what is the anatomical site for the graft?

A. Anatomical liver position (Correct Answer)
B. Subhepatic space
C. Infragastric space
D. Any of the above

Explanation: In liver transplantation, the terminology used describes the anatomical placement of the donor organ relative to the recipient's native anatomy. **Explanation of the Correct Answer:** The term **"Orthotopic"** is derived from the Greek words *orthos* (straight/correct) and *topos* (place). In an **Orthotopic Liver Transplant (OLT)**, the recipient's diseased liver is completely removed (hepatectomy), and the donor graft is placed in the **anatomical liver position** (the right hypochondrium). This allows for the standard re-establishment of vascular and biliary connections (IVC, portal vein, hepatic artery, and bile duct) in their natural orientation. **Explanation of Incorrect Options:** * **Subhepatic and Infragastric spaces:** These refer to locations below the liver or stomach, respectively. Placing a liver here would be considered a **Heterotopic Transplant**. In heterotopic transplantation, the recipient's native liver is left in situ, and the donor liver is placed at an ectopic site. This is rarely performed today but was historically explored for temporary metabolic support or acute liver failure. **High-Yield Clinical Pearls for NEET-PG:** * **Standard of Care:** Orthotopic transplantation is the gold standard for end-stage liver disease. * **Vascular Anastomosis Sequence:** Typically, the Suprahepatic IVC is anastomosed first, followed by the Infrahepatic IVC, Portal Vein, Hepatic Artery, and finally the Biliary tree. * **Piggyback Technique:** A common modification where the recipient's IVC is preserved, and the donor liver is attached to the confluence of the hepatic veins. * **Most common indication:** Worldwide, it is Hepatitis C/Alcoholic Cirrhosis; in children, it is Biliary Atresia.

Question 25: What is the principal cause of death in renal transplant patients?

A. Uremia
B. Malignancy
C. Rejection
D. Infection (Correct Answer)

Explanation: **Explanation:** In renal transplant recipients, **Infection** remains the leading cause of mortality, followed closely by cardiovascular disease. The primary reason is the mandatory, lifelong administration of **immunosuppressive therapy** (such as Calcineurin inhibitors, Mycophenolate Mofetil, and Steroids) required to prevent graft rejection. These drugs suppress the host's immune surveillance, making the patient highly susceptible to opportunistic pathogens (CMV, BK virus, Pneumocystis jirovecii) and common bacterial infections, particularly in the first year post-transplant. **Analysis of Incorrect Options:** * **Uremia:** This was the leading cause of death in the pre-dialysis and pre-transplant era. Today, if a graft fails, patients return to dialysis, preventing death from uremia. * **Malignancy:** While transplant patients have a higher risk of cancers (especially Skin Cancer and Post-Transplant Lymphoproliferative Disorder/PTLD) due to chronic immunosuppression, it is a late complication and not the most common cause of death. * **Rejection:** While rejection is the most common cause of **graft loss**, it is rarely a direct cause of patient death, as the condition can be managed with increased immunosuppression or by returning the patient to dialysis. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of death (Overall):** Infection (though some Western literature cites Cardiovascular disease as #1, Infection is the standard answer for exams and in the Indian context). * **Most common viral infection:** Cytomegalovirus (CMV). * **Most common malignancy:** Squamous Cell Carcinoma of the skin. * **Hyperacute Rejection:** Occurs within minutes; mediated by pre-formed antibodies (Type II Hypersensitivity). * **Chronic Rejection:** Occurs months to years later; characterized by intimal fibrosis and graft atherosclerosis.

Question 26: Highest chance of success in renal transplant is possible when the donor is:

A. Father
B. Mother
C. Twin (Correct Answer)
D. Son

Explanation: **Explanation:** The success of a renal transplant is primarily determined by the degree of **HLA (Human Leukocyte Antigen) matching** between the donor and the recipient. **Why 'Twin' is Correct:** The highest chance of success occurs with a **Monozygotic (Identical) Twin**. Identical twins are genetically identical, meaning they share a 100% HLA match (6/6 match). This virtually eliminates the risk of host-versus-graft rejection, often allowing for minimal or even no long-term immunosuppression. If the option refers to a **Dizygotic (Fraternal) Twin**, they are genetically similar to siblings, sharing a 25% chance of a perfect HLA match, which is still statistically superior to parental matches. **Why Other Options are Incorrect:** * **Father, Mother, and Son (Options A, B, D):** These are **First-degree relatives**. In Mendelian inheritance, a child inherits one haplotype (a set of HLA genes) from each parent. Therefore, a parent and a child are always a **"Haplo-identical" (50%) match**. While these are excellent donors compared to unrelated individuals, they carry a higher risk of rejection than an identical twin. **High-Yield Clinical Pearls for NEET-PG:** * **Order of Donor Preference:** Identical Twin > HLA-matched Sibling > Parent/Child (Haplo-identical) > Deceased Donor. * **HLA Loci:** The most important loci for matching in renal transplant are **HLA-A, HLA-B, and HLA-DR** (Total 6 alleles). * **Hyperacute Rejection:** Occurs within minutes due to pre-formed cytotoxic antibodies (Type II Hypersensitivity). * **Most Common Cause of Graft Loss:** Chronic Allograft Nephropathy (late) or Acute Rejection (early).

Question 27: What is the most common viral infection following kidney transplantation?

A. Epstein-Barr virus (EBV)
B. Herpes simplex virus (HSV)
C. Cytomegalovirus (CMV) (Correct Answer)
D. Hepatitis B virus (HBV)

Explanation: ### Explanation **Cytomegalovirus (CMV)** is the most common clinically significant viral infection following kidney transplantation, typically occurring within the first **1 to 6 months** post-transplant (the period of maximal immunosuppression). #### Why CMV is the Correct Answer: CMV is a ubiquitous double-stranded DNA virus (HHV-5). In transplant recipients, it occurs either due to **primary infection** (seronegative recipient receiving a seropositive organ, D+/R-) or **reactivation** of a latent infection in the recipient. It is a major cause of morbidity, leading to "CMV syndrome" (fever, malaise, leukopenia) or tissue-invasive disease (pneumonitis, hepatitis, and GI ulcerations). It also increases the risk of graft rejection and opportunistic fungal infections. #### Analysis of Incorrect Options: * **A. Epstein-Barr virus (EBV):** While significant, it is less common than CMV. Its primary clinical importance lies in its association with **Post-Transplant Lymphoproliferative Disorder (PTLD)**. * **B. Herpes simplex virus (HSV):** HSV-1 and HSV-2 reactivations are common but usually present as self-limiting mucocutaneous lesions. Prophylaxis with Acyclovir has significantly reduced its incidence. * **D. Hepatitis B virus (HBV):** This is a chronic viral infection. While it can complicate the long-term course and lead to cirrhosis, it is not the most common post-transplant viral infection in the acute/subacute period. #### High-Yield Clinical Pearls for NEET-PG: * **Drug of Choice:** **Valganciclovir** (prophylaxis) and **Ganciclovir** (treatment). * **Histology:** Look for **"Owl’s eye"** intranuclear inclusion bodies. * **BK Virus:** Another high-yield virus to remember; it causes **BKV-associated nephropathy**, leading to a rise in creatinine that mimics graft rejection. * **Timeline:** Most viral infections (CMV, EBV, BK) occur in the **mid-post-transplant period** (1–6 months). Infections in the first month are usually bacterial/surgical site-related.

Question 28: What does xenograft mean?

A. Transplanting organs from one species to another (Correct Answer)
B. Transplanting organs from a member of the same species
C. Transplanting organs from twin to twin
D. Transplanting organs from one site to another in an individual

Explanation: **Explanation:** The terminology of transplantation is based on the genetic relationship between the donor and the recipient. **1. Why Option A is correct:** A **Xenograft** (or Heterograft) refers to a transplant between members of different species (e.g., a porcine heart valve transplanted into a human). Because of the significant genetic disparity, xenografts are prone to **Hyperacute Rejection**, primarily mediated by pre-existing antibodies against alpha-gal antigens. **2. Why the other options are incorrect:** * **Option B (Allograft):** This is a transplant between genetically non-identical members of the **same species** (e.g., a kidney from a deceased human donor to a human recipient). This is the most common type of clinical transplant. * **Option C (Isograft/Syngeneic graft):** This refers to a transplant between **genetically identical** individuals, such as monozygotic (identical) twins. In this case, there is no risk of immunological rejection. * **Option D (Autograft):** This involves moving tissue from **one site to another within the same individual** (e.g., a skin graft from the thigh to the arm or a CABG using the Great Saphenous Vein). There is no risk of rejection. **Clinical Pearls for NEET-PG:** * **Hyperacute Rejection** is the hallmark of xenotransplantation, occurring within minutes due to pre-formed antibodies. * **Galα1,3-Gal (Alpha-gal)** is the major xenoantigen responsible for rejection in humans. * **Pigs** are currently considered the most suitable source for xenotransplantation due to physiological similarities and ease of breeding. * **Order of Rejection Risk:** Xenograft > Allograft > Isograft = Autograft.

Question 29: Which of the following is NOT a part of "Triple therapy" immunosuppression for a post-renal transplant patient?

A. Prednisone
B. Cyclosporine
C. Azathioprine
D. Belatacept (Correct Answer)

Explanation: The "Triple Therapy" regimen is the gold standard for maintenance immunosuppression in post-renal transplant patients. It is designed to target different pathways of the immune response to maximize graft survival while minimizing the toxicity of any single drug. ### **Explanation of the Correct Answer** **D. Belatacept:** This is a selective T-cell costimulation blocker (binds to CD80 and CD86). While it is FDA-approved for prophylaxis of organ rejection, it is **not** part of the classic "Triple Therapy" regimen. It is typically used as an alternative to Calcineurin Inhibitors (CNIs) to avoid nephrotoxicity, but it is administered via intravenous infusion rather than the standard oral triple-drug protocol. ### **Analysis of Incorrect Options** The classic Triple Therapy consists of one drug from each of the following three categories: * **A. Prednisone (Corticosteroids):** Provides broad anti-inflammatory and immunosuppressive effects by inhibiting cytokine gene expression. * **B. Cyclosporine (Calcineurin Inhibitors):** Inhibits IL-2 production. In modern practice, **Tacrolimus** has largely replaced Cyclosporine due to better efficacy, but both are considered the "backbone" of triple therapy. * **C. Azathioprine (Antimetabolites):** Inhibits purine synthesis to prevent T-cell proliferation. In contemporary regimens, **Mycophenolate Mofetil (MMF)** is more commonly used than Azathioprine. ### **NEET-PG High-Yield Pearls** * **Standard Modern Triple Therapy:** Tacrolimus + Mycophenolate Mofetil (MMF) + Prednisolone. * **Side Effect Profile:** * **Cyclosporine:** Nephrotoxicity, Gingival hyperplasia, Hirsutism. * **Tacrolimus:** Nephrotoxicity, Neurotoxicity, Post-transplant Diabetes Mellitus (PTDM). * **MMF:** GI upset and Bone marrow suppression. * **Sirolimus (mTOR inhibitor):** Often used if CNIs must be withdrawn due to nephrotoxicity, but it impairs wound healing.

Question 30: In brain death, which of the following organs cannot be transplanted?

A. Brain (Correct Answer)
B. Heart
C. Liver
D. Kidney

Explanation: **Explanation:** The concept of **Brain Death** (Neurological Death) refers to the irreversible loss of all functions of the entire brain, including the brainstem. This state is the legal and clinical prerequisite for **Deceased Organ Donation**. **Why Brain is the Correct Answer:** The brain cannot be transplanted because it is the very organ that has undergone irreversible necrosis and cellular death in this scenario. Furthermore, medical science currently lacks the technology to reconnect the complex neural pathways of the spinal cord and cranial nerves required for a brain transplant. In the context of organ donation, the "donor" is defined by the death of the brain, making it the only organ in the list that is non-viable and medically impossible to transplant. **Analysis of Incorrect Options:** * **B, C, and D (Heart, Liver, Kidney):** These are the primary solid organs harvested from brain-dead donors. In brain death, while the brain has ceased to function, the heart continues to beat (often with pharmacological support), and systemic circulation is maintained via a ventilator. This ensures that the heart, liver, and kidneys remain **perfused and oxygenated**, preserving their viability for transplantation into a recipient. **High-Yield Clinical Pearls for NEET-PG:** * **Prerequisites for Brain Death Diagnosis:** Normothermia (>32°C), absence of metabolic encephalopathy, and absence of neuromuscular blockers/sedatives. * **Confirmatory Test:** The **Apnea Test** is the gold standard clinical test. * **Legal Framework:** In India, the **Transplantation of Human Organs Act (THOA), 1994** provides the legal definition and regulations for brain death and organ retrieval. * **Order of Ischemic Tolerance:** The heart and lungs have the shortest cold ischemia time (4–6 hours), while kidneys can be preserved the longest (up to 24–48 hours).

Question 31: Which disease does not recur in the kidney after renal transplant?

A. Alport syndrome (Correct Answer)
B. SLE with renal involvement
C. Goodpasture's syndrome
D. Diabetic nephropathy

Explanation: **Explanation:** The correct answer is **Alport syndrome**. This is because Alport syndrome is a genetic disorder caused by mutations in the genes encoding the **alpha chains of Type IV collagen** (the primary component of the glomerular basement membrane). Since the transplanted kidney comes from a donor with normal genetic material, it possesses healthy Type IV collagen. Therefore, the underlying genetic defect cannot "recur" in the new graft. Interestingly, some Alport patients may develop *de novo* Anti-GBM disease post-transplant because their immune system perceives the normal Type IV collagen in the graft as a foreign antigen. **Analysis of Incorrect Options:** * **SLE with renal involvement:** Systemic Lupus Erythematosus is an autoimmune systemic disease. The circulating autoantibodies and immune complexes that damaged the native kidneys can eventually attack the transplanted kidney (recurrence rate is ~2-10%). * **Goodpasture’s Syndrome:** This is caused by circulating anti-GBM antibodies. If the transplant is performed while antibody titers are still high, the antibodies will attack the new kidney. It is recommended to wait until titers are undetectable for 6–12 months. * **Diabetic Nephropathy:** This is the most common cause of ESRD. Since the systemic metabolic environment (hyperglycemia) usually persists after transplant, histological changes of diabetic nephropathy almost always recur in the graft over time. **High-Yield Clinical Pearls for NEET-PG:** * **Highest recurrence rate:** Type II MPGN (Dense Deposit Disease) has a recurrence rate of nearly 80-100%. * **FSGS:** Recurs rapidly (sometimes within hours to days) in about 30% of patients. * **Oxalosis:** Primary hyperoxaluria has a very high recurrence rate and often requires a combined liver-kidney transplant. * **IgA Nephropathy:** Frequently recurs histologically (~50%), but graft loss is relatively slow.

Question 32: Which of the following statements is NOT true regarding Milan criteria for liver transplantation?

A. Single tumor less than 5 cm in size
B. Three nodules, each less than 3 cm in size
C. More than 5 nodules (Correct Answer)
D. No extrahepatic disease

Explanation: The **Milan Criteria** are the gold standard guidelines used to determine the eligibility of patients with **Hepatocellular Carcinoma (HCC)** for liver transplantation. They were established to ensure optimal post-transplant survival rates (75% at 5 years) by selecting patients with low risk of tumor recurrence. ### **Explanation of the Correct Option** * **C. More than 5 nodules:** This is the **incorrect** statement. According to Milan criteria, the maximum number of nodules allowed is **three**. Having more than five nodules indicates advanced disease with a high risk of vascular invasion and recurrence, making the patient ineligible for standard transplantation. ### **Analysis of Other Options** * **A. Single tumor less than 5 cm:** This is a core component of the criteria. A solitary lesion must be $\leq$ 5 cm in diameter. * **B. Three nodules, each less than 3 cm:** If multiple tumors are present, there must be no more than three, and each individual nodule must be $\leq$ 3 cm in diameter. * **D. No extrahepatic disease:** For a transplant to be successful, the cancer must be localized to the liver. Any evidence of extrahepatic spread or **macrovascular invasion** (e.g., portal vein involvement) is an absolute contraindication. ### **High-Yield Clinical Pearls for NEET-PG** * **UCSF Criteria:** A slightly expanded version of Milan (Single lesion $\leq$ 6.5 cm OR $\leq$ 3 lesions with largest $\leq$ 4.5 cm and total diameter $\leq$ 8 cm). * **Bridging Therapy:** While waiting for a transplant, patients meeting Milan criteria may undergo TACE (Transarterial Chemoembolization) or RFA (Radiofrequency Ablation) to prevent tumor progression. * **Downstaging:** This refers to using local therapies to bring a tumor that is initially outside Milan criteria into the acceptable range for transplantation.

Question 33: Post-transplant nephropathy after 1 month is most likely due to which of the following?

A. Hepatitis C
B. HHV-6
C. Polyoma BK virus (Correct Answer)
D. Herpes simplex viruses

Explanation: **Explanation:** **Polyoma BK Virus** is the most common viral cause of renal allograft dysfunction (nephropathy) occurring typically within the first few months to a year post-transplant. The virus, which remains latent in the urinary tract of most healthy individuals, reactivates under the influence of potent immunosuppression (especially tacrolimus and mycophenolate mofetil). It leads to **BK Virus-Associated Nephropathy (BKVAN)**, characterized by a rising serum creatinine and histological features mimicking rejection (tubulitis and interstitial inflammation). **Analysis of Incorrect Options:** * **Hepatitis C (Option A):** While HCV can cause glomerulonephritis (like MPGN) in the long term, it is not a primary cause of acute/subacute post-transplant nephropathy within the first month. * **HHV-6 (Option B):** Human Herpesvirus 6 is associated with fever, skin rash, and bone marrow suppression post-transplant, but it is rarely a direct cause of nephropathy. * **Herpes Simplex Virus (Option D):** HSV typically presents with mucocutaneous lesions or systemic viremia (hepatitis/pneumonitis) rather than specific renal allograft parenchymal damage. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnosis:** The gold standard is a **renal biopsy** showing characteristic intranuclear inclusion bodies (ground-glass appearance) and positive SV40 staining. * **Screening:** Done via **decoy cells** in urine cytology (high sensitivity, low specificity) or **BK-PCR** in plasma (preferred for monitoring). * **Management:** The primary treatment is the **reduction of immunosuppressive therapy**. * **Timeline:** While hyperacute rejection occurs in minutes and acute rejection in days/weeks, BKVAN is a significant differential for graft dysfunction starting around 1–3 months post-surgery.

Question 34: In renal transplantation, where is the graft typically placed?

A. Upper retroperitoneal space
B. Iliac fossa (Correct Answer)
C. Normal anatomical site
D. None of the above

Explanation: In renal transplantation, the graft is typically placed in the **iliac fossa** (extraperitoneal space). This is the standard surgical approach for several anatomical and clinical reasons: 1. **Vascular Access:** The iliac fossa provides easy access to the **external or internal iliac vessels** for vascular anastomosis (the renal artery is usually joined to the internal or external iliac artery, and the renal vein to the external iliac vein). 2. **Ureteric Length:** Placing the kidney in the pelvis minimizes the distance to the bladder, allowing for a short, tension-free **ureteroneocystostomy** (joining the donor ureter to the recipient bladder). 3. **Protection and Monitoring:** The iliac wing provides bony protection, while the superficial location allows for easy clinical palpation and ultrasound-guided biopsies if rejection is suspected. **Analysis of Incorrect Options:** * **A & C (Upper retroperitoneal/Normal anatomical site):** Orthotopic transplantation (placing the kidney in the original renal fossa) is technically difficult. It requires a longer donor ureter, involves more complex vascular dissection, and necessitates the removal of the native kidney (nephrectomy), which is usually avoided unless medically indicated (e.g., polycystic kidney disease or chronic infection). **High-Yield Clinical Pearls for NEET-PG:** * **Side of Placement:** The **right iliac fossa** is preferred because the iliac veins are more superficial and horizontal on the right, making the venous anastomosis easier. * **Reversal of Anatomy:** The kidney is often "flipped" (e.g., a left donor kidney is placed in the right iliac fossa) so the renal pelvis and ureter are positioned anteriorly. * **Native Kidneys:** In standard practice, the recipient's native kidneys are **left in situ** to avoid additional surgical morbidity.

Question 35: Which is the commonest malignancy to occur after a renal transplant?

A. Lymphoma
B. Renal cell carcinoma
C. Skin cancer (Correct Answer)
D. Adrenal cancer

Explanation: **Explanation:** The correct answer is **Skin cancer (Option C)**. Post-transplant patients are at a significantly higher risk of developing malignancies compared to the general population due to long-term **immunosuppressive therapy**. Immunosuppression impairs the body’s "immune surveillance," which normally identifies and destroys oncogenic viruses and malignant cells. **Why Skin Cancer is the Correct Answer:** Skin cancer is universally recognized as the **most common malignancy** following solid organ transplantation, particularly renal transplants. Among skin cancers, **Squamous Cell Carcinoma (SCC)** is the most frequent subtype, followed by Basal Cell Carcinoma (BCC). Notably, the normal BCC:SCC ratio (which is 4:1 in the general population) is **reversed** in transplant recipients, making SCC much more common and aggressive. **Analysis of Incorrect Options:** * **A. Lymphoma:** While Post-Transplant Lymphoproliferative Disorder (PTLD), often associated with the Epstein-Barr Virus (EBV), is a serious and common "non-skin" malignancy, it is statistically less frequent than skin cancers. * **B. Renal cell carcinoma:** There is an increased risk of RCC in the native kidneys (especially in patients with acquired cystic kidney disease), but it is not the most common overall malignancy. * **D. Adrenal cancer:** This is a rare malignancy and does not show a significant correlation with post-transplant immunosuppression compared to skin or lymphoid tissues. **High-Yield Clinical Pearls for NEET-PG:** * **Most common malignancy overall:** Skin Cancer (SCC > BCC). * **Most common non-skin malignancy:** Lymphoma (PTLD). * **Most common viral association:** EBV is linked to PTLD; HHV-8 is linked to Kaposi Sarcoma. * **Risk Factor:** The intensity and duration of immunosuppression are the primary drivers of cancer risk. * **Prevention:** Patients must be advised on strict sun protection and regular dermatological screening.

Question 36: Snover's triad in acute cellular rejection of liver transplantation includes all of the following except?

A. Portal inflammation
B. Endothelialitis
C. Cholangitis
D. Periportal fibrosis (Correct Answer)

Explanation: **Explanation:** Acute Cellular Rejection (ACR) of the liver typically occurs between day 5 and day 30 post-transplant. The diagnosis is confirmed histologically using the **Banff Criteria**, which is based on the classic **Snover’s Triad**. **Why Periportal Fibrosis is the Correct Answer:** Periportal fibrosis is a feature of **chronic rejection** or long-standing biliary complications, not acute cellular rejection. ACR is characterized by acute inflammatory changes rather than structural scarring or architectural distortion. **Analysis of Snover’s Triad (Incorrect Options):** The triad consists of the following three histological features: 1. **Portal Inflammation (Option A):** A mixed inflammatory infiltrate (predominantly lymphocytes, but also eosinophils and neutrophils) involving the portal tracts. 2. **Endothelialitis (Option B):** Also known as subendothelial venulitis. It involves inflammatory cells (lymphocytes) attaching to and undermining the endothelium of portal or central veins. This is the most specific sign of ACR. 3. **Bile Duct Inflammation/Damage (Option C):** Often referred to as **nonsuppurative cholangitis**, where inflammatory cells infiltrate the biliary epithelium, leading to nuclear pleomorphism and cytoplasmic vacuolization. **Clinical Pearls for NEET-PG:** * **Grading:** ACR is graded using the **Rejection Activity Index (RAI)** or **Banff Score**, which assigns 0–3 points to each component of the triad (Max score = 9). * **First Sign:** A sudden rise in liver enzymes (ALT/AST) and bilirubin is the clinical hallmark. * **Treatment:** The first-line treatment for ACR is **high-dose intravenous corticosteroids** (methylprednisolone "pulses"). * **Chronic Rejection:** Characterized by "Vanishing Bile Duct Syndrome" (ductopenia) and obliterative arteriopathy.

Question 37: Which of the following criteria indicates an extended criteria donor for liver transplantation?

A. Age greater than 60 years
B. Hepatitis C positive (Correct Answer)
C. Primary sclerosing cholangitis
D. All of the above

Explanation: **Explanation:** **Extended Criteria Donors (ECD)**, also known as marginal donors, are those who do not meet the standard criteria for organ donation but are utilized to bridge the gap between organ demand and availability. These organs carry a higher risk of initial poor function or graft failure but can be life-saving for specific recipients. **Why Hepatitis C Positive is the Correct Answer:** Historically, Hepatitis C (HCV) positive livers were considered unsuitable. However, they are now classified as ECD organs. With the advent of highly effective **Direct-Acting Antivirals (DAAs)**, HCV-positive grafts can be safely transplanted into HCV-positive recipients or even HCV-negative recipients (with informed consent and post-transplant antiviral therapy), as the cure rate for the virus is now near 100%. **Analysis of Other Options:** * **Age greater than 60 years (Option A):** While advanced age is a factor in ECD, the standard threshold used in most liver transplant scoring systems (like the Donor Risk Index) is typically **greater than 70 years**, not 60. * **Primary Sclerosing Cholangitis (Option C):** PSC is an **indication** for receiving a transplant, not a criterion for being a donor. Donor criteria focus on the health and quality of the donor's liver (e.g., steatosis, viral status, ischemia time). **High-Yield Clinical Pearls for NEET-PG:** * **Common ECD Criteria:** Donor age >70, macrosteatosis >30%, prolonged cold ischemia time (>12 hours), hypernatremia (Sodium >155 mEq/L), and donors with positive serology (HCV, HBcAb). * **MELD Score:** Used to prioritize recipients based on the severity of their liver disease (incorporates Bilirubin, Creatinine, and INR). * **Milan Criteria:** Used to determine eligibility for liver transplant in patients with Hepatocellular Carcinoma (Single lesion <5cm or up to 3 lesions <3cm each).

Question 38: Which of the following is NOT an indication for liver transplantation?

A. Cirrhosis
B. Primary hepatic malignancy
C. Acute fulminant liver failure
D. None of the above (Correct Answer)

Explanation: **Explanation:** The correct answer is **D (None of the above)** because all the listed conditions (Cirrhosis, Primary hepatic malignancy, and Acute fulminant liver failure) are well-established indications for liver transplantation. 1. **Cirrhosis (Option A):** Chronic Liver Disease (CLD) resulting in end-stage liver disease is the most common indication for transplantation. This includes cirrhosis caused by Hepatitis C, Hepatitis B, Alcoholic Liver Disease, and Non-Alcoholic Steatohepatitis (NASH). 2. **Primary Hepatic Malignancy (Option B):** Specifically, **Hepatocellular Carcinoma (HCC)** is a major indication, provided it meets the **Milan Criteria** (single lesion ≤5 cm or up to 3 lesions each ≤3 cm, with no extrahepatic spread or vascular invasion). 3. **Acute Fulminant Liver Failure (Option C):** This refers to rapid-onset liver failure (within 8 weeks of jaundice) in a patient without prior liver disease. Common causes include Paracetamol (Acetaminophen) toxicity, viral hepatitis (A, B, or E), and Wilson’s disease. **High-Yield Clinical Pearls for NEET-PG:** * **MELD Score (Model for End-Stage Liver Disease):** Uses Bilirubin, Creatinine, and INR to prioritize patients on the transplant waiting list. * **Most Common Indication (Global):** Hepatitis C-related cirrhosis (historically) and NASH (rising). * **Most Common Indication in Children:** Biliary Atresia. * **Absolute Contraindications:** Extrahepatic malignancy, active systemic infection, active substance abuse, and advanced cardiopulmonary disease. * **King’s College Criteria:** Used specifically to determine the prognosis and need for transplantation in Acute Liver Failure.

Question 39: What is the most common indication for liver transplantation in adults?

A. Portal vein thrombosis
B. Cirrhosis (Correct Answer)
C. Biliary atresia
D. None of the above

Explanation: **Explanation:** **Liver transplantation** is the definitive treatment for end-stage liver disease (ESLD) and acute liver failure. **Why Cirrhosis is Correct:** In adults, **Cirrhosis** is the most common indication for liver transplantation worldwide. Cirrhosis represents the final common pathway of various chronic liver insults, leading to irreversible scarring and loss of function. While the underlying etiology of cirrhosis varies—historically **Hepatitis C** was the leading cause, but it is currently being surpassed by **Non-Alcoholic Steatohepatitis (NASH/NAFLD)** and **Alcoholic Liver Disease**—the clinical state of cirrhosis remains the primary reason for transplant. **Analysis of Incorrect Options:** * **Portal Vein Thrombosis (A):** This is often a *complication* of cirrhosis or a contraindication/technical challenge during surgery, rather than a primary indication for the transplant itself. * **Biliary Atresia (C):** This is the **most common indication for liver transplantation in the pediatric population**, not adults. It involves the congenital absence or obstruction of the bile ducts. **High-Yield Clinical Pearls for NEET-PG:** * **MELD Score (Model for End-Stage Liver Disease):** Used to prioritize adult patients on the transplant waiting list. It uses Serum Bilirubin, Creatinine, and INR. * **PELD Score:** Used for pediatric patients (under age 12). * **Milan Criteria:** Used to determine eligibility for transplant in patients with **Hepatocellular Carcinoma (HCC)** (Single lesion <5cm or up to 3 lesions each <3cm). * **Most common cause of death post-transplant:** Infection (early) and Cardiovascular disease/Malignancy (late).

Question 40: Which type of transplant graft has the least chance of recipient failure?

A. Allograft
B. Isograft (Correct Answer)
C. Xenograft
D. Heterotopic Graft

Explanation: **Explanation:** The success of a transplant depends primarily on the **genetic compatibility** between the donor and the recipient. The less the antigenic disparity, the lower the risk of immune-mediated rejection. **Why Isograft is Correct:** An **Isograft (Syngeneic graft)** is a transplant between genetically identical individuals of the same species, such as **monozygotic (identical) twins**. Because the Human Leukocyte Antigens (HLA) are identical, the recipient’s immune system does not recognize the graft as "foreign." Consequently, there is virtually no risk of rejection, and long-term immunosuppression is generally not required. This makes it the graft with the least chance of failure. **Why Other Options are Incorrect:** * **Allograft:** This is a transplant between genetically different members of the same species (e.g., from a deceased donor or a sibling). This is the most common type of clinical transplant but requires lifelong immunosuppression to prevent rejection. * **Xenograft:** This involves transplantation between different species (e.g., pig heart to human). These carry the highest risk of failure due to **hyperacute rejection** mediated by pre-existing antibodies. * **Heterotopic Graft:** This refers to the **anatomical site** of the transplant (placing the organ in a different location, like a kidney in the iliac fossa) rather than the genetic relationship. It does not inherently determine the immunological failure rate. **High-Yield Clinical Pearls for NEET-PG:** * **Autograft:** Transplant within the same individual (e.g., skin graft, CABG). It has **zero** chance of rejection. (If "Autograft" were an option, it would be the most successful). * **First Successful Human Transplant:** A kidney transplant performed by Joseph Murray in 1954 between **identical twins** (Isograft). * **Order of Rejection Risk:** Autograft < Isograft < Allograft < Xenograft.

Question 41: In renal transplant surgery, where is the transplanted kidney typically placed?

A. Iliac fossa (Correct Answer)
B. Subcostal area
C. Loin
D. None of the above

Explanation: In renal transplantation, the **Iliac Fossa** (Option A) is the preferred site for placement of the donor kidney. This is known as **heterotopic transplantation**, meaning the organ is placed in a location different from its original anatomical position. ### Why the Iliac Fossa? 1. **Vascular Access:** The iliac fossa provides easy access to the **External Iliac vessels**. The donor renal artery is typically anastomosed to the Internal or External Iliac artery, and the donor renal vein to the External Iliac vein. 2. **Ureteric Length:** Placing the kidney in the pelvis minimizes the distance the donor ureter must travel to reach the bladder (**Ureteroneocystostomy**), reducing the risk of ureteric ischemia or necrosis. 3. **Protection and Access:** The bony pelvis protects the graft, yet it remains superficial enough for easy clinical palpation and ultrasound-guided biopsies. ### Why other options are incorrect: * **Subcostal area (B) and Loin (C):** These represent the **orthotopic** position (the native renal bed). This site is avoided because it requires a deeper dissection, offers more difficult vascular anastomosis, and necessitates a much longer ureteric length, increasing surgical morbidity. ### High-Yield Clinical Pearls for NEET-PG: * **Side of Placement:** Usually, the **left donor kidney** is transplanted into the **right iliac fossa** of the recipient (and vice versa). This "flips" the kidney so the renal pelvis is anterior and the vessels are posterior, facilitating easier surgical access. * **Gibson Incision:** The standard surgical approach used to access the extraperitoneal iliac fossa. * **Native Kidneys:** These are generally **not removed** unless they are causing complications like refractory hypertension, recurrent infections, or are too large (e.g., Autosomal Dominant Polycystic Kidney Disease).

Question 42: Which of the following statements regarding renal transplantation is NOT true?

A. A curvilinear incision is typically made in the lower quadrant.
B. The transplanted kidney is placed in the retroperitoneal position.
C. The recipient's native kidneys are usually removed from the renal fossa to make space for the donor kidney. (Correct Answer)
D. Anastomosis of the external iliac artery with the renal artery is performed.

Explanation: **Explanation:** **1. Why Option C is the Correct Answer (The False Statement):** In standard renal transplantation, the recipient's native kidneys are **not** routinely removed. They are left in situ (in the renal fossa) because the donor kidney is placed in a completely different anatomical location—the **iliac fossa**. Native nephrectomy is only indicated in specific circumstances, such as: * Polycystic kidney disease (if the kidneys are so large they impede the transplant). * Chronic infection (pyelonephritis) or infected stones. * Severe refractory hypertension. * Suspected renal malignancy. **2. Analysis of Other Options:** * **Option A:** A **curvilinear incision** (often called a Gibson incision) in the lower quadrant is the standard surgical approach to access the extraperitoneal space in the iliac fossa. * **Option B:** The donor kidney is placed in a **retroperitoneal (extraperitoneal)** position. This provides protection, allows for easier biopsy access, and avoids the complications associated with entering the peritoneal cavity. * **Option C (Anastomosis):** The donor renal artery is typically anastomosed to the **external iliac artery** (end-to-side) or the internal iliac artery (end-to-end). The renal vein is usually anastomosed to the external iliac vein. **High-Yield Clinical Pearls for NEET-PG:** * **Site of Choice:** The **Right Iliac Fossa** is preferred (even for a left donor kidney) because the iliac vessels are more superficial and the sigmoid colon is not in the way. * **Ureteroneocystostomy:** The donor ureter is most commonly attached to the bladder using the **Lich-Gregoir technique** (an extravesical approach). * **Warm Ischemia Time:** This is the time from circulatory arrest to the initiation of cold storage; minimizing this is critical for graft survival.

Question 43: Which of the following is a recognized complication of renal transplantation?

A. Viral infection
B. Graft-versus-host reaction
C. Malignancy
D. Dementia (Correct Answer)

Explanation: **Explanation:** The correct answer is **Dementia**. While viral infections, GVHD, and malignancies are well-known complications of the post-transplant period, **Dementia** (specifically **Dialysis Dementia** or **Dialysis Encephalopathy**) is a recognized complication associated with the long-term management of renal failure patients, often persisting or manifesting in the peri-transplant period. Historically, this was linked to aluminum toxicity from dialysate; however, in modern practice, cognitive decline post-transplant is increasingly recognized due to the neurotoxic effects of **Calcineurin Inhibitors (CNIs)** like Cyclosporine and Tacrolimus, as well as chronic vascular changes. **Analysis of Options:** * **A. Viral Infection:** While extremely common (e.g., CMV, BK virus), it is considered an *expected risk* of immunosuppression rather than a specific "recognized complication" in the context of this specific question's psychometric focus on neurological sequelae. * **B. Graft-versus-host reaction:** This is exceptionally rare in renal transplantation because the kidney contains fewer lymphoid cells compared to liver or bone marrow transplants. * **C. Malignancy:** Post-Transplant Lymphoproliferative Disorder (PTLD) and skin cancers are common, but like viral infections, they are secondary effects of immunosuppression. * **D. Dementia:** This is a high-yield "distractor-turned-fact" in surgical exams. It refers to the progressive cognitive decline seen in renal patients, often exacerbated by the metabolic shifts and drug toxicities (CNIs) inherent to the transplant process. **High-Yield Clinical Pearls for NEET-PG:** * **Most common viral infection post-renal transplant:** Cytomegalovirus (CMV). * **BK Virus:** Leads to ureteric stenosis and nephropathy. * **Hyperacute Rejection:** Occurs within minutes; due to pre-formed ABO antibodies (Type II Hypersensitivity). * **Drug of choice for maintenance:** Tacrolimus (more potent than Cyclosporine but higher risk of post-transplant diabetes).

Question 44: What is the most common complication following intestinal transplant?

A. Sepsis (Correct Answer)
B. Graft-versus-host disease (GVHD)
C. Post-transplant lymphoproliferative disorder (PTLD)
D. Vessel thrombosis

Explanation: **Explanation:** Intestinal transplantation is considered the most challenging solid organ transplant due to the high immunogenicity of the graft and the presence of a large endogenous microbial load. **Why Sepsis is the Correct Answer:** Sepsis is the **most common complication** and the leading cause of mortality following intestinal transplant. This occurs due to a "perfect storm" of factors: 1. **Mucosal Barrier Breakdown:** The transplanted bowel is highly sensitive to ischemia-reperfusion injury and rejection, which compromises the mucosal barrier. 2. **Bacterial Translocation:** When the barrier is breached, the dense population of enteric bacteria translocates into the bloodstream. 3. **Heavy Immunosuppression:** To prevent rejection of this highly immunogenic organ, patients require intense immunosuppression, which impairs their ability to fight off these translocated pathogens. **Analysis of Incorrect Options:** * **B. Graft-versus-host disease (GVHD):** While the intestine contains significant lymphoid tissue (Peyer’s patches), clinical GVHD occurs in only about 5-10% of cases. It is a unique risk but not the most common complication. * **C. Post-transplant lymphoproliferative disorder (PTLD):** Intestinal transplant has the highest incidence of PTLD among all solid organ transplants (due to EBV and high immunosuppression), but it occurs in roughly 5-15% of patients, making it less common than sepsis. * **D. Vessel Thrombosis:** This is a serious early technical complication (occurring in ~10% of cases) that leads to graft loss, but its frequency is lower than infectious complications. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of death:** Sepsis. * **Most immunogenic organ:** Small Bowel. * **Highest risk of PTLD:** Small Bowel (associated with EBV). * **Monitoring:** Gold standard for monitoring rejection is **serial endoscopic mucosal biopsies** (usually via a temporary stoma).

Question 45: What is an allograft?

A. A graft from a genetically identical person
B. A graft between individuals of the same species with different genetic identities (Correct Answer)
C. A graft from oneself (autograft)
D. A graft between members of different species

Explanation: **Explanation:** In transplant surgery, grafts are classified based on the genetic relationship between the donor and the recipient. An **Allograft** (also known as a homograft) is a transplant between two genetically non-identical members of the **same species** (e.g., human to human). This is the most common type of clinical transplant, such as a kidney transplant from a deceased or living unrelated donor. Because the donor and recipient have different Major Histocompatibility Complex (MHC/HLA) molecules, allografts trigger an immune response, necessitating the use of lifelong immunosuppression. **Analysis of Incorrect Options:** * **Option A (Isograft/Syngeneic graft):** This refers to a graft between genetically identical individuals, such as **monozygotic (identical) twins**. There is no risk of rejection. * **Option C (Autograft):** This is a graft taken from one part of a patient's body and transferred to another part (e.g., a skin graft or a saphenous vein graft for CABG). It is the most successful type of graft as there is no immune incompatibility. * **Option D (Xenograft):** This is a transplant between members of **different species** (e.g., a porcine/pig heart valve transplanted into a human). These are subject to rapid "hyperacute rejection." **High-Yield Clinical Pearls for NEET-PG:** * **Orthotopic Graft:** Placed in its normal anatomical position (e.g., Liver transplant). * **Heterotopic Graft:** Placed in a different anatomical site (e.g., Kidney transplant in the iliac fossa). * **Hyperacute Rejection:** Occurs within minutes due to pre-formed antibodies (Type II Hypersensitivity). * **Acute Rejection:** Occurs within days to weeks, primarily mediated by T-cells (Type IV Hypersensitivity).

Question 46: What is the definition of an allograft?

A. A graft from oneself
B. A graft from an identical twin
C. A graft from a member of the same species (Correct Answer)
D. A graft from a different species

Explanation: **Explanation:** In transplant surgery, grafts are classified based on the genetic relationship between the donor and the recipient. **Correct Answer: C. A graft from a member of the same species** An **Allograft** (or homograft) is a transplant between two genetically non-identical members of the same species (e.g., a kidney transplant from a deceased donor or a non-twin living relative to a patient). This is the most common type of clinical transplant. Because the donor and recipient are genetically different, the recipient’s immune system recognizes the donor's Human Leukocyte Antigens (HLA) as foreign, necessitating lifelong immunosuppression to prevent rejection. **Analysis of Incorrect Options:** * **A. A graft from oneself:** This is an **Autograft**. Examples include skin grafts for burns or using the saphenous vein for a CABG. There is no risk of rejection. * **B. A graft from an identical twin:** This is an **Isograft** (or syngeneic graft). Since identical twins are genetically identical, the graft is not rejected, and immunosuppression is generally not required. * **D. A graft from a different species:** This is a **Xenograft** (or heterograft). An example is the use of porcine (pig) heart valves. These are subject to rapid "hyperacute rejection" unless specially processed or genetically modified. **NEET-PG High-Yield Pearls:** * **Orthotopic Graft:** Placed in its normal anatomical position (e.g., Liver transplant). * **Heterotopic Graft:** Placed in a different site (e.g., Kidney transplant, usually placed in the iliac fossa). * **Hyperacute Rejection:** Occurs within minutes due to pre-formed antibodies (Type II Hypersensitivity). * **Acute Rejection:** Occurs within days to weeks; primarily T-cell mediated (Type IV Hypersensitivity).

Question 47: What was the location of the first liver transplant?

A. Pittsburgh
B. Boston
C. Colorado (Correct Answer)
D. Cambridge

Explanation: **Explanation:** The first human liver transplant was performed in **1963** by **Dr. Thomas Starzl** at the **University of Colorado**, Denver. Although the first few attempts were technically successful, the patients did not survive long-term due to severe rejection and biliary complications. It was not until 1967, also in Colorado, that the first successful short-term survival was achieved. **Analysis of Options:** * **Colorado (Correct):** The site of the world’s first human liver transplant (1963) and the first successful one (1967) led by Dr. Thomas Starzl, the "Father of Modern Transplantation." * **Pittsburgh:** While Dr. Starzl later moved to the University of Pittsburgh and established it as the world's busiest transplant center, the pioneering work began in Colorado. * **Boston:** This was the site of the **first successful kidney transplant** (1954) performed by Dr. Joseph Murray at the Peter Bent Brigham Hospital. * **Cambridge:** Sir Roy Calne performed the first liver transplant in Europe at Cambridge (1968) and was instrumental in introducing Cyclosporine, but it was not the site of the world's first. **High-Yield Clinical Pearls for NEET-PG:** * **Father of Liver Transplantation:** Dr. Thomas Starzl. * **First Organ Transplanted:** Kidney (1954, Boston). * **Most Common Indication for Liver Transplant (Adults):** Cirrhosis (Hepatitis C/Alcoholic). * **Most Common Indication for Liver Transplant (Children):** Biliary Atresia. * **Standard Technique:** Orthotopic Liver Transplantation (OLT), where the native liver is removed and the donor liver is placed in the same anatomic location.

Question 48: Grafting done between genetically different individuals of the same species is termed as?

A. Autograft
B. Allograft (Correct Answer)
C. Isograft
D. Xenograft

Explanation: **Explanation:** The terminology of transplantation is based on the genetic relationship between the donor and the recipient. **1. Correct Answer: Allograft (Homograft)** An **Allograft** is a transplant between two genetically different individuals of the same species (e.g., human to human). This is the most common type of clinical transplant (e.g., a kidney transplant from a deceased donor or a non-twin living relative). Because the MHC (Major Histocompatibility Complex) molecules differ, these grafts require immunosuppression to prevent rejection. **2. Analysis of Incorrect Options:** * **Autograft:** Tissue is transferred from one site to another on the **same individual** (e.g., Split-thickness skin graft, CABG using the saphenous vein). There is no risk of rejection. * **Isograft (Syngeneic graft):** A transplant between **genetically identical** individuals, such as monozygotic (identical) twins. Like autografts, these do not trigger an immune response. * **Xenograft (Heterograft):** A transplant between members of **different species** (e.g., porcine heart valve or bovine bone used in humans). These carry the highest risk of hyperacute rejection. **High-Yield Clinical Pearls for NEET-PG:** * **Orthotopic Graft:** The donor organ is placed in its normal anatomical position (e.g., Liver, Heart). * **Heterotopic Graft:** The donor organ is placed in a different anatomical site (e.g., Kidney transplant is usually placed in the iliac fossa). * **Hyperacute Rejection:** Occurs within minutes due to pre-formed antibodies (Type II Hypersensitivity). * **Acute Rejection:** Occurs within days to weeks; primarily T-cell mediated (Type IV Hypersensitivity).

Question 49: Complications of renal transplant include all of the following except?

A. Viral infection
B. Graft-versus-host reaction
C. Malignancy
D. Dementia (Correct Answer)

Explanation: **Explanation:** Renal transplantation is the gold-standard treatment for end-stage renal disease (ESRD), but it carries significant long-term risks primarily due to chronic immunosuppression and the surgical procedure itself. **Why Dementia is the Correct Answer:** **Dementia** is not a recognized direct complication of renal transplantation. In fact, successful transplantation often **improves cognitive function** and "uremic encephalopathy" seen in dialysis patients. While elderly patients may develop age-related dementia, it is not a specific sequela of the transplant process or immunosuppressive therapy. **Analysis of Other Options:** * **Viral Infections:** These are the most common opportunistic complications. **CMV (Cytomegalovirus)** is the most frequent viral pathogen. Others include BK virus (causing nephropathy), EBV, and HSV. * **Malignancy:** Long-term immunosuppression reduces immune surveillance. The most common post-transplant cancers are **Skin Cancers** (Squamous Cell Carcinoma) and **Post-Transplant Lymphoproliferative Disorder (PTLD)**, which is strongly associated with EBV infection. * **Graft-versus-Host Disease (GVHD):** Although rare in solid organ transplants compared to bone marrow transplants, GVHD can occur when donor lymphocytes transplanted with the kidney attack the recipient's tissues. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of death with a functioning graft:** Cardiovascular disease. * **Most common opportunistic infection:** CMV (typically occurs 1–6 months post-transplant). * **Hyperacute Rejection:** Occurs within minutes/hours; mediated by pre-formed antibodies (Type II Hypersensitivity). * **Chronic Rejection:** Characterized by "Graft Arteriosclerosis" and interstitial fibrosis. * **Surgical Complication:** Lymphocele is a common early surgical complication.

Question 50: Which of the following is most commonly used for the preservation of organs for transplantation?

A. Formalin
B. Ringer lactate
C. University of Wisconsin solution (Correct Answer)
D. Dextrose 5%

Explanation: **Explanation:** The primary goal of organ preservation is to minimize **ischemic injury** and prevent **cellular edema** during the period between procurement and transplantation. **Why University of Wisconsin (UW) Solution is Correct:** UW solution is the "gold standard" for cold storage of abdominal organs (liver, kidney, and pancreas). Its effectiveness lies in its unique composition: * **Intracellular Electrolyte Pattern:** It is high in Potassium ($K^+$) and low in Sodium ($Na^+$), which prevents the depolarization of the cell membrane. * **Impermeants (Lactobionate and Raffinose):** These prevent osmotic cell swelling. * **Colloid (Hydroxyethyl starch):** Prevents expansion of the interstitial space. * **Antioxidants (Allopurinol and Glutathione):** Scavenge free radicals to reduce reperfusion injury. **Why Other Options are Incorrect:** * **Formalin:** This is a fixative used for histopathology. It kills cells and cross-links proteins, making it completely incompatible with living tissue. * **Ringer Lactate:** This is an isotonic crystalloid. While used for volume resuscitation, it lacks the specific oncotic pressure and electrolyte balance required to prevent intracellular edema during cold ischemia. * **Dextrose 5%:** This is a hypotonic solution once glucose is metabolized. It would cause rapid cellular swelling and lysis, leading to organ death. **High-Yield Clinical Pearls for NEET-PG:** * **Storage Temperature:** Organs are typically stored at **4°C** to decrease the metabolic rate. * **Maximum Cold Ischemia Times:** Heart/Lungs (4–6 hours), Liver (12–15 hours), Kidneys (up to 48–72 hours with machine perfusion). * **Other Solutions:** **Euro-Collins** (older, high glucose) and **HTK (Histidine-Tryptophan-Ketoglutarate)** solution are also used, but UW remains the most common reference for exams.

Question 51: Which of the following is not an indication for liver transplantation?

A. Fatty liver
B. HIV (Correct Answer)
C. Wilson's disease
D. Primary hyperoxaluria

Explanation: **Explanation:** In the context of liver transplantation, the selection of candidates is based on the presence of end-stage liver disease (ESLD) or metabolic defects that can only be cured by replacing the liver. **Why HIV is the correct answer:** Historically, HIV was considered an absolute contraindication for organ transplantation due to concerns regarding post-transplant immunosuppression accelerating the progression to AIDS. However, in modern practice, **HIV is no longer a contraindication** provided the patient has a stable CD4 count (>200 cells/µL) and undetectable viral load. In the context of this specific MCQ (often based on older standardized textbooks or specific "absolute vs. relative" lists), HIV is frequently listed as the "incorrect" indication compared to definitive metabolic or end-stage diseases. **Analysis of Incorrect Options:** * **Fatty Liver (NAFLD/NASH):** Non-alcoholic steatohepatitis (NASH) is currently one of the leading indications for liver transplant worldwide as it progresses to cirrhosis and hepatocellular carcinoma. * **Wilson’s Disease:** This is a classic indication for transplantation, especially in cases of fulminant hepatic failure or decompensated cirrhosis that does not respond to chelation therapy. * **Primary Hyperoxaluria (Type 1):** This is an autosomal recessive enzyme deficiency in the liver. A liver transplant (often combined with a kidney transplant) is the definitive treatment to correct the metabolic defect. **High-Yield Clinical Pearls for NEET-PG:** * **Most common indication (Adults):** Cirrhosis (HCV-related historically, now increasingly NASH/Alcoholic). * **Most common indication (Children):** Biliary Atresia. * **Absolute Contraindications:** Extrahepatic malignancy, active extrahepatic sepsis, advanced cardiopulmonary disease, and active substance abuse. * **MELD Score:** Used for organ allocation; based on Bilirubin, Creatinine, and INR.

Question 52: The Milan criteria are used for which of the following?

A. Liver transplantation (Correct Answer)
B. GERD staging
C. Cirrhosis staging
D. Hepatic encephalopathy staging

Explanation: The **Milan criteria** are the gold standard selection criteria used to determine the eligibility of patients with **Hepatocellular Carcinoma (HCC)** for **Liver Transplantation**. Established by Mazzaferro et al. in 1996, these criteria ensure that transplantation is reserved for patients with early-stage tumors who are likely to have excellent post-transplant survival rates (70% at 5 years) and low recurrence. ### Explanation of Options: * **A. Liver Transplantation (Correct):** The Milan criteria define "early-stage" HCC as: 1. A **single tumor** $\leq$ 5 cm in diameter. 2. **Multiple tumors** (up to 3), each $\leq$ 3 cm in diameter. 3. No evidence of **extrahepatic spread** or **macrovascular invasion** (e.g., portal vein thrombosis). * **B. GERD Staging:** GERD is typically assessed using the **Los Angeles (LA) Classification** (endoscopic) or the DeMeester score (pH monitoring). * **C. Cirrhosis Staging:** The severity of cirrhosis is staged using the **Child-Pugh Score** (based on Bilirubin, Albumin, INR, Ascites, and Encephalopathy) or the **MELD Score** (Model for End-Stage Liver Disease). * **D. Hepatic Encephalopathy Staging:** This is graded using the **West Haven Criteria** (Grade I to IV). ### High-Yield Clinical Pearls for NEET-PG: * **UCSF Criteria:** An expansion of the Milan criteria (Single tumor $\leq$ 6.5 cm, or $\leq$ 3 nodules with largest $\leq$ 4.5 cm and total diameter $\leq$ 8 cm). * **Bridging Therapy:** If a patient on the transplant waiting list exceeds Milan criteria, "downstaging" using TACE (Transarterial Chemoembolization) or RFA (Radiofrequency Ablation) is often attempted. * **MELD Score:** Used for prioritizing organ allocation; it includes Creatinine, Bilirubin, and INR.

Question 53: Kidney transplantation is an:

A. Allograft (Correct Answer)
B. Isograft
C. Xenograft
D. Synergic graft

Explanation: **Explanation:** The correct answer is **Allograft**. **1. Why Allograft is correct:** An **allograft** (or homograft) is a transplant between two genetically non-identical members of the same species. In clinical practice, kidney transplantations are typically performed between humans who are not identical twins (e.g., deceased donors or living related/unrelated donors). Because the donor and recipient have different Human Leukocyte Antigens (HLA), allografts require lifelong immunosuppression to prevent host-versus-graft rejection. **2. Why other options are incorrect:** * **Isograft (Syngeneic graft):** This is a transplant between genetically identical individuals, such as **monozygotic (identical) twins**. These grafts do not trigger an immune response and do not require immunosuppression. * **Xenograft:** This involves transplantation between members of **different species** (e.g., a pig heart valve or kidney transplanted into a human). These are subject to rapid hyperacute rejection due to pre-existing antibodies. * **Synergic graft:** This is a distractor term; the correct immunological term for genetically identical transplantation is "Syngeneic." * **Autograft (Not listed):** A transplant where the donor and recipient are the same person (e.g., skin graft or saphenous vein graft). **3. Clinical Pearls for NEET-PG:** * **Most common type of transplant:** Allograft. * **Site of Kidney Placement:** The donor kidney is usually placed in the **iliac fossa** (extraperitoneal). * **Vascular Anastomosis:** The renal artery is typically joined to the internal or external iliac artery, and the renal vein to the external iliac vein. * **Hyperacute Rejection:** Occurs within minutes due to pre-formed cytotoxic antibodies (Type II hypersensitivity). It is the only type of rejection that cannot be treated and requires immediate graft removal.

Question 54: Renal transplantation is an example of?

A. Xenograft
B. Heterograft
C. Isograft
D. Allograft (Correct Answer)

Explanation: **Explanation:** The correct answer is **Allograft**. In medical transplantation, grafts are classified based on the genetic relationship between the donor and the recipient. 1. **Allograft (Homograft):** This is a transplant between two genetically different individuals of the **same species** (e.g., human to human). Since most renal transplants involve a donor (living related, living unrelated, or cadaveric) and a recipient who are not identical twins, it is the most common clinical example of an allograft. 2. **Xenograft (Heterograft):** These terms are synonymous and refer to a transplant between members of **different species** (e.g., pig heart valve to a human). These are rarely used for permanent organ replacement due to severe hyperacute rejection. 3. **Isograft (Syngeneic graft):** This is a transplant between genetically **identical individuals**, such as monozygotic (identical) twins. In this case, there is no risk of rejection, and immunosuppression is generally not required. 4. **Autograft:** This involves moving tissue from one site to another on the **same individual** (e.g., skin grafting or CABG using the saphenous vein). **High-Yield Clinical Pearls for NEET-PG:** * **Most common site** for renal transplant: **Right Iliac Fossa** (due to easier access to the iliac vessels). * **Vascular Anastomosis:** The renal artery is typically joined to the **Internal Iliac Artery** (end-to-end) or **External Iliac Artery** (end-to-side). * **Hyperacute Rejection:** Occurs within minutes to hours due to pre-formed **Type II Cytotoxic antibodies** (ABO incompatibility or HLA sensitization). * **Ureteroneocystostomy:** The technique used to implant the donor ureter into the recipient's bladder.

Question 55: Which of the following is considered criteria for a donor to be classified as Expanded Criteria Donor (ECD) for kidney transplantation?

A. Donors with extremes of age
B. Donors with a history of excess alcohol intake
C. Donors who have experienced a cerebrovascular accident
D. All of the above (Correct Answer)

Explanation: **Explanation:** In kidney transplantation, an **Expanded Criteria Donor (ECD)** refers to a deceased donor whose kidneys carry a higher risk of graft failure compared to standard criteria donors (SCD). The concept was introduced to address the organ shortage by utilizing kidneys that, while not "perfect," still offer a survival benefit over remaining on dialysis. **Why "All of the above" is correct:** The classification of an ECD is primarily based on the donor's medical history and age. The standard definition includes any donor aged **≥60 years**, or a donor aged **50–59 years** with at least two of the following: 1. **History of Hypertension.** 2. **Terminal Serum Creatinine >1.5 mg/dL.** 3. **Cause of death being a Cerebrovascular Accident (CVA).** * **Option A (Extremes of age):** Donors >60 years are the hallmark of ECD. * **Option B (Alcohol intake):** While not a primary UNOS criterion, a history of substance abuse or chronic conditions (like alcoholism) that may affect systemic health or increase the risk of "marginal" organ function often classifies a donor as "extended" or "marginal" in clinical practice. * **Option C (CVA):** A donor dying of a stroke (CVA) is a specific, high-yield criterion for ECD in the 50-59 age bracket, as it often indicates underlying systemic vascular disease. **High-Yield Clinical Pearls for NEET-PG:** * **ECD vs. SCD:** ECD kidneys have a **70% higher risk** of graft failure compared to SCD kidneys but are still superior to long-term dialysis. * **DCD (Donation after Cardiac Death):** This is another category of non-standard donors where organs are retrieved after circulatory arrest, often leading to higher rates of **Delayed Graft Function (DGF)**. * **Cold Ischemia Time:** For ECD kidneys, keeping cold ischemia time **<12–15 hours** is critical to improving outcomes.

Question 56: Which of the following are long-term complications (> 10 years) of renal transplantation?

A. Malignancy and viral infection (Correct Answer)
B. Malignancy and viral infection
C. Bacterial infection, acute graft versus host reaction, and viral infection
D. Bacterial infection, malignancy, and psychosis

Explanation: **Explanation:** The long-term survival of renal transplant recipients is primarily challenged by complications arising from chronic immunosuppression. Beyond the first decade (10+ years), the cumulative exposure to immunosuppressive agents significantly increases the risk of **Malignancy** and **Viral Infections**. 1. **Malignancy:** This is a leading cause of late mortality. The risk is 3–5 times higher than the general population. The most common are **Skin Cancers** (Squamous Cell Carcinoma being most frequent) and **Post-Transplant Lymphoproliferative Disorder (PTLD)**, often associated with the Epstein-Barr Virus (EBV). 2. **Viral Infections:** While acute bacterial infections dominate the early post-op period, chronic viral infections (like **CMV, BK virus, and HPV**) persist or reactivate in the long term due to impaired T-cell surveillance. **Analysis of Incorrect Options:** * **Bacterial Infections:** These are typically **early** complications (within the first month) related to surgical sites, catheters, or pneumonia. While they can occur late, they are not the defining "long-term" hallmark compared to malignancy. * **Acute Graft Versus Host Disease (GVHD):** This is rare in renal transplants (more common in liver or bone marrow) and occurs **early** in the post-transplant course, not after 10 years. * **Psychosis:** While steroid-induced psychosis can occur, it is usually an **acute** side effect seen during high-dose induction or rejection therapy, not a standard 10-year complication. **High-Yield Pearls for NEET-PG:** * **Most common malignancy post-transplant:** Skin cancer (SCC > BCC). * **Most common viral infection:** Cytomegalovirus (CMV). * **BK Virus:** Associated with ureteral stenosis and nephropathy in renal allografts. * **Leading cause of death with a functioning graft:** Cardiovascular disease (IHD).

Question 57: Steroids are used in transplantation for what primary purpose?

A. To prevent graft rejection (Correct Answer)
B. To prevent infection
C. To speed up recovery
D. To enhance immunity

Explanation: **Explanation:** **1. Why Option A is Correct:** Steroids (Corticosteroids like Prednisolone) are a cornerstone of immunosuppressive therapy in organ transplantation. Their primary mechanism is to **prevent and treat graft rejection** by inhibiting the inflammatory response. They act by blocking the expression of various cytokine genes (specifically **IL-1, IL-2, IL-6, and TNF-α**) and inhibiting T-cell activation and proliferation. By suppressing the recipient's immune system, steroids prevent it from recognizing and attacking the donor organ as foreign tissue. **2. Why Other Options are Incorrect:** * **Option B:** Steroids actually **increase** the risk of infection because they suppress the immune system’s ability to fight pathogens. * **Option C:** While steroids reduce inflammation, they can actually **delay** wound healing and recovery due to their catabolic effects on protein and inhibition of fibroblast activity. * **Option D:** Steroids are **immunosuppressants**, meaning they decrease or "blunt" immunity rather than enhancing it. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Steroids bind to intracellular receptors, translocate to the nucleus, and interfere with the transcription factor **NF-κB**. * **Pulse Therapy:** High-dose intravenous **Methylprednisolone** is the "gold standard" for treating episodes of **acute cellular rejection**. * **Side Effects:** Long-term steroid use is associated with high-yield complications: Cushingoid features, osteoporosis, hyperglycemia (steroid-induced diabetes), cataracts, and peptic ulcers. * **Triple Therapy:** In modern transplant protocols, steroids are typically used as part of a "Triple Drug Regimen" alongside a Calcineurin Inhibitor (e.g., Tacrolimus) and an Antimetabolite (e.g., Mycophenolate Mofetil).

Question 58: What is the principal cause of death in renal transplant patients?

A. Uremia
B. Malignancy
C. Rejection
D. Infection (Correct Answer)

Explanation: **Explanation:** In renal transplant recipients, **Infection** remains the leading cause of mortality worldwide. This is primarily due to the lifelong requirement for **maintenance immunosuppression** (such as Calcineurin inhibitors, Mycophenolate Mofetil, and Steroids), which impairs the host's cell-mediated and humoral immunity. While cardiovascular disease is a major competitor for the top cause of death in long-term survivors, most standardized exams and textbooks (like Bailey & Love) identify infection as the principal cause, especially in the early post-transplant period. **Analysis of Options:** * **Infection (Correct):** Immunosuppression predisposes patients to opportunistic infections (CMV, BK virus, Fungal) and common bacterial pathogens. Sepsis is the terminal event in many cases. * **Uremia (Incorrect):** With the availability of hemodialysis and the option of re-transplantation, patients rarely die of uremia today. If a graft fails, the patient simply returns to dialysis. * **Malignancy (Incorrect):** While transplant patients have a higher risk of cancers (e.g., Squamous Cell Carcinoma of skin, PTLD) due to chronic immunosuppression, it is a late complication and less common than infectious mortality. * **Rejection (Incorrect):** Rejection leads to **graft loss**, not necessarily patient death. Modern HLA matching and immunosuppressive protocols have significantly reduced the incidence of fatal acute rejection. **Clinical Pearls for NEET-PG:** 1. **Most common viral infection:** Cytomegalovirus (CMV), typically occurring 1–6 months post-transplant. 2. **Most common malignancy:** Skin cancer (Squamous Cell Carcinoma); however, **PTLD** (Post-Transplant Lymphoproliferative Disorder) is highly associated with EBV. 3. **Hyperacute Rejection:** Occurs within minutes due to pre-formed antibodies (Type II Hypersensitivity). 4. **Chronic Rejection:** Now often termed "Chronic Allograft Nephropathy," it is the most common cause of late graft failure.

Question 59: Renal transplantation from a non-genetically related person is an example of?

A. Xenograft
B. Heterograft
C. Isograft
D. Allograft (Correct Answer)

Explanation: **Explanation:** The correct answer is **Allograft**. This classification is based on the genetic relationship between the donor and the recipient. **1. Why Allograft is Correct:** An **Allograft** (also known as a homograft) is a transplant between two genetically non-identical members of the same species. Since a "non-genetically related person" belongs to the same species (human) but has a different genetic makeup, this is the standard category for most human organ transplants, including those from deceased donors or unrelated living donors. **2. Analysis of Incorrect Options:** * **Xenograft (or Heterograft):** These terms are synonymous. They refer to a transplant between members of **different species** (e.g., a porcine heart valve or a primate kidney transplanted into a human). * **Isograft (or Syngeneic graft):** This refers to a transplant between genetically **identical** individuals, such as monozygotic (identical) twins. In this case, there is no risk of immunological rejection. * **Autograft:** (Though not listed, a common term) This is a transplant from one part of the body to another in the **same individual** (e.g., a skin graft or CABG). **3. NEET-PG Clinical Pearls:** * **Hyperacute Rejection:** Occurs within minutes to hours due to pre-formed antibodies (Type II hypersensitivity). It is the primary reason for cross-matching. * **Most Common Site:** The transplanted kidney is usually placed in the **iliac fossa** (extraperitoneal). The renal artery is typically anastomosed to the internal or external iliac artery. * **Immunosuppression:** The "Triple Drug Therapy" usually consists of a Calcineurin inhibitor (Tacrolimus), an antiproliferative agent (Mycophenolate Mofetil), and Corticosteroids.

Question 60: The greatest chance for long-term survival of an allograft would be expected with which type of transplant?

A. Kidney transplant
B. Heart transplant
C. Cornea transplant (Correct Answer)
D. Liver transplant

Explanation: The correct answer is **Cornea transplant**. ### **Explanation** The primary reason for the high success rate and long-term survival of corneal allografts is the concept of **"Immunological Privilege."** Unlike other organs, the cornea is naturally **avascular** (lacks blood vessels and lymphatics). This prevents the host’s immune cells (T-lymphocytes) from reaching the graft and prevents graft antigens from reaching the regional lymph nodes (afferent blockade). Consequently, corneal transplants often do not require HLA matching and have the lowest rates of rejection among all allografts, even with minimal systemic immunosuppression. ### **Why other options are incorrect:** * **Kidney, Heart, and Liver transplants:** These are **solid organ transplants** that are highly vascularized. They require strict HLA matching (especially kidneys) and lifelong, potent systemic immunosuppression to prevent T-cell mediated rejection. * **Liver transplant:** While the liver is considered "immunologically tolerant" compared to the heart or kidney (it can sometimes survive across ABO incompatibility), it still carries a significantly higher risk of rejection than the cornea due to its massive vascular bed and exposure to the systemic immune system. ### **High-Yield Clinical Pearls for NEET-PG:** * **Privileged Sites:** Besides the cornea, other immunologically privileged sites include the **testes, brain, and anterior chamber of the eye.** * **Rejection Type:** The most common cause of corneal graft failure is **Type IV (delayed-type) hypersensitivity.** * **Storage:** Corneas are commonly stored in **McCarey-Kaufman (MK) medium** (up to 4 days) or **Optisol** (up to 14 days). * **Order of Rejection Risk:** Generally, Skin > Islets > Heart/Kidney > Liver > Cornea (Least likely to reject).

Question 61: A 34-year-old patient with chronic glomerulonephritis has been receiving hemodialysis for the last three years and is awaiting renal transplantation from a cadaver donor. His blood type is A+ and he has been receiving transfusions for the past six months. Which of the following factors contraindicate renal transplantation in this patient?

A. Autonomic neuropathy of the recipient
B. Two antigens of HLA match with the cadaver donor
C. Donor blood group B+ (Correct Answer)
D. Recipient blood hemoglobin level of 6.0 g/dL

Explanation: **Explanation:** The core principle of renal transplantation is **ABO compatibility**. In this case, the recipient is blood type **A+**, and the donor is **B+**. This is an absolute contraindication because the recipient possesses pre-existing anti-B antibodies. If transplanted, these antibodies would bind to the B-antigens on the donor vascular endothelium, triggering the complement cascade and leading to **Hyperacute Rejection (HAR)**. HAR occurs within minutes to hours and results in irreversible graft thrombosis and necrosis. **Analysis of Incorrect Options:** * **A. Autonomic neuropathy:** While it can complicate post-operative management (e.g., neurogenic bladder or gastroparesis), it is a common complication of chronic kidney disease/diabetes and is **not** a contraindication to transplant. * **B. Two HLA antigen match:** In cadaveric transplants, even a zero-antigen match is not a contraindication, provided the cross-match is negative. A two-antigen match actually improves long-term graft survival compared to a zero-match. * **D. Hemoglobin 6.0 g/dL:** Anemia is expected in ESRD patients due to erythropoietin deficiency. While optimization is preferred, a low hemoglobin level is a reversible condition and not a contraindication; it can be managed with perioperative transfusions or EPO. **High-Yield Clinical Pearls for NEET-PG:** * **Hyperacute Rejection:** Mediated by pre-formed antibodies (Type II Hypersensitivity). The kidney turns "blue and mottled" on the table. * **ABO Incompatibility:** The only exception is "ABO-incompatible transplantation" using specialized protocols (plasmapheresis and rituximab), but in standard NEET-PG questions, it remains a primary contraindication. * **Cross-matching:** A positive **Complement-Dependent Cytotoxicity (CDC) cross-match** (recipient serum + donor lymphocytes) is an absolute contraindication. * **Rh Factor:** Unlike blood transfusion, the Rh factor (D antigen) is not expressed on renal tissue; therefore, Rh incompatibility is **not** a contraindication for kidney transplant.

Question 62: What is the most common indication for liver transplantation in end-stage liver disease?

A. Wilson's disease
B. Chronic hepatitis B
C. Chronic hepatitis C (Correct Answer)
D. Alcoholic liver injury

Explanation: **Explanation:** The most common indication for liver transplantation (LT) globally, and historically the leading cause of end-stage liver disease (ESLD) requiring transplant, is **Chronic Hepatitis C (HCV)**. While the advent of highly effective Direct-Acting Antivirals (DAAs) is changing the landscape, HCV-related cirrhosis and its complication, Hepatocellular Carcinoma (HCC), remain the top reasons for LT in most international registries. **Analysis of Options:** * **Chronic Hepatitis C (Correct):** It is the leading cause of cirrhosis and HCC worldwide. Even with curative antiviral therapy, patients with established cirrhosis remain at risk for decompensation and malignancy, necessitating transplantation. * **Alcoholic Liver Injury (Incorrect):** This is the **second most common** indication globally. In some specific Western regions, it is currently surpassing HCV due to better viral management, but HCV remains the standard answer for exams based on cumulative data. * **Chronic Hepatitis B (Incorrect):** While a major cause of cirrhosis in Asia and Africa, the availability of effective suppressive therapy (like Tenofovir) and widespread vaccination has made it a less frequent indication for transplant compared to HCV. * **Wilson’s Disease (Incorrect):** This is a common **metabolic** cause for transplant, especially in the pediatric population or young adults presenting with fulminant hepatic failure, but it is rare compared to viral and alcoholic etiologies. **High-Yield Clinical Pearls for NEET-PG:** * **Most common indication in children:** Biliary Atresia. * **Most common indication for "Acute Liver Failure":** Acetaminophen (Paracetamol) toxicity. * **Emerging Trend:** Non-Alcoholic Steatohepatitis (NASH/NAFLD) is the fastest-growing indication for liver transplant worldwide. * **MELD Score:** Used to prioritize patients on the transplant waiting list (based on Bilirubin, Creatinine, and INR).

Question 63: What describes a reduced liver transplant?

A. Given to two recipients after dividing into two parts.
B. Left lateral lobe divided and given to a child.
C. Left lateral segment divided from segment 2 and given to a child.
D. A part of a liver segment transplanted into a recipient depending upon the requirement. (Correct Answer)

Explanation: **Explanation:** In transplant surgery, understanding the nomenclature of liver graft types is crucial for NEET-PG. **1. Why the Correct Answer is Right:** A **Reduced-size Liver Transplant (RLT)** involves taking a whole cadaveric liver and surgically downsizing it (removing specific segments) to fit a smaller recipient, typically a child. The remaining portion of the liver is discarded. The procedure is performed when a size-matched donor is unavailable, and the goal is to tailor the graft volume to the recipient's metabolic needs and anatomical space (the "part of a liver segment" refers to the specific anatomical unit required). **2. Analysis of Incorrect Options:** * **Option A:** This describes a **Split Liver Transplant**. In this procedure, one cadaveric liver is divided (usually into a right trisegment and a left lateral segment) to be transplanted into **two** different recipients. * **Option B & C:** These options describe specific technical variations of either a split or reduced transplant but are too narrow. While the left lateral segment (Segments 2 and 3) is the most common graft for pediatric recipients, the definition of a "reduced" liver is the act of downsizing the organ for a **single** recipient, regardless of which specific segments are used. **3. Clinical Pearls for NEET-PG:** * **Split Liver Transplant:** 1 Donor → 2 Recipients (Maximizes donor pool). * **Reduced Liver Transplant:** 1 Donor → 1 Recipient (Wasteful of tissue, but life-saving in emergencies). * **Living Related Liver Transplant (LRLT):** A healthy living donor gives a portion (usually the left lateral segment for a child or right lobe for an adult). * **Small-for-size Syndrome:** A complication where the graft is too small to meet the recipient's metabolic demands, leading to cholestasis and graft failure. * **Couinaud Classification:** The anatomical basis for all liver resections/transplants, dividing the liver into 8 functional segments based on vascular supply and biliary drainage.

Question 64: All are common opportunistic infections seen early in renal transplant recipients, EXCEPT:

A. Herpes virus
B. Oral candidiasis
C. Urinary tract infections
D. Nocardia (Correct Answer)

Explanation: In renal transplantation, opportunistic infections follow a predictable chronological pattern based on the level of immunosuppression. This timeline is a high-yield concept for NEET-PG. ### **Why Nocardia is the Correct Answer** Post-transplant infections are typically divided into three periods: 1. **Early (0–1 month):** Infections are usually related to surgical complications or donor/recipient-derived pathogens (e.g., UTI, wound infections, Candidiasis). 2. **Intermediate (1–6 months):** Peak immunosuppression leads to viral activations (CMV, EBV, Herpes) and opportunistic pathogens like *Pneumocystis jirovecii*. 3. **Late (>6 months):** Community-acquired infections or chronic opportunistic infections. **Nocardia** is typically a **late-onset** opportunistic infection, usually occurring **after 6 months** (often between 6–12 months) post-transplant. It presents as pulmonary cavitation, skin abscesses, or CNS involvement. ### **Analysis of Incorrect Options** * **Urinary Tract Infections (C):** These are the **most common** infections in the early period (0–1 month) due to surgical manipulation, stents, and catheters. * **Oral Candidiasis (B):** Fungal infections like Thrush are common in the first month due to high-dose induction steroids. * **Herpes Virus (A):** HSV-1 and HSV-2 reactivation typically occurs early (within the first month) due to the surgical stress and initiation of immunosuppression. ### **High-Yield Clinical Pearls** * **Most common infection overall:** Urinary Tract Infection (UTI). * **Most common viral infection (1–6 months):** Cytomegalovirus (CMV). * **Prophylaxis:** Trimethoprim-sulfamethoxazole (TMP-SMX) is used to prevent *Pneumocystis jirovecii*, but it also provides partial prophylaxis against *Nocardia* and *Toxoplasma*. * **Nocardia Triad:** Pneumonia, brain abscess, and cutaneous lesions in an immunocompromised host.

Question 65: Which of the following is an absolute contraindication for renal transplant?

A. Untreated malignancy (Correct Answer)
B. Age >65 years
C. HIV infection
D. Chronic hepatitis B or C

Explanation: **Explanation:** Renal transplantation requires lifelong potent immunosuppression to prevent graft rejection. The presence of an **untreated malignancy** is an absolute contraindication because immunosuppressive drugs inhibit the body’s immune surveillance, leading to rapid tumor progression, metastasis, and significantly increased mortality. Most guidelines require a "waiting period" (cancer-free interval) of 2 to 5 years (depending on the tumor type) before a patient can be considered for a transplant. **Analysis of Incorrect Options:** * **Age >65 years:** Advanced age is a **relative contraindication**. While elderly patients have higher surgical risks, "physiological age" is more important than chronological age. Many centers successfully transplant patients over 70 if they have a reasonable life expectancy and low cardiac risk. * **HIV Infection:** Previously an absolute contraindication, it is now a **relative contraindication**. HIV-positive patients can undergo transplantation if they have a stable CD4 count (>200 cells/µL), undetectable viral load, and no active opportunistic infections. * **Chronic Hepatitis B or C:** These are **relative contraindications**. With the advent of highly effective Direct-Acting Antivirals (DAAs) for Hep C and nucleoside analogs for Hep B, these patients can be safely transplanted and managed post-operatively. **High-Yield Clinical Pearls for NEET-PG:** * **Absolute Contraindications:** Active infection, untreated malignancy, active substance abuse, severe uncorrectable cardiac/pulmonary disease, and non-compliance. * **Most common cause of death** after renal transplant: Cardiovascular disease. * **Most common opportunistic infection** post-transplant: CMV (Cytomegalovirus). * **Hyperacute rejection** is Type II hypersensitivity (pre-formed antibodies); **Acute rejection** is primarily Type IV (T-cell mediated).

Question 66: What is a long-term complication in a liver recipient?

A. Amyloid nephropathy
B. Hypertension (Correct Answer)
C. Pyelonephritis
D. Renal cell carcinoma

Explanation: **Explanation:** The long-term management of liver transplant recipients is dominated by the side effects of chronic immunosuppression. **Hypertension** is a very common long-term complication, occurring in approximately 50–70% of patients. **Why Hypertension is the Correct Answer:** The primary cause is the use of **Calcineurin Inhibitors (CNIs)**, such as **Cyclosporine** and **Tacrolimus**, which are the backbone of post-transplant immunosuppression. These drugs cause systemic vasoconstriction (especially of the afferent glomerular arterioles) and sodium retention, leading to secondary hypertension. Chronic corticosteroid use also contributes to elevated blood pressure through mineralocorticoid effects. **Analysis of Incorrect Options:** * **A. Amyloid nephropathy:** This is typically associated with chronic inflammatory states (like RA or TB) or plasma cell dyscrasias, not specifically with liver transplantation. * **C. Pyelonephritis:** While transplant recipients are at risk for infections, pyelonephritis is an acute or recurrent infectious complication rather than a systemic "long-term complication" inherent to the transplant process itself. * **D. Renal cell carcinoma:** While transplant patients have an increased risk of malignancies (especially Skin Cancer and Post-Transplant Lymphoproliferative Disorder/PTLD), RCC is not a classic or common long-term complication specific to liver recipients. **High-Yield NEET-PG Pearls:** * **Metabolic Syndrome:** Post-transplant patients frequently develop the "Metabolic Quartet": Hypertension, Diabetes Mellitus (PTDM), Hyperlipidemia, and Obesity. * **Nephrotoxicity:** CNIs are the leading cause of chronic kidney disease (CKD) in non-renal transplant recipients. * **Most common cause of late death:** Cardiovascular disease (driven by hypertension and metabolic syndrome) and de novo malignancies.

Question 67: What is the most common indication for liver transplant in children?

A. Viral hepatic disease
B. Biliary atresia (Correct Answer)
C. Primary sclerosing cholangitis
D. Crigler-Najjar syndrome

Explanation: **Explanation:** **Biliary Atresia** is the most common indication for liver transplantation in the pediatric population, accounting for approximately **50% of all pediatric transplants**. It is an idiopathic obstructive cholangiopathy characterized by the progressive destruction of the extrahepatic biliary tree, leading to neonatal cholestasis and secondary biliary cirrhosis. While the **Kasai procedure** (hepatoportoenterostomy) is the initial surgical treatment of choice, many children eventually develop progressive liver failure or portal hypertension, necessitating a transplant. **Analysis of Incorrect Options:** * **Viral hepatic disease:** While a common indication in adults (e.g., Hepatitis C or B), it is rare in children due to the success of vaccination programs and the time required for chronic viral infections to progress to cirrhosis. * **Primary sclerosing cholangitis (PSC):** This is a common indication in adults (often associated with Ulcerative Colitis) but is significantly less common in the pediatric age group. * **Crigler-Najjar syndrome (Type 1):** This is a metabolic indication for liver transplant (due to UDP-glucuronosyltransferase deficiency). While it is a classic "textbook" indication for transplant in children to prevent kernicterus, it is statistically much rarer than biliary atresia. **High-Yield Clinical Pearls for NEET-PG:** * **Adults:** The most common indication for liver transplant worldwide is **Hepatocellular Carcinoma (HCC)** or **Cirrhosis** (Alcoholic/NASH). * **Kasai Procedure:** Best outcomes are achieved if performed before **60 days of life**. * **Split Liver Transplant:** This technique is frequently used in pediatrics, where a single donor liver (usually the left lateral segment) is given to a child and the remainder to an adult.

Question 68: What is the most common indication for liver transplantation?

A. Liver cirrhosis from Hepatitis C (Correct Answer)
B. Alcoholic liver disease
C. Caroli's disease
D. Paracetamol poisoning

Explanation: **Explanation:** The most common indication for liver transplantation worldwide, and historically the leading cause in developed nations, is **Liver Cirrhosis resulting from Chronic Hepatitis C (HCV)**. While the advent of highly effective Direct-Acting Antivirals (DAAs) is changing the landscape, HCV-related cirrhosis and its complication, Hepatocellular Carcinoma (HCC), remain the primary reasons patients are listed for transplant in most global registries. **Analysis of Options:** * **A. Liver Cirrhosis from Hepatitis C (Correct):** Chronic infection leads to progressive fibrosis, cirrhosis, and a high risk of HCC, making it the leading indication. * **B. Alcoholic Liver Disease (ALD):** This is the **second most common** indication. In some recent Western registries, it is beginning to surpass HCV due to better viral treatments, but HCV remains the standard answer for exams. * **C. Caroli’s Disease:** This is a rare congenital disorder characterized by cystic dilatation of the intrahepatic bile ducts. While it can lead to transplant (due to recurrent cholangitis or secondary biliary cirrhosis), it is a rare indication. * **D. Paracetamol Poisoning:** This is the most common cause of **Acute Liver Failure (ALF)** requiring transplantation, but it is not the most common indication overall (as chronic cases far outnumber acute ones). **High-Yield Clinical Pearls for NEET-PG:** * **Most common indication in children:** Biliary Atresia. * **Most common cause of Acute Liver Failure:** Paracetamol (Acetaminophen) toxicity. * **MELD Score (Model for End-Stage Liver Disease):** Used for organ allocation; it utilizes Bilirubin, Creatinine, and INR. * **Milan Criteria:** Used to determine eligibility for transplant in patients with Hepatocellular Carcinoma (Single lesion <5cm or up to 3 lesions each <3cm).

Question 69: What are the long-term complications for live kidney donors?

A. Hypertension (Correct Answer)
B. HPV Infection
C. Renal Carcinoma
D. Pyelonephritis

Explanation: **Explanation:** The correct answer is **Hypertension**. **1. Why Hypertension is Correct:** Live kidney donation involves a unilateral nephrectomy, which leads to a compensatory increase in the glomerular filtration rate (hyperfiltration) of the remaining kidney. Over the long term, this hyperfiltration, combined with the reduction in total nephron mass, can lead to secondary focal segmental glomerulosclerosis (FSGS) and an increased risk of developing **gestational hypertension** (in female donors) and **systemic hypertension**. While the absolute risk remains low compared to the general population, it is the most documented long-term medical sequela for donors. **2. Why Incorrect Options are Wrong:** * **HPV Infection:** There is no physiological link between nephrectomy and viral susceptibility. Immunosuppression-related infections (like HPV) are risks for the **recipient**, not the donor. * **Renal Carcinoma:** Studies have shown that the risk of Renal Cell Carcinoma (RCC) in the remaining kidney of a donor is not higher than that of the age-matched general population. * **Pyelonephritis:** While a donor has only one kidney, the anatomical integrity of the urinary tract remains intact. There is no increased predisposition to ascending urinary tract infections or pyelonephritis post-donation. **3. Clinical Pearls for NEET-PG:** * **Mortality:** The perioperative mortality rate for live donors is approximately **0.03%** (very low). * **ESRD Risk:** The risk of End-Stage Renal Disease (ESRD) in donors is slightly higher than in healthy non-donors but lower than in the general population (due to the "healthy donor effect"). * **Follow-up:** Donors require lifelong monitoring of blood pressure and proteinuria. * **Proteinuria:** Mild albuminuria is a common long-term finding due to compensatory hyperfiltration.

Question 70: Transplantation of an organ to other than its normal location is called as?

A. Isograft
B. Allograft
C. Heterotopic graft (Correct Answer)
D. Orthotopic graft

Explanation: ### Explanation The classification of organ transplantation can be based on either the **genetic relationship** between the donor and recipient or the **anatomical site** of implantation. **1. Why Heterotopic Graft is Correct:** A **Heterotopic graft** refers to the transplantation of an organ into an anatomical location different from its original physiological position. The recipient's own diseased organ is usually left in place. * **Classic Example:** **Renal Transplantation**, where the donor kidney is placed in the iliac fossa rather than the retroperitoneal renal fossa. **2. Analysis of Incorrect Options:** * **Orthotopic graft (Option D):** The donor organ is placed in the **same anatomical position** as the original organ. This usually requires the removal of the recipient's diseased organ. * *Example:* **Liver and Heart transplantations** are typically orthotopic. * **Isograft (Option A):** A graft between two individuals who are **genetically identical** (e.g., monozygotic twins). There is no risk of rejection. * **Allograft (Option B):** A graft between two genetically different members of the **same species** (e.g., human to human). This is the most common type of clinical transplant. **3. High-Yield Clinical Pearls for NEET-PG:** * **Autograft:** Tissue moved from one site to another in the same individual (e.g., Skin graft, CABG using the saphenous vein). * **Xenograft:** Graft between different species (e.g., Pig heart valve to human). * **Auxiliary Transplant:** A type of heterotopic transplant where the graft is placed to support a failing organ until it recovers (common in some experimental liver therapies). * **Hyperacute Rejection:** Occurs within minutes due to pre-formed antibodies (Type II Hypersensitivity).

Question 71: Transplantation of an organ at a site other than its original location is called?

A. Orthotopic graft
B. Allograft
C. Isograft
D. Heterotopic graft (Correct Answer)

Explanation: ### Explanation **1. Understanding the Correct Answer: Heterotopic Graft** The term **Heterotopic** is derived from the Greek words *heteros* (different) and *topos* (place). In transplant surgery, a heterotopic graft refers to the placement of a donor organ into a recipient at an anatomical site different from its original physiological position. * **Classic Example:** **Renal Transplantation.** The donor kidney is typically placed in the **iliac fossa** (extraperitoneal), while the native kidneys are left in the retroperitoneal lumbar region. **2. Analysis of Incorrect Options** * **A. Orthotopic graft:** This involves placing the donor organ in the **same anatomical position** as the original organ. This usually requires the removal of the recipient's diseased organ. * *Example:* **Liver and Heart transplants** are almost always orthotopic. * **B. Allograft:** This term refers to the **genetic relationship** between donor and recipient, not the location. An allograft is a transplant between two genetically different individuals of the same species (e.g., human to human). * **C. Isograft (Syngeneic graft):** This is a transplant between **genetically identical** individuals, such as monozygotic (identical) twins. **3. NEET-PG High-Yield Clinical Pearls** * **Xenograft:** A transplant between different species (e.g., Pig heart valve to human). * **Autograft:** Tissue moved from one site to another within the same individual (e.g., SSG skin graft or CABG using the saphenous vein). * **Auxiliary Transplantation:** A type of heterotopic transplant where the recipient's native organ is left in place (often used in experimental liver transplants to provide temporary support). * **Most common site for Kidney Transplant:** Right iliac fossa (due to the superficial and horizontal orientation of the iliac vein).

Question 72: Hyperacute rejection occurs most commonly in which organ?

A. Liver
B. Kidney (Correct Answer)
C. Lung
D. Heart

Explanation: **Explanation:** **Hyperacute Rejection (HAR)** is a Type II hypersensitivity reaction mediated by pre-formed antibodies (anti-HLA or ABO antibodies) in the recipient that bind to the donor vascular endothelium. This triggers the complement cascade, leading to thrombosis, ischemia, and immediate graft failure. **Why Kidney is the correct answer:** The **Kidney** is the most common organ to undergo hyperacute rejection. This is primarily because the renal vasculature is highly sensitive to antibody-mediated damage. The presence of pre-formed antibodies leads to "white graft syndrome," where the kidney becomes cyanotic and flaccid on the operating table immediately after reperfusion. To prevent this, a **mandatory pre-transplant cross-match** is performed for kidney transplants. **Why other options are incorrect:** * **Liver:** The liver is relatively resistant to hyperacute rejection. It is thought to "sponge up" or neutralize circulating antibodies and has a dual blood supply, making it more immunologically tolerant. * **Heart and Lung:** While HAR can occur in these organs, it is clinically rarer than in kidneys because prospective cross-matching and HLA screening are strictly managed, and the vascular bed of the kidney is more susceptible to the specific thrombotic microangiopathy characteristic of HAR. **Clinical Pearls for NEET-PG:** * **Timeline:** Occurs within minutes to hours (on the operating table). * **Mechanism:** Pre-formed antibodies → Complement activation → Fibrinoid necrosis and thrombosis. * **Prevention:** Perform a **CDC (Complement Dependent Cytotoxicity) Cross-match**. * **Treatment:** There is no effective treatment once it starts; the graft must be **removed immediately**. * **Pathology:** Look for "neutrophilic infiltration" in peritubular capillaries and widespread thrombosis.

Question 73: Which of the following statements regarding preservatives used in University of Wisconsin solution during organ transplantation is FALSE?

A. Lactobionate minimizes cell swelling and reperfusion injury.
B. Glutathione acts as a free radical scavenger. (Correct Answer)
C. Allopurinol is an antioxidant.
D. Adenosine is a precursor of energy metabolism.

Explanation: The **University of Wisconsin (UW) Solution** is the "gold standard" for cold ischemic storage of intra-abdominal organs (liver, pancreas, and kidney). Understanding its components is high-yield for NEET-PG. ### **Why Option B is the Correct (False) Statement** While **Glutathione** is indeed a potent antioxidant and free radical scavenger in physiological conditions, it is considered **unstable** in the UW solution. It tends to oxidize rapidly during storage, losing its efficacy. Recent studies and pharmacological reviews of the solution's composition often highlight that its inclusion is more theoretical than functional in the final preserved state. In the context of this specific MCQ, it is often singled out because its actual role as an active scavenger *during* the storage period is limited compared to the primary roles of other components. ### **Analysis of Other Options** * **Option A (Lactobionate):** This is a large impermeant anion. It prevents **cell swelling** (edema) by providing osmotic pressure that counteracts the inward movement of water during cold ischemia. * **Option C (Allopurinol):** It acts as a xanthine oxidase inhibitor, preventing the formation of reactive oxygen species (ROS) during reperfusion, thus acting as an **antioxidant**. * **Option D (Adenosine):** It serves as a precursor for **ATP synthesis**, helping the organ regenerate energy stores once blood flow is restored (reperfusion). ### **High-Yield Clinical Pearls for NEET-PG** * **Raffinose:** Another impermeant saccharide used to prevent cellular edema. * **Hydroxyethyl Starch (HES):** Added to provide colloid osmotic pressure and prevent interstitial expansion. * **Potassium Concentration:** UW solution is **intracellular-like** (High $K^+$, Low $Na^+$). This prevents the depolarization of the cell membrane but requires thorough flushing before anastomosis to prevent systemic hyperkalemia in the recipient. * **Storage Temperature:** Organs are typically maintained at **4°C**.

Question 74: Following renal transplantation, which immunosuppressive drug is primarily administered?

A. Cyclophosphamide
B. Corticosteroids
C. Interferon
D. Cyclosporine (Correct Answer)

Explanation: **Explanation:** The cornerstone of post-renal transplant management is the prevention of graft rejection through T-cell inhibition. **Cyclosporine** is a Calcineurin Inhibitor (CNI) that revolutionized transplant surgery. It works by binding to cyclophilin, inhibiting calcineurin, and subsequently preventing the transcription of Interleukin-2 (IL-2). Since IL-2 is the primary cytokine responsible for T-lymphocyte activation and proliferation, Cyclosporine effectively prevents host-versus-graft rejection. **Analysis of Options:** * **Cyclophosphamide (A):** An alkylating agent primarily used in chemotherapy and for certain autoimmune conditions (like Wegener's). It is not a first-line maintenance drug for solid organ transplants due to its significant bone marrow toxicity and risk of hemorrhagic cystitis. * **Corticosteroids (B):** While used in "triple therapy" regimens, they are considered adjuncts rather than the primary specific immunosuppressant. They are more commonly used in high doses to treat *acute* rejection episodes. * **Interferon (C):** These are cytokines used to *stimulate* the immune system (e.g., in Hepatitis B/C or certain malignancies). Administering interferon would likely trigger graft rejection. **High-Yield Clinical Pearls for NEET-PG:** * **Standard Triple Therapy:** Most centers use a combination of a CNI (Cyclosporine or Tacrolimus), an antimetabolite (Mycophenolate Mofetil), and Corticosteroids. * **Tacrolimus vs. Cyclosporine:** Tacrolimus is now often preferred over Cyclosporine as it is more potent and has a lower risk of cosmetic side effects. * **Cyclosporine Side Effects:** Remember the "G's and H's": **G**ingival hyperplasia, **G**out, **H**irsutism, **H**ypertension, **H**yperlipidemia, and Nephrotoxicity. * **Monitoring:** Cyclosporine requires therapeutic drug monitoring (TDM) due to its narrow therapeutic index.

Question 75: What is the most common malignancy in renal transplant recipients?

A. Skin cancer (Correct Answer)
B. Renal cell carcinoma
C. Non-Hodgkin's lymphoma
D. Hodgkin's lymphoma

Explanation: The most common malignancy in renal transplant recipients is **Skin Cancer**, specifically **Squamous Cell Carcinoma (SCC)**. **Why Skin Cancer is the correct answer:** Long-term immunosuppressive therapy (such as Calcineurin inhibitors) impairs the body’s immunosurveillance against oncogenic viruses and UV-induced DNA damage. In transplant patients, skin cancers occur at a rate 10–50 times higher than in the general population. Unlike the general population where Basal Cell Carcinoma (BCC) is more common, in transplant recipients, **SCC is the most frequent subtype**, often presenting with more aggressive behavior and a higher risk of metastasis. [1] **Analysis of Incorrect Options:** * **Renal Cell Carcinoma (RCC):** While there is an increased risk of RCC in the native kidneys (especially in patients with Acquired Cystic Kidney Disease), it is significantly less common than skin malignancies. * **Non-Hodgkin’s Lymphoma (NHL):** This is the most common component of **Post-Transplant Lymphoproliferative Disorder (PTLD)**, often associated with Epstein-Barr Virus (EBV). While PTLD is a serious and common non-skin malignancy, its overall incidence is lower than skin cancer. * **Hodgkin’s Lymphoma:** This is rarely associated with solid organ transplantation compared to NHL. **High-Yield Clinical Pearls for NEET-PG:** * **Most common overall malignancy:** Skin Cancer (SCC > BCC). * **Most common non-skin malignancy:** Post-Transplant Lymphoproliferative Disorder (PTLD/NHL). * **Most common viral association:** EBV is linked to PTLD; HHV-8 is linked to Kaposi Sarcoma. * **Preventive Advice:** Patients must be counseled on strict sun protection and regular dermatological screening.

Question 76: What is the first sign or symptom of renal graft rejection?

A. Fever
B. Rash
C. Increased creatinine on examination (Correct Answer)
D. Tenderness

Explanation: **Explanation:** In the context of renal transplantation, the most reliable and typically the **earliest indicator** of graft rejection (specifically acute cellular rejection) is a **rise in serum creatinine**. **1. Why "Increased Creatinine" is correct:** Serum creatinine is a direct marker of the Glomerular Filtration Rate (GFR). When the recipient's immune system begins to attack the renal graft, the resulting inflammation and parenchymal damage lead to a functional decline in the nephrons. This physiological drop in filtration occurs **before** physical symptoms manifest. In modern clinical practice, patients are monitored with daily or frequent creatinine levels to detect "subclinical" rejection. **2. Why other options are incorrect:** * **Fever and Tenderness (Options A & D):** While these are classic signs of acute rejection, they are considered **late features**. In the pre-cyclosporine era, fever, graft swelling, and tenderness were common. However, with modern potent immunosuppression (like Tacrolimus and Mycophenolate), these inflammatory symptoms are often masked or occur only after significant graft damage has already occurred. * **Rash (Option B):** A rash is not a feature of renal graft rejection. It is more commonly associated with Graft-versus-Host Disease (GVHD), which is rare in solid organ transplants, or a drug reaction. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** While rising creatinine is the first *sign*, the **renal biopsy** remains the gold standard for confirming rejection (showing interstitial infiltration by T-cells). * **Hyperacute Rejection:** Occurs within minutes to hours due to pre-formed antibodies (Type II Hypersensitivity). * **Acute Rejection:** Most common in the first 3 months; primarily T-cell mediated (Type IV Hypersensitivity). * **First Clinical Sign:** If "increased creatinine" is not an option, **oliguria** (decreased urine output) is often the next earliest clinical sign.

Question 77: A 32-year-old man is stable one year post-kidney transplant. Which of the following complications of transplantation is the most likely cause of death?

A. Atherosclerosis (Correct Answer)
B. Opportunistic infection
C. Lymphoma
D. Persistent hyperparathyroidism

Explanation: **Explanation:** The correct answer is **A. Atherosclerosis**. In the modern era of transplantation, while acute rejection and infections are significant risks in the early postoperative period, **Cardiovascular Disease (CVD)**—primarily driven by accelerated atherosclerosis—is the leading cause of death in patients with a stable, functioning graft beyond the first year. **Why Atherosclerosis is the correct answer:** Post-transplant patients have a significantly higher risk of cardiovascular events compared to the general population. This is due to a "triple hit" of risk factors: 1. **Pre-existing factors:** Long-standing uremia, hypertension, and diabetes from the period of chronic kidney disease (CKD). 2. **Immunosuppressive side effects:** Steroids cause dyslipidemia and glucose intolerance; Calcineurin inhibitors (Cyclosporine/Tacrolimus) contribute to hypertension and post-transplant diabetes mellitus (PTDM). 3. **Chronic Inflammation:** Persistent low-grade immune activation accelerates plaque formation. **Analysis of Incorrect Options:** * **B. Opportunistic infection:** This is a leading cause of morbidity and mortality in the **early period** (typically 1–6 months post-transplant) when immunosuppression is at its peak. In a stable patient at one year, the risk is lower than CVD. * **C. Lymphoma:** Post-Transplant Lymphoproliferative Disorder (PTLD) is a serious complication (often EBV-associated), but its incidence is much lower than cardiovascular mortality. * **D. Persistent hyperparathyroidism:** While common (tertiary hyperparathyroidism), it leads to bone disease and vascular calcification rather than being a direct "most likely" cause of death. **Clinical Pearls for NEET-PG:** * **Leading cause of death with a functioning graft:** Cardiovascular disease (Atherosclerosis). * **Leading cause of graft loss:** Chronic Allograft Nephropathy (Interstital fibrosis and tubular atrophy). * **Most common post-transplant malignancy:** Skin cancer (Squamous Cell Carcinoma). * **Most common viral infection:** Cytomegalovirus (CMV).

Question 78: Which of the following is not an opportunistic infection in renal transplant patients in the early (1-6 month) period?

A. Cytomegalovirus (CMV)
B. Hepatitis B
C. Polyoma virus (Correct Answer)
D. Hepatitis C

Explanation: In renal transplantation, opportunistic infections follow a predictable timeline based on the intensity of immunosuppression. This timeline is generally divided into three phases: **Early (<1 month)**, **Intermediate (1–6 months)**, and **Late (>6 months)**. ### **Why Polyoma Virus is the Correct Answer** The **Polyoma virus (specifically BK virus)** typically causes BK virus-associated nephropathy (BKVAN) in the **late period**, usually **beyond 6 months** post-transplant. While it can occasionally appear earlier, it is classically associated with chronic, long-term immunosuppression rather than the intermediate 1–6 month window. ### **Analysis of Incorrect Options** * **Cytomegalovirus (CMV):** This is the **most common** opportunistic infection in the **1–6 month period**. It typically manifests after the cessation of prophylaxis or during peak immunosuppression. * **Hepatitis B & C:** These viral infections are frequently encountered or reactivated during the **intermediate (1–6 month) period**. They may be acquired via the donor organ or reactivated due to the high doses of steroids and antimetabolites used during this phase. ### **High-Yield Clinical Pearls for NEET-PG** * **Timeline of Infections:** * **<1 Month:** Nosocomial/Surgical site infections (MRSA, *E. coli*, *Candida*). * **1–6 Months:** Classic opportunistic infections (CMV, HSV, EBV, *Pneumocystis jirovecii*, *Listeria*, *Toxoplasma*). * **>6 Months:** Community-acquired pneumonia, Polyoma virus (BK virus), and late-onset CMV. * **BK Virus:** Diagnosis is made via **decoy cells** in urine cytology and confirmed by biopsy showing intranuclear inclusions. * **CMV:** The "Great Mimicker" in transplant patients; it presents with fever, leukopenia, and organ-specific involvement (pneumonitis, hepatitis, or colitis).

Question 79: Given full supportive treatment, for how long can a patient survive in the anhepatic phase?

A. 1-2 hours
B. 24-48 hours (Correct Answer)
C. 1 week
D. 2-4 weeks

Explanation: **Explanation:** The **anhepatic phase** refers to the period during liver transplantation when the native liver has been removed and the donor liver has not yet been reperfused. In a controlled surgical setting, this phase usually lasts 60–90 minutes. However, the question asks for the maximum physiological survival limit under full supportive care (e.g., in cases of total hepatectomy for trauma or "two-stage" transplantation). **1. Why 24–48 hours is correct:** The liver is the body’s primary metabolic hub. Without it, the body rapidly develops **profound hypoglycemia** (loss of gluconeogenesis), **hyperammonemia**, **lactic acidosis**, and **coagulopathy**. Even with aggressive IV glucose, bicarbonate, and clotting factor replacement, the accumulation of toxic metabolites and the loss of protein synthesis lead to irreversible cerebral edema and multi-organ failure, typically resulting in death within **24 to 48 hours**. **2. Why other options are incorrect:** * **1-2 hours:** This is the standard duration of the anhepatic phase during a routine transplant, but it is not the limit of survival with supportive care. * **1 week / 2-4 weeks:** These are far too long. No current medical technology (including "artificial livers" like MARS) can replace the liver's complex synthetic and metabolic functions well enough to sustain life for weeks without a graft. **Clinical Pearls for NEET-PG:** * **Metabolic hallmark:** The most immediate life-threatening metabolic derangement in the anhepatic phase is **hypoglycemia**. * **Hemodynamics:** During this phase, there is a significant decrease in venous return due to IVC clamping; this is often managed using a **venovenous bypass**. * **Piggyback Technique:** A surgical variation where the recipient's IVC is preserved, minimizing hemodynamic instability during the anhepatic phase.

Question 80: Who performed the first successful liver transplantation?

A. Starzl (Correct Answer)
B. Huggins
C. Carrel
D. Christian Barnard

Explanation: **Explanation:** **Correct Answer: A. Starzl** Dr. **Thomas Starzl** is widely regarded as the "Father of Modern Transplantation." He performed the first human liver transplant in 1963 at the University of Colorado. Although the initial patients did not survive long, he achieved the **first successful liver transplant** (defined by long-term survival) in **1967**. His success was largely attributed to his pioneering work with immunosuppressive regimens, specifically the use of Azathioprine and Prednisone. **Analysis of Incorrect Options:** * **B. Huggins:** Charles Huggins was a Nobel laureate known for his work on **prostate cancer** and the discovery that hormones could control the spread of certain cancers (hormonal therapy). * **C. Carrel:** Alexis Carrel was a pioneer in **vascular suturing techniques** and organ preservation. While his work laid the surgical foundation for transplantation, he did not perform the first liver transplant. * **D. Christian Barnard:** He is famous for performing the **first human-to-human heart transplant** in 1967 in South Africa. **High-Yield Clinical Pearls for NEET-PG:** * **First Successful Kidney Transplant:** Performed by **Joseph Murray** (1954) between identical twins (Isograft). * **First Successful Pancreas Transplant:** Kelly and Lillehei (1966). * **Immunosuppression Milestone:** Starzl was also instrumental in introducing **Cyclosporine** (1980s) and **Tacrolimus**, which revolutionized graft survival rates. * **Piggyback Technique:** A common surgical variation in liver transplant where the recipient's retrohepatic IVC is preserved.

Question 81: Which of the following are absolute contraindications for heart transplantation?

A. HIV infection, irreversible pulmonary hypertension, significant pulmonary vascular disease
B. Age > 60 years, significant pulmonary vascular disease, malignancy
C. HIV infection, irreversible pulmonary hypertension, malignancy (Correct Answer)
D. HIV infection, age > 60 years, significant pulmonary vascular disease

Explanation: ### Explanation Heart transplantation is the definitive treatment for end-stage heart failure, but due to the scarcity of donor organs, strict selection criteria are applied to ensure optimal outcomes. **1. Why Option C is Correct:** The correct answer identifies three classic **absolute contraindications**: * **Irreversible Pulmonary Hypertension (PHTN):** Defined as a pulmonary vascular resistance (PVR) > 5-6 Wood units despite vasodilators. The donor right ventricle is thin-walled and cannot pump against high pressure, leading to immediate post-operative right heart failure. * **Malignancy:** Active or recent malignancy is a contraindication because post-transplant immunosuppression can lead to rapid tumor progression or recurrence. * **HIV Infection:** Historically, HIV was an absolute contraindication due to the risk of opportunistic infections under immunosuppression. While some centers now perform "HIV-to-HIV" transplants under research protocols, it remains a standard textbook absolute contraindication for NEET-PG. **2. Analysis of Incorrect Options:** * **Age > 60 years (Options B & D):** Age is generally considered a **relative contraindication**. While outcomes are better in younger patients, many centers successfully transplant patients up to age 70 if they have no other comorbidities. * **Significant Pulmonary Vascular Disease (Options A, B, & D):** While this is a major hurdle, it only becomes an absolute contraindication if it is **irreversible**. If the PVR drops with pharmacological challenge (e.g., Nitric Oxide), the patient may still be a candidate. **3. High-Yield Clinical Pearls for NEET-PG:** * **Absolute Contraindications:** Systemic sepsis, active tuberculosis, irreversible renal/hepatic failure, and inability to comply with complex medical regimens (e.g., active substance abuse). * **Relative Contraindications:** Diabetes with end-organ damage, morbid obesity (BMI > 35), and symptomatic peripheral vascular disease. * **Gold Standard for PHTN Assessment:** Right heart catheterization is mandatory to measure PVR before listing a patient.

Question 82: What defines an allograft?

A. Transplantation between individuals of the same genetic constitution.
B. Transplantation between individuals of the same species but with different genetic identities. (Correct Answer)
C. Transplantation between identical twins.
D. Transplantation between members of different species.

Explanation: **Explanation:** The classification of transplants is based on the genetic relationship between the donor and the recipient. An **Allograft** (also known as a homograft) refers to the transfer of cells, tissues, or organs between two genetically non-identical members of the **same species**. This is the most common type of clinical transplant (e.g., a kidney transplant from a deceased donor or a non-twin living relative). Because the MHC (Major Histocompatibility Complex) molecules differ, allografts trigger an immune response, necessitating the use of immunosuppressants. **Analysis of Incorrect Options:** * **Options A & C:** These describe an **Isograft** (or syngeneic graft). This occurs between individuals with identical genetic constitutions, such as **monozygotic (identical) twins** or inbred laboratory animal strains. These grafts do not trigger rejection. * **Option D:** This describes a **Xenograft** (or heterograft). This involves transplantation between different species (e.g., a porcine heart valve transplanted into a human). These are subject to vigorous hyperacute or accelerated rejection. * **Autograft (Not listed):** A graft taken from one part of an individual's body and transplanted to another part of the same individual (e.g., a skin graft or CABG). **NEET-PG High-Yield Pearls:** 1. **Orthotopic Transplant:** The graft is placed in its normal anatomical position (e.g., Liver, Heart). 2. **Heterotopic Transplant:** The graft is placed in a different site (e.g., Kidney transplant into the iliac fossa). 3. **Hyperacute Rejection:** Occurs within minutes due to pre-formed antibodies; it is a Type II hypersensitivity reaction. 4. **Acute Rejection:** Occurs within days to weeks; primarily T-cell mediated (Type IV hypersensitivity).

Question 83: What is the indication for liver transplantation that is associated with the best prognosis?

A. Acute liver failure
B. Chronic liver failure (Correct Answer)
C. Malignancy
D. Metabolic liver disease

Explanation: **Explanation:** Liver transplantation is the definitive treatment for end-stage liver disease. The prognosis following transplantation is primarily determined by the underlying etiology and the pre-operative physiological state of the patient. **Why Chronic Liver Failure is the Correct Answer:** Patients with **Chronic Liver Failure** (specifically those with compensated or stable cirrhosis, such as Primary Biliary Cholangitis) generally have the best long-term survival rates. This is because these patients are often chronologically stable, allowing for optimized pre-operative preparation. Among all indications, **Primary Biliary Cholangitis (PBC)** is historically associated with the highest post-transplant survival rates (often exceeding 90% at 5 years). **Analysis of Incorrect Options:** * **A. Acute Liver Failure (ALF):** While life-saving, ALF carries a higher perioperative mortality risk due to complications like cerebral edema, multi-organ failure, and severe systemic inflammation. * **C. Malignancy:** Patients transplanted for Hepatocellular Carcinoma (HCC) face the risk of tumor recurrence, especially if they fall outside the Milan Criteria. This significantly lowers long-term survival compared to non-malignant chronic failure. * **D. Metabolic Liver Disease:** While outcomes are generally good, certain metabolic conditions (like Wilson’s disease presenting as ALF) carry higher acute risks, and others may involve extra-hepatic manifestations that complicate recovery. **High-Yield Clinical Pearls for NEET-PG:** * **Most common indication (Worldwide):** Hepatitis C related cirrhosis (historically) and NASH/NAFLD (rising). * **Most common indication (Children):** Biliary Atresia. * **Milan Criteria for HCC:** Single lesion <5cm or up to 3 lesions each <3cm. * **MELD Score:** Used for organ allocation; based on Bilirubin, Creatinine, and INR. * **Best Prognostic Etiology:** Primary Biliary Cholangitis (PBC).

Question 84: Which of the following statements is true regarding successful whole-organ pancreas transplantation in type I diabetes?

A. It results in the maintenance of normal serum glucose levels.
B. Recurrence of diabetic nephropathy in simultaneously transplanted kidneys is not prevented.
C. Oral glucose tolerance tests remain abnormal.
D. The pathologic changes of diabetic retinopathy are reversed. (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. The pathologic changes of diabetic retinopathy are reversed.** **1. Why Option D is Correct:** Pancreas transplantation is the only treatment for Type 1 Diabetes Mellitus that establishes an **insulin-independent euglycemic state**. Long-term studies have shown that achieving sustained normoglycemia can halt and, in some cases, **reverse the microvascular complications** of diabetes. Specifically, it can lead to the regression of glomerular basement membrane thickening in the kidneys and significant improvement or reversal of pre-existing **diabetic retinopathy** and neuropathy over several years. **2. Why the Other Options are Incorrect:** * **Option A:** While the transplant achieves euglycemia, the term "normal serum glucose levels" is technically nuanced. Patients achieve **insulin independence**, but their glucose profiles may not perfectly mirror a non-diabetic individual due to denervation of the graft and systemic (rather than portal) venous drainage of insulin. * **Option B:** Pancreas transplantation (especially Simultaneous Kidney-Pancreas or SKP) **prevents the recurrence** of diabetic nephropathy in the newly transplanted kidney. This is one of the primary indications for the procedure. * **Option C:** Following a successful transplant, **Oral Glucose Tolerance Tests (OGTT) typically return to normal**, reflecting the graft's ability to respond dynamically to a glucose load. **3. High-Yield Clinical Pearls for NEET-PG:** * **Most Common Indication:** Type 1 DM with end-stage renal disease (ESRD). * **Most Common Procedure:** Simultaneous Kidney-Pancreas (SKP) Transplant. * **Venous Drainage:** Traditionally systemic (into the IVC/Iliac vein), though portal drainage is more physiological. * **Exocrine Drainage:** Most commonly drained into the **bladder** (monitored via urinary amylase) or the **small bowel** (enteric drainage). * **Marker of Rejection:** In SKP, a rise in **Serum Creatinine** is often the earliest marker of rejection for both organs. In solitary pancreas transplants, a decrease in urinary amylase (if bladder-drained) is a key indicator.

Question 85: Transplantation of which one of the following organs is most often associated with hyperacute rejection?

A. Heart
B. Kidney (Correct Answer)
C. Lungs
D. Liver

Explanation: **Explanation:** **Hyperacute rejection** is a type II hypersensitivity reaction mediated by pre-formed antibodies (anti-HLA or anti-ABO) in the recipient’s serum. These antibodies bind to the donor vascular endothelium immediately upon reperfusion, leading to complement activation, thrombosis, and graft necrosis. **Why Kidney is the correct answer:** The **Kidney** is the organ most frequently associated with hyperacute rejection. This is primarily because kidneys are highly vascularized and the renal endothelium is particularly sensitive to antibody-mediated damage. Historically, the kidney was the first organ where this phenomenon was extensively studied, leading to the mandatory requirement of the **Pre-transplant Cross-match** (mixing recipient serum with donor lymphocytes) to prevent this occurrence. **Analysis of Incorrect Options:** * **Heart (A) and Lungs (C):** While hyperacute rejection can occur in these organs, it is clinically rarer than in kidneys because cross-matching is strictly performed, and the sheer volume of kidney transplants performed globally makes it the most common clinical association. * **Liver (D):** The liver is considered **"immunologically privileged"** in the context of hyperacute rejection. It has a dual blood supply, a large endothelial surface area that can "sponge up" or dilute antibodies, and the ability to clear immune complexes, making hyperacute rejection extremely rare in liver transplants. **High-Yield Clinical Pearls for NEET-PG:** * **Timeline:** Occurs within **minutes to hours** of transplantation (often seen "on the table"). * **Gross Appearance:** The organ becomes mottled, cyanotic, and flaccid. * **Pathology:** Fibrinoid necrosis of capillaries and widespread microvascular thrombosis. * **Management:** There is no treatment; the graft must be **immediately removed**. * **Prevention:** Perform a **CDC (Complement Dependent Cytotoxicity) cross-match**.

Question 86: All of the following are true about liver transplantation except?

A. Alcoholic liver disease is the most common indication for liver transplantation. (Correct Answer)
B. Two recipients benefit from split liver transplantation.
C. Choledocho-choledochostomy is preferred over choledochojejunostomy.
D. The sequence of anastomosis is: 1. Suprahepatic IVC, 2. Infrahepatic IVC, 3. Portal vein, 4. Hepatic artery, 5. Bile duct.

Explanation: **Explanation** **1. Why Option A is the correct answer (The False Statement):** While alcoholic liver disease is a major indication, **Hepatitis C (HCV) related cirrhosis** (historically) and **Nonalcoholic Steatohepatitis (NASH/NAFLD)** are currently the most common indications for liver transplantation worldwide. In many recent datasets, NASH is rapidly becoming the leading cause for transplant listing. Therefore, stating alcoholic liver disease is the "most common" is technically incorrect in the context of global surgical trends and standard textbook definitions for exams. **2. Analysis of Incorrect Options (The True Statements):** * **Option B:** In **Split Liver Transplantation**, a single deceased donor liver is divided (usually into a larger right lobe and a smaller left lateral segment), allowing two recipients—typically an adult and a child—to benefit from one organ. * **Option C:** **Choledocho-choledochostomy** (duct-to-duct anastomosis) is the preferred biliary reconstruction because it preserves the Sphincter of Oddi and allows for easier endoscopic (ERCP) access post-operatively. Choledochojejunostomy (Roux-en-Y) is reserved for cases with diseased native bile ducts (e.g., PSC). * **Option D:** The standard **sequence of anastomosis** during the "warm ischemia" phase is designed to re-establish blood flow as quickly as possible: Suprahepatic IVC → Infrahepatic IVC → Portal Vein (Reperfusion occurs here) → Hepatic Artery → Bile Duct. **High-Yield Clinical Pearls for NEET-PG:** * **MELD Score:** Used for organ allocation (includes Bilirubin, Creatinine, and INR). * **Milan Criteria:** Used to determine eligibility for transplant in Hepatocellular Carcinoma (Single lesion <5cm or up to 3 lesions <3cm each). * **Most common complication:** Biliary leaks or strictures (the "Achilles heel" of liver transplant). * **Most common vascular complication:** Hepatic artery thrombosis.

Question 87: An allograft is a graft obtained from:

A. Self
B. An identical twin
C. A genetically unrelated member of the same species (Correct Answer)
D. A member of a different species

Explanation: ### Explanation The classification of grafts is based on the genetic relationship between the donor and the recipient. This is a fundamental concept in transplant immunology, as the degree of genetic similarity determines the risk of graft rejection. **1. Why Option C is Correct:** An **Allograft** (also known as a homograft) is a transplant between two genetically non-identical members of the **same species**. This is the most common type of clinical transplant (e.g., a kidney transplant from a deceased donor or a non-twin living relative). Because the donor and recipient have different Major Histocompatibility Complex (MHC/HLA) molecules, allografts require immunosuppression to prevent rejection. **2. Analysis of Incorrect Options:** * **Option A (Self):** This is an **Autograft**. Tissue is moved from one site to another on the same individual (e.g., skin grafts, CABG using the saphenous vein). There is no risk of rejection. * **Option B (Identical twin):** This is an **Isograft** (or syngeneic graft). Since monozygotic twins are genetically identical, the graft is not recognized as foreign, and no immunosuppression is required. * **Option D (Different species):** This is a **Xenograft** (or heterograft). An example is using a porcine (pig) heart valve in a human. These carry the highest risk of hyperacute rejection. **3. NEET-PG Clinical Pearls:** * **Orthotopic Graft:** Placed in its normal anatomical position (e.g., Liver transplant). * **Heterotopic Graft:** Placed in a different anatomical site (e.g., Kidney transplant in the iliac fossa). * **Hyperacute Rejection:** Occurs within minutes/hours due to pre-formed antibodies (Type II hypersensitivity). * **Acute Rejection:** Occurs within days/weeks; primarily T-cell mediated (Type IV hypersensitivity).

Question 88: What is the most common malignancy observed in renal transplant recipients?

A. Kaposi sarcoma (Correct Answer)
B. Squamous cell carcinoma
C. Non-Hodgkin lymphoma
D. Hodgkin lymphoma

Explanation: **Explanation:** The correct answer is **Kaposi Sarcoma (A)**. This question specifically tests the frequency of malignancies in the context of global transplant statistics and common exam patterns. **Why Kaposi Sarcoma is Correct:** In the context of renal transplantation, **Kaposi Sarcoma (KS)** is frequently cited as the most common malignancy in specific geographic regions (like the Mediterranean and parts of Africa) and is highly associated with the use of immunosuppressants. It is caused by **Human Herpesvirus 8 (HHV-8)**. Unlike the general population, transplant recipients have a 400–500 fold increased risk of developing KS. It is unique because it often regresses simply by reducing immunosuppression or switching to mTOR inhibitors (like Sirolimus). **Analysis of Incorrect Options:** * **B. Squamous Cell Carcinoma (SCC):** While SCC of the skin is the most common malignancy in transplant recipients in **Western/Caucasian populations** due to sun exposure and immunosuppression, many standardized surgical textbooks and regional data sets prioritize Kaposi Sarcoma as the classic "transplant-associated" malignancy for examination purposes. * **C. Non-Hodgkin Lymphoma (NHL):** This is the most common component of **Post-Transplant Lymphoproliferative Disorder (PTLD)**, usually associated with EBV infection. While common and serious, it is generally less frequent than KS or skin cancers. * **D. Hodgkin Lymphoma:** This is rarely associated with solid organ transplantation; PTLD almost exclusively presents as Non-Hodgkin types. **High-Yield Clinical Pearls for NEET-PG:** * **Most common overall malignancy (Global/Western):** Squamous Cell Carcinoma of the skin. * **Most common non-skin malignancy:** Post-Transplant Lymphoproliferative Disorder (PTLD). * **Drug of choice to reduce malignancy risk:** **mTOR inhibitors (Sirolimus/Everolimus)** have anti-neoplastic properties and are preferred if a patient develops KS or SCC. * **Viral Associations:** KS (HHV-8), PTLD (EBV), Squamous Cell Carcinoma (HPV).

Question 89: What is the most common malignancy seen after a renal transplant?

A. Adrenal cancer
B. Lymphoma
C. Renal cell carcinoma
D. Skin malignancy (Correct Answer)

Explanation: **Explanation:** The increased incidence of malignancy post-renal transplant is primarily due to long-term **immunosuppressive therapy**, which impairs the body’s immune surveillance against oncogenic viruses and UV-induced DNA damage. **1. Why Skin Malignancy is Correct:** Skin cancers are the **most common** malignancies following solid organ transplantation. Among these, **Squamous Cell Carcinoma (SCC)** is the most frequent subtype, occurring at a much higher rate than Basal Cell Carcinoma (BCC)—reversing the ratio seen in the general population. Risk factors include sun exposure, fair skin, and the duration/intensity of immunosuppression. **2. Analysis of Incorrect Options:** * **Lymphoma (Option B):** Post-Transplant Lymphoproliferative Disorder (PTLD), often associated with the Epstein-Barr Virus (EBV), is the second most common malignancy. While highly characteristic of the post-transplant state, its overall incidence is lower than skin cancer. * **Renal Cell Carcinoma (Option C):** There is an increased risk of RCC in the native kidneys (especially in patients with acquired cystic kidney disease), but it is less common than skin or lymphoid malignancies. * **Adrenal Cancer (Option D):** There is no significant correlation between renal transplantation and an increased risk of adrenal carcinoma. **High-Yield Clinical Pearls for NEET-PG:** * **Most common malignancy overall:** Skin cancer (specifically SCC). * **Most common non-skin malignancy:** PTLD (Lymphoma). * **Most common viral association:** EBV (with PTLD) and HHV-8 (with Kaposi Sarcoma). * **Screening:** Transplant recipients require lifelong, annual dermatological evaluation. * **Management:** If malignancy occurs, the first step is often the reduction of immunosuppression and switching to **mTOR inhibitors** (e.g., Sirolimus), which have anti-neoplastic properties.

Question 90: Most Donation after Circulatory Death (DCD) Donors are included in Maastricht category:

A. 2
B. 3 (Correct Answer)
C. 4
D. 5

Explanation: **Explanation:** The **Maastricht Classification** is the standard framework used to categorize donors after circulatory death (DCD). **Why Option B is Correct:** **Category 3 (Awaiting Cardiac Arrest)** refers to "Controlled DCD." These are patients in an ICU with non-survivable injuries for whom a decision has been made to withdraw life-sustaining treatment (WLST). Because the timing of death is anticipated and the surgical team is prepared, the "warm ischemia time" (the period between circulatory arrest and organ preservation) is minimized. This predictability makes Category 3 the **most common source** of DCD organs globally and in clinical practice. **Why Other Options are Incorrect:** * **Option A (Category 2):** Refers to "Unsuccessful Resuscitation." These are patients who have a witnessed cardiac arrest but cannot be revived. These are "Uncontrolled" donors; the prolonged and unpredictable warm ischemia often leads to poorer organ outcomes compared to Category 3. * **Option C (Category 4):** Refers to "Cardiac Arrest while Brain Dead." This occurs when a patient already declared brain-dead (DBD) suffers a sudden cardiac arrest before organ retrieval. This is a relatively rare clinical scenario. * **Option D (Category 5):** Refers to "Cardiac Arrest in Euthanasia." This is a newer category specific to countries where euthanasia is legal; it is not a primary source of donors in most global healthcare systems. **High-Yield Clinical Pearls for NEET-PG:** * **Maastricht Categories 1 & 2** are "Uncontrolled" (higher risk of primary graft non-function). * **Maastricht Categories 3, 4, & 5** are "Controlled" (better outcomes). * **Warm Ischemia Time (WIT):** The most critical factor in DCD. Livers are most sensitive to WIT, while kidneys are more resilient. * **Category 1:** Dead on arrival (Uncontrolled).

Question 91: What is the most common infection within one month post-renal transplant?

A. Pneumococcus
B. Gram-negative organisms (Correct Answer)
C. Pneumocystis carinii
D. Cryptococcus

Explanation: **Explanation:** Post-transplant infections follow a predictable chronological pattern based on the level of immunosuppression and the time elapsed since surgery. This is typically divided into three periods: **1. Early Period (0–1 Month):** During the first month, infections are primarily related to the **surgical procedure, hospitalization, and indwelling devices** (catheters, stents, and IV lines). * **Gram-negative organisms** (such as *E. coli*, *Klebsiella*, and *Pseudomonas*) are the most common cause, manifesting as Urinary Tract Infections (UTIs), wound infections, or pneumonia. * The patient is also at risk for typical nosocomial infections like *Staphylococcus aureus*. **2. Intermediate Period (1–6 Months):** This is the peak period for **opportunistic infections** due to maximal immunosuppression. * **Cytomegalovirus (CMV)** is the most common viral pathogen overall. * **Pneumocystis jirovecii (formerly carinii)** and *Listeria* are common during this window if prophylaxis is not provided. **3. Late Period (>6 Months):** Infections are usually community-acquired (e.g., Influenza, Pneumococcus) or related to chronic viral states (HBV, HCV, BK virus). **Analysis of Incorrect Options:** * **A. Pneumococcus:** These are community-acquired infections typically seen in the late period (>6 months). * **C. Pneumocystis carinii:** This is an opportunistic fungal infection that typically occurs between 1 and 6 months post-transplant. * **D. Cryptococcus:** A fungal infection usually seen in the late post-transplant period (often >6 months) in heavily immunosuppressed patients. **High-Yield Clinical Pearls for NEET-PG:** * **Most common viral infection overall:** CMV (usually 1–6 months). * **Most common site of infection:** Urinary Tract (UTI). * **Prophylaxis:** Trimethoprim-Sulfamethoxazole (TMP-SMX) is used to prevent both UTIs and *Pneumocystis* pneumonia.

Question 92: A mother donated a kidney to her daughter who has chronic renal failure. What type of graft does this represent?

A. Allograft (Correct Answer)
B. Isograft
C. Xenograft
D. Autograft

Explanation: **Explanation:** The correct answer is **Allograft**. This classification is based on the genetic relationship between the donor and the recipient. 1. **Why Allograft is correct:** An allograft (or homograft) is a transplant between two genetically non-identical members of the same species. Since a mother and daughter share 50% of their genes but are not genetically identical, the transplant is classified as an allograft. This is the most common type of organ transplantation in clinical practice. 2. **Why other options are incorrect:** * **Isograft (Syngeneic graft):** This occurs between genetically identical individuals, such as **monozygotic (identical) twins**. In this case, there is no risk of rejection. * **Xenograft (Heterograft):** This involves a transplant between members of **different species** (e.g., a porcine/pig heart valve transplanted into a human). * **Autograft:** This is a transplant where the donor and recipient are the **same individual** (e.g., a skin graft from the thigh to the arm or a saphenous vein used for CABG). **High-Yield Clinical Pearls for NEET-PG:** * **Hyperacute Rejection:** Occurs within minutes to hours due to pre-formed cytotoxic antibodies (Type II Hypersensitivity). * **Acute Rejection:** Occurs within days to weeks; primarily mediated by T-cells (Type IV Hypersensitivity). * **Chronic Rejection:** Occurs months to years later, characterized by fibrosis and intimal thickening of graft vessels. * **HLA Matching:** The most important HLA loci for renal transplant success are **HLA-A, HLA-B, and HLA-DR**.

Question 93: Which type of Maastricht classification is a brought dead patient?

A. Type 1 (Correct Answer)
B. Type 2
C. Type 3
D. Type 4

Explanation: The **Maastricht Classification** is used to categorize **Donation after Circulatory Death (DCD)**. It classifies potential donors based on the circumstances of their death, which helps determine the viability and legal protocols for organ retrieval. ### **Explanation of Options** * **Type 1: Brought Dead (Correct):** This category includes patients who are dead on arrival (DOA) at the hospital. These are "uncontrolled" donors where cardiac arrest occurred outside the hospital setting, and resuscitation was either not attempted or unsuccessful. * **Type 2: Unsuccessful Resuscitation:** These are patients who suffer a witnessed cardiac arrest in the hospital (e.g., in the Emergency Department) but cannot be revived despite full Advanced Life Support (ALS) efforts. * **Type 3: Awaiting Cardiac Arrest:** These are "controlled" donors. These patients have a non-survivable brain injury but do not meet brain-death criteria. The family and medical team decide to withdraw life-sustaining treatment (WLST), and the patient is monitored until circulatory death occurs. * **Type 4: Cardiac Arrest while Brain Dead:** This occurs when a patient who has already been declared brain-dead (Donation after Brain Death - DBD) suffers a sudden cardiac arrest before organ retrieval can take place. ### **High-Yield Clinical Pearls for NEET-PG** * **Uncontrolled vs. Controlled:** Types 1, 2, and 5 are considered **uncontrolled** (unpredictable), while Type 3 is **controlled** (planned). * **Type 5:** A newer category added later, referring to cardiac arrest in a hospitalized patient (often in the ICU). * **Warm Ischemia Time (WIT):** This is the most critical factor in DCD. Type 1 and 2 donors have higher WIT, often leading to poorer graft outcomes (especially in kidneys and livers) compared to Type 3 or standard brain-dead donors.

Question 94: Which type of Maastricht classification is a brought dead patient?

A. Type 1 (Correct Answer)
B. Type 2
C. Type 3
D. Type 4

Explanation: The **Maastricht Classification** is used to categorize **Donors after Circulatory Death (DCD)**. This classification is crucial for determining the viability of organs based on the duration of warm ischemia. ### **Explanation of Options** * **Type 1: Brought Dead (Correct):** This category includes patients who are dead on arrival (DOA) at the hospital. These are "uncontrolled" donors because the exact time of cardiac arrest is often unknown, leading to significant warm ischemia. * **Type 2: Unsuccessful Resuscitation:** This refers to patients who suffer a witnessed cardiac arrest (usually in the ER or hospital) but cannot be revived despite full cardiopulmonary resuscitation (CPR) efforts. This is also an "uncontrolled" donor category. * **Type 3: Awaiting Cardiac Arrest:** These are "controlled" donors. These patients have non-survivable injuries, and a decision has been made to withdraw life-sustaining treatment (WLST). Organ procurement begins immediately after the heart stops. * **Type 4: Cardiac Arrest while Brain Dead:** This occurs when a patient who is already diagnosed as brain dead (a heart-beating donor) suffers a sudden cardiac arrest before organ retrieval can be completed. ### **High-Yield Clinical Pearls for NEET-PG** * **Uncontrolled DCD:** Types 1, 2, and 5 (sudden death in an inpatient). * **Controlled DCD:** Types 3 and 4 (better graft outcomes due to shorter warm ischemia). * **Warm Ischemia Time:** This is the period between the cessation of perfusion and the initiation of cold storage. It is highest in Type 1 donors, making their organs (especially kidneys) more prone to delayed graft function. * **Most common DCD type used clinically:** Type 3.

Question 95: Who performed the first autologous renal transplantation?

A. Hardy (Correct Answer)
B. Kavosis
C. Higgins
D. Studor

Explanation: **Explanation:** The correct answer is **Hardy (James D. Hardy)**. In 1963, James Hardy performed the first **autologous renal transplantation** (autotransplantation). This procedure involves removing a patient's own kidney and reimplanting it into a different site (usually the iliac fossa) within the same individual. It is clinically indicated for complex ureteral injuries, renal artery aneurysms, or extensive ureteral tumors where "bench surgery" is required before reimplantation. **Analysis of Options:** * **Hardy (A):** Beyond autotransplantation, James Hardy is a monumental figure in transplant history, having also performed the first human lung transplant (1963) and the first xenogeneic heart transplant (1964). * **Kavosis (B):** Likely refers to Kavoussi, who is a pioneer in **laparoscopic urology** and performed the first laparoscopic live donor nephrectomy in 1995. * **Higgins (C):** Charles Higgins is known for his work on hormone therapy for prostate cancer (Nobel Prize) and contributions to urological oncology, not the first autotransplant. * **Studer (D):** Known for the **Studer Pouch**, an orthotopic ileal neobladder construction used after radical cystectomy. **High-Yield Clinical Pearls for NEET-PG:** * **First Successful Human Kidney Transplant:** Performed by **Joseph Murray** (1954) between identical twins (Isograft). * **First Cadaveric Renal Transplant:** Performed by **Yurii Voronoy** (1933), though it was technically unsuccessful due to rejection. * **Site of Renal Transplant:** Usually the **Right Iliac Fossa** (extraperitoneal). * **Vascular Anastomosis:** Renal artery is typically joined to the Internal Iliac artery (end-to-end) or External Iliac artery (end-to-side).

Question 96: Recovery of renal functions after renal transplant usually takes how long?

A. 15 days
B. 1 month (Correct Answer)
C. 6 months
D. 7 days

Explanation: **Explanation:** The recovery of renal function following a kidney transplant is a gradual process that depends on the resolution of pre-existing uremic complications and the stabilization of the new graft. While urine output often begins immediately (in living donor transplants), the complete normalization of metabolic functions, erythropoiesis, and the stabilization of serum creatinine typically takes about **1 month**. * **Why Option B is correct:** By the end of the first month, the acute inflammatory response to surgery subsides, immunosuppressant dosages reach steady-state maintenance levels, and the graft undergoes functional hypertrophy to meet the metabolic demands of the recipient. * **Why Option D is incorrect:** While the "immediate" post-operative phase (first 7 days) shows a rapid drop in creatinine, the patient is still in a state of flux, high-dose steroid transition, and risk for hyperacute or accelerated acute rejection. * **Why Options A & C are incorrect:** 15 days is often too early to declare full functional recovery, especially if there was Delayed Graft Function (DGF). Conversely, 6 months refers more to the long-term "set-point" of the graft (nadir creatinine) rather than the initial recovery of renal homeostasis. **High-Yield Clinical Pearls for NEET-PG:** * **Immediate Function:** Most common in living donor transplants. * **Delayed Graft Function (DGF):** Defined as the need for dialysis within the first week post-transplant; more common in deceased donor (cadaveric) transplants due to longer cold ischemia time. * **Hyperacute Rejection:** Occurs within minutes to hours; mediated by pre-formed antibodies (Type II Hypersensitivity). * **Acute Rejection:** Most common within the first 3 months; primarily T-cell mediated (Type IV Hypersensitivity).

Question 97: Hypothermia (0deg to 4deg C) is a critical component of successful organ cold storage because:

A. Oxygen is more soluble in cold solutions and provides a continual supply for energy metabolism
B. There is no way to suppress microbial growth except by cooling and slowing the growth rate
C. Hypothermia diminishes energy requirements and allows the limited energy reserve to keep the organ alive
D. It slows metabolism and the enzymic processes that would destroy the cell (Correct Answer)

Explanation: **Explanation:** The primary goal of organ preservation is to minimize the damage caused by **warm ischemia**. When an organ is removed from its blood supply, it shifts from aerobic to anaerobic metabolism, leading to ATP depletion, lactic acidosis, and eventual cell death. **Why Option D is Correct:** Hypothermia (0°C to 4°C) is the cornerstone of cold storage because it significantly **reduces the metabolic rate** (by approximately 10-12 fold). By slowing down cellular metabolism and the activity of degradative lysosomal enzymes (autolysis), the organ’s limited energy stores are preserved, and the accumulation of toxic metabolic byproducts is delayed. This extends the "ex-vivo" life of the organ, allowing time for transport and HLA matching. **Analysis of Incorrect Options:** * **Option A:** While oxygen solubility increases slightly in cold liquids, it is insufficient to support aerobic metabolism. Cold storage relies on **metabolic suppression**, not oxygen delivery. * **Option B:** While cooling does inhibit microbial growth, this is a secondary benefit. The primary purpose of hypothermia in transplantation is to prevent **ischemic cellular injury**, not infection control. * **Option C:** This is partially true but less precise than Option D. While it diminishes energy requirements, the critical factor is the **inhibition of enzymatic destruction** (like the Na+/K+ ATPase pump failure and lysosomal leakage) that occurs when metabolism is not slowed. **High-Yield Clinical Pearls for NEET-PG:** * **Q10 Effect:** For every 10°C drop in temperature, the metabolic rate decreases by 2-3 times. * **Preservation Solutions:** Solutions like **University of Wisconsin (UW)** or **Euro-Collins** are used. They are "intracellular-like" (high Potassium, low Sodium) to prevent cell swelling during cold storage. * **Maximum Cold Ischemia Times:** Heart/Lungs (4–6 hours), Liver (12–16 hours), Kidney (up to 48–72 hours).

Question 98: Which disease does not recur in the kidney after renal transplant?

A. Alport syndrome (Correct Answer)
B. Amyloidosis
C. Goodpasture syndrome
D. Diabetic nephropathy

Explanation: **Explanation:** The correct answer is **Alport syndrome**. This is because Alport syndrome is a genetic disorder caused by mutations in the genes encoding the **Type IV collagen** alpha chains (COL4A3, COL4A4, or COL4A5). Since the defect is intrinsic to the patient’s own genetic makeup and basement membrane structure, the transplanted kidney—which comes from a donor with normal collagen genes—will possess a normal glomerular basement membrane (GBM). Therefore, the disease cannot "recur" in the donor tissue. Interestingly, a small percentage of Alport patients may develop **Anti-GBM disease (de novo Goodpasture syndrome)** post-transplant because their immune system recognizes the normal Type IV collagen in the graft as foreign. **Analysis of Incorrect Options:** * **Amyloidosis:** This is a systemic metabolic process. The underlying plasma cell dyscrasia or chronic inflammation continues to produce amyloid proteins, which will eventually deposit in the new graft. * **Goodpasture Syndrome:** This is an autoimmune disease mediated by circulating anti-GBM antibodies. If the transplant is performed while antibody titers are still high, the antibodies will attack the new kidney. * **Diabetic Nephropathy:** As long as the patient remains diabetic, the systemic metabolic environment (hyperglycemia) will eventually cause characteristic histological changes (Kimmelstiel-Wilson nodules) in the transplanted kidney. **High-Yield Clinical Pearls for NEET-PG:** * **Most common disease to recur post-transplant:** MPGN Type II (Dense Deposit Disease) — nearly 100% recurrence. * **Most common cause of graft loss due to recurrence:** FSGS (Focal Segmental Glomerulosclerosis). * **Oxalosis:** High rate of recurrence; often requires a combined liver-kidney transplant. * **IgA Nephropathy:** Frequently recurs histologically, but rarely leads to early graft loss.

Question 99: What is considered a contraindication for liver transplant?

A. Acute fulminant hepatic failure
B. Metabolic disease
C. Metastasis (Correct Answer)
D. Primary liver malignancy

Explanation: ### Explanation In transplant surgery, the primary goal is to ensure long-term survival and optimal utility of the donor organ. **Metastasis (Option C)** is a definitive contraindication for liver transplantation because the systemic spread of malignancy implies that replacing the liver will not cure the patient. Furthermore, the mandatory post-transplant immunosuppression would accelerate the growth of micrometastases elsewhere in the body, leading to rapid recurrence and poor outcomes. **Analysis of Incorrect Options:** * **Acute Fulminant Hepatic Failure (Option A):** This is a **primary indication** for emergency liver transplantation (e.g., paracetamol toxicity or viral hepatitis) when the patient meets the King’s College Criteria. * **Metabolic Disease (Option B):** Conditions like Wilson’s disease, Alpha-1 antitrypsin deficiency, and Crigler-Najjar syndrome type 1 are classic indications, as the liver is the site of the underlying enzymatic defect. * **Primary Liver Malignancy (Option D):** Hepatocellular Carcinoma (HCC) is a common indication for transplant, provided it falls within the **Milan Criteria** (single lesion ≤5 cm or up to 3 lesions each ≤3 cm). **High-Yield Clinical Pearls for NEET-PG:** * **Absolute Contraindications:** Extrahepatic malignancy (metastasis), active extrahepatic infection/sepsis, advanced cardiopulmonary disease, and active substance abuse (alcohol/drugs). * **Milan Criteria:** The gold standard for selecting HCC patients for transplant to ensure low recurrence rates. * **MELD Score:** Used for organ allocation; it includes Bilirubin, Creatinine, and INR. * **Most common indication (Adults):** Cirrhosis (HCV/Alcohol). * **Most common indication (Pediatrics):** Biliary Atresia.

Question 100: Highest chance of success in renal transplant is seen when the donor is:

A. Identical twin (Correct Answer)
B. Father
C. Mother
D. Sister

Explanation: **Explanation:** The success of a renal transplant is primarily determined by the degree of **HLA (Human Leukocyte Antigen) matching** between the donor and the recipient. **1. Why Identical Twin is Correct:** Identical (monozygotic) twins are genetically identical, meaning they share a **100% HLA match** (6/6 antigens). Because the recipient’s immune system recognizes the donor tissue as "self," there is virtually no risk of host-versus-graft rejection. This eliminates the need for long-term maintenance immunosuppression, leading to the highest graft survival rates and the best long-term outcomes. **2. Why Other Options are Incorrect:** * **Father/Mother (Options B & C):** These are "Haploidentical" donors. A child inherits one HLA haplotype from each parent, resulting in only a **50% (3/6) match**. While successful, they carry a higher risk of rejection compared to an identical twin. * **Sister (Option D):** Siblings have a 25% chance of being a perfect HLA match, a 50% chance of being a half-match, and a 25% chance of being a total mismatch. While a "HLA-identical sibling" is the second-best choice after an identical twin, the option simply states "Sister," which does not guarantee a 100% match. **High-Yield Clinical Pearls for NEET-PG:** * **Order of Donor Preference:** Identical Twin > HLA-identical Sibling > Parent/Haploidentical Sibling > Deceased (Cadaveric) Donor. * **First Successful Transplant:** Performed by Joseph Murray in 1954 between identical twins (the Herrick brothers). * **Hyperacute Rejection:** Occurs within minutes/hours due to pre-formed antibodies (Type II Hypersensitivity). * **Most Common Site:** The donor kidney is usually placed in the **Right Iliac Fossa** (extraperitoneal) for easier vascular access and ureteral implantation.

Question 101: Which of the following organs obtained from a cadaver is not used for transplant?

A. Blood vessels
B. Lung
C. Liver
D. Urinary bladder (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Urinary bladder**. In transplant surgery, organs and tissues are harvested from cadaveric donors (typically brain-dead or heart-beating donors) based on their functional necessity and the feasibility of the procedure. **Why Urinary Bladder is not used:** The urinary bladder is currently **not** a standard organ for transplantation. This is primarily because the bladder is a complex muscular reservoir that requires intricate neural coordination for storage and voiding. Transplanting a bladder would involve difficult reinnervation that current medical technology cannot reliably achieve. Furthermore, for patients with end-stage bladder disease or malignancy, effective alternatives exist, such as **urinary diversion** (e.g., Ileal conduit) or **neobladder reconstruction** using the patient's own bowel segments (enterocystoplasty). **Analysis of Incorrect Options:** * **A. Blood vessels:** Vascular allografts (arteries and veins) are frequently harvested from cadavers and used in bypass surgeries or complex reconstructions when autologous grafts are unavailable. * **B. Lung:** Lung transplantation is a standard procedure for end-stage pulmonary diseases like COPD, cystic fibrosis, and ILD. * **C. Liver:** The liver is one of the most commonly transplanted cadaveric organs, used for end-stage liver disease and acute liver failure. **High-Yield Clinical Pearls for NEET-PG:** * **Most common organ transplanted:** Kidney (followed by Liver). * **Most common tissue transplanted:** Cornea. * **Warm Ischemia Time:** The time an organ remains at body temperature after its blood supply is cut off. The heart and lungs are most sensitive (approx. 4–6 hours). * **Preservation Solution:** University of Wisconsin (UW) solution is the gold standard for multi-organ preservation.

Question 102: Which of the following is a criterion for a pancreas donor?

A. No history of diabetes (Correct Answer)
B. No history of liver donation
C. No replaced hepatic artery vessels arising from the superior mesenteric artery (SMA)
D. No previous splenectomy

Explanation: ### Explanation **Correct Answer: A. No history of diabetes** The primary goal of pancreas transplantation is to restore endogenous insulin secretion and achieve a normoglycemic state. Therefore, the most critical criterion for a donor is **intact endocrine function**. A history of diabetes (Type 1 or Type 2) implies pancreatic beta-cell dysfunction or exhaustion, making the organ unsuitable for transplantation. Ideal donors are typically aged 10–40 years, have no history of glucose intolerance, and have normal serum amylase/lipase levels. **Analysis of Incorrect Options:** * **B. No history of liver donation:** This is incorrect. Combined liver-pancreas transplants or sequential donations are common. The liver and pancreas can be harvested from the same deceased donor simultaneously. * **C. No replaced hepatic artery:** This is a common anatomical variation (up to 15–20%) where the right hepatic artery arises from the SMA. While this requires careful surgical dissection and vascular reconstruction (the "Y-graft" technique using the donor iliac artery), it is **not** a contraindication to donation. * **D. No previous splenectomy:** While the tail of the pancreas is anatomically related to the splenic hilum, a prior splenectomy does not preclude pancreas donation, provided the pancreatic blood supply and parenchyma remain undamaged. **High-Yield Clinical Pearls for NEET-PG:** * **Most common indication:** Type 1 Diabetes Mellitus with end-stage renal disease (usually performed as a **Simultaneous Kidney-Pancreas (SKP) transplant**). * **Vascular Supply:** The donor pancreas is typically harvested with the **Celiac axis and SMA**, which are reconstructed using a **Y-graft** (Donor Iliac Artery) to the recipient's Common Iliac Artery. * **Venous Drainage:** Most modern transplants use **systemic venous drainage** (to the IVC or Iliac vein), though portal drainage is more physiological. * **Exocrine Drainage:** Can be **Bladder drainage** (monitored via urinary amylase) or **Enteric drainage** (more common now due to fewer metabolic complications).

Question 103: What is the correct order of anastomosis in a lung transplant?

A. Pulmonary artery, pulmonary vein, bronchus
B. Pulmonary vein, bronchus, pulmonary artery (Correct Answer)
C. Pulmonary vein, pulmonary artery, bronchus
D. Pulmonary artery, bronchus, pulmonary vein

Explanation: In lung transplantation, the sequence of anastomosis is strategically designed to minimize warm ischemia time and ensure the structural stability of the graft. ### **The Correct Sequence: Bronchus → Pulmonary Vein → Pulmonary Artery** *(Note: While the provided answer key lists Pulmonary Vein first, the standard surgical protocol in modern thoracic surgery typically follows the **Posterior-to-Anterior** rule: **Bronchus → Pulmonary Vein (Left Atrium) → Pulmonary Artery**.)* 1. **Bronchus (Posterior):** The bronchus is the deepest (most posterior) structure. It is anastomosed first to provide a stable "anchor" for the lung and because it is the most difficult to access once the vascular structures are joined. 2. **Pulmonary Vein (Left Atrial Cuff):** The venous anastomosis (via a left atrial cuff) is performed next. 3. **Pulmonary Artery (Anterior):** The pulmonary artery is the most superficial (anterior) structure and is completed last. **Why Option B is the designated "Correct" answer in many Indian PG exams:** In several classic surgical textbooks and previous exam patterns, the sequence is prioritized by **re-establishing outflow before inflow**. By anastomosing the **Pulmonary Vein** first, the surgeon ensures that once the arterial clamp is released, there is a clear path for blood to exit the lung, preventing acute pulmonary congestion and "stunning" of the graft. ### **Why Other Options are Incorrect:** * **Options A & D:** Placing the **Pulmonary Artery** first is technically difficult because it is the most anterior structure; completing it first would obstruct the surgeon’s view and access to the deeper bronchus and veins. * **Option C:** Placing the **Bronchus** last is avoided because manipulating the lung to reach the posterior airway after the delicate vascular sutures are in place risks tearing the vessels. ### **High-Yield Clinical Pearls for NEET-PG:** * **Ischemia Time:** The maximum cold ischemia time for a lung graft is **4–6 hours**. * **Bronchial Healing:** The donor bronchus is prone to ischemia because its primary blood supply (bronchial arteries) is severed during procurement; it relies on collateral flow from the pulmonary circulation. * **Most Common Complication:** In the early post-op period, **Primary Graft Dysfunction (PGD)** is a leading cause of mortality. * **Immunosuppression:** Lung transplants require higher levels of immunosuppression compared to kidneys due to constant exposure to the external environment.

Question 104: A 55-year-old woman with cirrhosis requires liver transplantation. Her MELD score is 28, and she has been on the waiting list for 8 months. She presents with confusion, asterixis, and ammonia level of 150 μg/dL (normal 15-45). What is the most important consideration for transplant candidacy at this time?

A. Presence of ascites
B. Length of time on waiting list
C. Reversibility of hepatic encephalopathy with treatment
D. Hepatic encephalopathy suggests end-stage disease (Correct Answer)

Explanation: ***Hepatic encephalopathy suggests end-stage disease*** - The presence of **hepatic encephalopathy** (confusion, asterixis, elevated ammonia) indicates severe, **end-stage liver disease**, making liver transplantation highly urgent and potentially the only definitive treatment. - While MELD score dictates initial priority, the acute presentation of encephalopathy in a patient with a high MELD score highlights the critical need for a transplant. *Presence of ascites* - While ascites is a common complication of cirrhosis, it is a **less urgent indicator** for transplant candidacy than acute hepatic encephalopathy. - Ascites can often be managed medically, unlike acute severe encephalopathy, which necessitates an immediate transplant. *Length of time on waiting list* - The length of time on the waiting list is a factor in **transplant allocation**, but it does not supersede the urgency of acute, severe complications like hepatic encephalopathy. - A patient's medical status and **likelihood of survival** are primary considerations, overriding waiting time alone. *Reversibility of hepatic encephalopathy with treatment* - Although treatment for hepatic encephalopathy (e.g., lactulose, rifaximin) can temporarily improve symptoms, it does not address the underlying **progressive liver failure**. - The goal of transplantation is to treat the **irreversible liver disease**, not just its transient complications.

Question 105: A 42-year-old surgeon is diagnosed with hepatitis C and requests evaluation for liver transplantation. Her viral load is high, and she has early cirrhosis. She wants to continue operating while awaiting transplant. Evaluate the ethical and medical considerations regarding her continued practice.

A. Allow continued practice with universal precautions
B. Restrict practice to non-invasive procedures only
C. Require immediate cessation of all surgical practice
D. Defer decision to hospital ethics committee (Correct Answer)

Explanation: ***Defer decision to hospital ethics committee*** - This complex scenario involves balancing the **autonomy** of the physician, patient safety, and institutional responsibility, making it suitable for a **multidisciplinary discussion**. - An ethics committee can provide a structured framework to consider **legal implications**, hospital policies, and the latest **medical guidelines** regarding infected healthcare workers. *Allow continued practice with universal precautions* - While **universal precautions** are essential, the risk of **blood-borne pathogen transmission** (HCV) still exists, particularly in invasive surgical procedures where sharps injuries can occur. - The surgeon's **high viral load** increases the risk, and relying solely on precautions may not adequately protect patients. *Restrict practice to non-invasive procedures only* - This option offers a compromise, reducing the direct exposure risk to patients from **blood-borne pathogens** during surgical procedures. - However, it significantly limits the surgeon's professional scope and may still raise ethical questions about the **physician's fitness** for any patient-facing role while actively infected with a transmissible disease. *Require immediate cessation of all surgical practice* - While this eliminates the immediate risk of **HCV transmission** to patients during surgery, it is a drastic measure with significant impact on the surgeon's career and livelihood. - Such a decision should not be made unilaterally without a thorough evaluation of all factors, including the **actual risk** and less restrictive alternatives.

Question 106: A 65-year-old man with cirrhosis (Child-Pugh B) and hepatocellular carcinoma presents with a 4 cm tumor. He has portal hypertension with esophageal varices and ascites. His MELD score is 18. Evaluate the optimal treatment strategy considering tumor stage, liver function, and available therapies.

A. Sorafenib chemotherapy
B. Radiofrequency ablation of the tumor
C. Liver transplantation evaluation (Correct Answer)
D. Transarterial chemoembolization (TACE)

Explanation: ***Liver transplantation evaluation*** - The presence of a 4 cm hepatocellular carcinoma within a background of advanced cirrhosis (Child-Pugh B, MELD 18) and portal hypertension (esophageal varices, ascites) makes **liver transplantation** the optimal treatment strategy. This addresses both the tumor and the underlying liver disease. - According to the **Milan criteria**, a single tumor up to 5 cm (or up to 3 tumors, each 3 cm or less) is within transplant eligibility, offering the best chance for long-term survival for appropriate candidates. *Sorafenib chemotherapy* - **Sorafenib** is a systemic therapy typically reserved for advanced HCC that is **not amenable to locoregional or surgical therapies**, or in cases of metastatic disease. - Given the tumor size and the patient's liver function, a more definitive and potentially curative option like transplantation should be considered first. *Radiofrequency ablation of the tumor* - **Radiofrequency ablation (RFA)** is a locoregional therapy often used for small HCCs, typically **< 3 cm**, in patients with good liver function. - A 4 cm tumor might be less effectively treated by RFA, and the patient's compromised liver function and portal hypertension make even effective local control less beneficial without addressing the underlying liver disease. *Transarterial chemoembolization (TACE)* - **TACE** is a locoregional treatment for intermediate-stage HCC (often multiple tumors or larger tumors not suitable for RFA or surgery). It is **not considered curative**. - While TACE can control tumor growth, it does not treat the underlying advanced liver disease, which is a major factor in this patient's prognosis.

Question 107: Xenograft is transplantation of tissue:

A. From same species
B. From genetically identical twins
C. From a different species (Correct Answer)
D. From one part of body to another

Explanation: ***From a different species*** - A **xenograft** (or heterograft) is the transplantation of cells, tissues, or organs from **one species to another**, such as from a pig to a human. - This type of transplant faces significant immunological challenges due to the **genetic disparity** between the donor and recipient. *From same species* - This describes an **allograft** (or homograft), where tissue is transplanted between genetically distinct individuals of the **same species**. - Examples include organ transplants between unrelated humans. *From genetically identical twins* - This describes an **isograft** (or syngeneic graft), which involves transplantation between **genetically identical individuals**, such as monozygotic twins. - These grafts typically have the **highest success rate** due to minimal immune rejection. *From one part of body to another* - This describes an **autograft**, where tissue is transplanted from one site to another **within the same individual**. - Examples include a skin graft from the thigh to a burned area on the arm or a **coronary artery bypass graft** using a leg vein; these grafts are not rejected as they originate from the patient's own body.

Question 108: Which is the common site of injection of islet cells in islet cell transplant for diabetes mellitus?

A. Portal vein (Correct Answer)
B. Forearm muscles
C. Pancreas
D. Pelvis

Explanation: ***Portal vein*** - Islet cells are infused into the **portal vein** to allow them to be carried to the liver, where they engraft and begin producing insulin. - The liver provides a **vascular-rich environment** suitable for islet cell survival and integration, and the portal system allows direct access to the systemic circulation for insulin delivery. *Forearm muscles* - While muscles can be used for cell delivery in some experimental therapies, they do not provide the **optimal vascularity** or direct circulatory access for effective islet cell function and insulin secretion required for diabetes management. - The forearm muscles would not allow the instilled insulin to be directly sent to target organs via **systemic circulation**. *Pancreas* - Directly injecting islet cells into the pancreas is technically challenging due to its **exocrine function** and has a higher risk of inflammation and damage to the remaining pancreatic tissue. - The goal is to replace the function of the pancreatic islets rather than directly integrate them into the diseased or damaged pancreas, especially since the autoimmune process often targets the pancreas itself. *Pelvis* - The pelvis, while having some vascularity, is not a primary site for islet cell transplantation due to its **lack of direct involvement** in glucose metabolism regulation and less optimal vascular architecture for widespread insulin distribution. - There is no specific physiological advantage for engrafting islet cells in the pelvis over other sites like the liver, and it would not ensure optimal insulin delivery to the systemic circulation.

Question 109: Graft between identical twins is known as

A. Heterograft
B. Autograft
C. Allograft
D. Isograft (Correct Answer)

Explanation: ***Isograft*** - An **isograft** refers to a transplant of tissue or organs between genetically identical individuals, such as **monozygotic (identical) twins**. - Due to their identical genetic makeup, there is **no immune rejection** of the graft. *Heterograft* - A heterograft, also known as a **xenograft**, is a transplant between individuals of **different species**. - These grafts typically face strong **immune rejection** due to significant genetic differences. *Autograft* - An autograft is a tissue graft taken from **one part of a person's body** and transplanted to another part of the **same individual**. - This type of graft experiences **no immune rejection** as the tissue is genetically identical to the recipient. *Allograft* - An allograft is a transplant between **genetically non-identical individuals of the same species**. - While possible, allografts require **immunosuppressive therapy** to prevent rejection due to genetic differences.

Question 110: What is the documented mortality rate for healthy liver donors undergoing donor hepatectomy?

A. Mortality for donor is 0.6 to 0.8 %
B. Mortality for donor is 0.5 %
C. Mortality for donor is 0.2 to 0.4 % (Correct Answer)
D. Mortality for donor is 1%

Explanation: ***Correct: Mortality for donor is 0.2 to 0.4%*** - Studies indicate that the **mortality rate** for healthy liver donors undergoing **donor hepatectomy** is very low, typically ranging from **0.2% to 0.4%**. - This rate reflects the extensive **pre-operative screening** and careful surgical techniques used to ensure donor safety. - Current data from major transplant centers worldwide support this range as the most accurate representation of donor risk. *Incorrect: Mortality for donor is 0.6 to 0.8%* - This range is **higher** than the generally accepted and documented mortality rates for healthy liver donors. - While complications can occur, fatal outcomes are rare, making this percentage an **overestimation** of actual risk. *Incorrect: Mortality for donor is 0.5%* - This mortality rate is also **higher** than the current reported rates for living liver donation in well-established centers. - Continuous advancements in surgical safety and donor selection have driven the mortality rate **below 0.5%** in most high-volume centers. *Incorrect: Mortality for donor is 1%* - A 1% mortality rate for healthy liver donors would be considered **unacceptably high** given the current standards of care. - This percentage severely **overestimates** the actual risks associated with living related liver donation and does not reflect modern surgical outcomes.

Question 111: All are Indications of liver transplant except

A. Biliary atresia
B. Cirrhosis
C. Fulminant hepatitis
D. Cholangiocarcinoma (Correct Answer)

Explanation: ***Cholangiocarcinoma*** - **Cholangiocarcinoma** is a **contraindication** for liver transplantation due to its aggressive nature and high recurrence rate post-transplant, except in highly selected early cases treated with neoadjuvant therapy. - The risk of **tumor recurrence** and poor long-term survival generally outweighs the benefits of transplantation for this malignancy. *Biliary atresia* - **Biliary atresia** is the most common indication for **pediatric liver transplantation**. - It involves the progressive destruction of bile ducts, leading to **cholestasis**, cirrhosis, and liver failure in infants. *Cirrhosis* - **Cirrhosis** from various etiologies (e.g., viral hepatitis, alcohol, NASH) is a primary indication for liver transplantation when it leads to **decompensated liver disease** or end-stage liver failure. - Patients with complications like **ascites**, **encephalopathy**, or recurrent variceal bleeding often require transplant. *Fulminant hepatitis* - **Fulminant hepatitis** (acute liver failure) rapidly progresses to severe liver dysfunction and encephalopathy in individuals without pre-existing liver disease. - It is an urgent indication for **emergent liver transplantation** to prevent multi-organ failure and death.

Question 112: An isograft indicates transfer of tissues between:

A. Monozygotic twins (Correct Answer)
B. Related donors
C. Unrelated donors
D. Parts of same individual

Explanation: ***Monozygotic twins*** - An **isograft**, also known as an **isogeneic graft**, refers to the transplantation of tissues or organs between two genetically identical individuals. - **Monozygotic (identical) twins** are genetically identical, making them ideal donors and recipients for isografts as there is minimal risk of immune rejection. *Related donors* - This describes **allografts** or **homografts**, where tissue is transferred between genetically non-identical individuals of the same species. - While related donors may have better histocompatibility than unrelated donors, they are typically not genetically identical, leading to a risk of immune rejection. *Unrelated donors* - This also describes **allografts**, where tissue is transferred between genetically non-identical individuals of the same species. - The greater genetic disparity between unrelated individuals increases the risk of **graft rejection** compared to related donors or identical twins. *Parts of same individual* - This describes an **autograft**, where tissue is transplanted from one part of an individual's body to another part of the *same* individual. - Autografts are immunologically ideal as there is no risk of rejection, but this is distinct from an isograft which involves two separate individuals.

Question 113: For transplantation, cornea can be removed from dead body up to:

A. 6 hours
B. 24 hours (Correct Answer)
C. 18 hours
D. 12 hours

Explanation: ***24 hours*** - Corneas can be harvested from a deceased donor within **24 hours** of death, provided the body is kept in a cool environment. - This time frame allows for adequate perfusion of the corneal tissue and maintains **cellular viability** for successful transplantation. *6 hours* - While some organs have a very limited window for retrieval, **corneas** generally have a longer viability compared to highly metabolic organs. - A 6-hour window is often too short and would significantly limit the availability of corneal tissue for transplantation. *18 hours* - An 18-hour window is a reasonable period but is often extended to 24 hours under proper storage conditions. - Extending to **24 hours** maximizes the opportunity for procurement and does not significantly compromise tissue quality for corneal transplantation. *12 hours* - A 12-hour window, although longer than 6 hours, is still a conservative estimate for corneal retrieval. - With advancements in preservation techniques, the **viability period** for corneas is now widely accepted to be up to 24 hours post-mortem.

Question 114: Most common complication after intestinal transplantation is

A. Intestinal obstruction
B. Graft vs host disease
C. Intestinal necrosis
D. Sepsis (Correct Answer)

Explanation: ***Sepsis*** - **Infection** is the leading cause of morbidity and mortality after intestinal transplantation, making **sepsis** the most common complication. - The immunocompromised state due to immunosuppressive therapy and the inherent bacterial load of the gastrointestinal tract contribute significantly to the high risk of severe infections. *Intestinal obstruction* - While intestinal obstruction can occur post-transplant due to adhesions or strictures, it is **less common** than infectious complications. - It typically manifests later and may require surgical intervention but doesn't have the same high frequency as sepsis. *Graft versus host disease* - **Graft-versus-host disease (GVHD)** is a significant complication in intestinal transplantation, but it is **not the most common**. - Its incidence varies, and while serious, it does not surpass the overall frequency of infectious complications and sepsis. *Intestinal necrosis* - **Intestinal necrosis** (e.g., due to infarction or severe rejection) is a severe complication but is **less frequent** than sepsis. - It is often a consequence of vascular compromise or overwhelming rejection, leading to graft failure or perforation.

Question 115: All of the following are true about the history of transplantation except:

A. First pancreas transplantation by Kelly & Lillhei
B. First successful intestinal transplantation by Hardy (Correct Answer)
C. First lung transplantation by Fritz Derom
D. First heart & lung transplantation by Reitz & Shumway

Explanation: ***First successful intestinal transplantation by Hardy*** - The **first successful intestinal transplantation** was **NOT performed by Hardy**. - **Hardy** is famous for the **first human lung transplant** in **1963** and the **first heart xenotransplant** (chimpanzee to human) in **1964**. - **Intestinal transplantation** had its first long-term success in the late **1980s** (notably by **Starzl** and others after the introduction of cyclosporine). - This statement is **FALSE**, making it the correct answer to this "EXCEPT" question. *First pancreas transplantation by Kelly & Lillhei* - The **first successful human pancreas transplant** was indeed performed by **William Kelly** and **Richard Lillehei** at the University of Minnesota in **1966**. - This was a **simultaneous pancreas-kidney transplant** for a patient with diabetes and renal failure. - This statement is **TRUE**. *First lung transplantation by Fritz Derom* - This is **contextually TRUE** when referring to the **first successful lung transplant with meaningful survival**. - **James Hardy** performed the **first human lung transplant** in **1963**, but the patient survived only **18 days**. - **Fritz Derom** (Belgium) performed a lung transplant in **1968** with the patient surviving **10 months**, representing the first case with significant survival. - In transplant history, Derom is often credited as this represented a more meaningful milestone. - This statement is generally considered **TRUE**. *First heart & lung transplantation by Reitz & Shumway* - **Bruce Reitz** and his team at Stanford University, working under **Norman Shumway**, performed the **first successful combined heart-lung transplant** in **1981**. - The patient, Mary Gohlke, survived for **5 years** post-transplant. - This statement is **TRUE**.

Question 116: Transplantation of liver is contraindicated in:

A. Metastasis to liver (Correct Answer)
B. Renal failure
C. Acute fulminant liver disease
D. Viral hepatitis

Explanation: ***Metastasis to liver*** - The presence of **metastasis to the liver** from another primary cancer is a general contraindication for liver transplantation. - This is because the underlying malignancy is systemic, and transplantation would not cure the cancer, with high risk of **disease recurrence** in the transplanted organ or elsewhere. *Renal failure* - **Renal failure** alone is not an absolute contraindication for liver transplantation; patients with **hepatorenal syndrome** or chronic kidney disease can undergo combined liver-kidney transplantation. - The decision depends on the reversibility of renal failure and the overall clinical picture. *Acute fulminant liver disease* - **Acute fulminant liver disease** is a common and often urgent **indication** for liver transplantation, not a contraindication. - Transplantation is life-saving in these cases when medical management fails due to rapid deterioration and high mortality. *Viral hepatitis* - **Viral hepatitis** (e.g., hepatitis C, hepatitis B) is a common cause of end-stage liver disease and is a leading **indication** for liver transplantation. - With modern antiviral therapies, patients can often receive a transplant and manage the viral recurrence post-transplant.

Question 117: A woman receives an organ transplant from her sister who is an identical twin. What type of graft is it?

A. Xenograft
B. Autograft
C. Isograft (Correct Answer)
D. Allograft

Explanation: ***Isograft*** - An isograft (or syngeneic graft) refers to tissue transplanted between **genetically identical** individuals, such as identical twins. - In such cases, there is no **immune rejection** because the donor and recipient share the exact same genetic makeup. *Xenograft* - A xenograft involves transplanting tissue or organs from one **species to another**, for example, from a pig to a human. - These grafts typically face strong and immediate **immune rejection** due to significant genetic differences. *Autograft* - An autograft is a transplant of tissue from one part of an individual's body to **another part of the same individual**. - Examples include a **skin graft** from a thigh to a burn on the arm, and there is no risk of immune rejection. *Allograft* - An allograft involves transplanting tissue or organs between **genetically non-identical individuals of the same species**, such as a transplant from one human to another unrelated human. - These grafts typically require **immunosuppressive drugs** to prevent rejection due to genetic differences.

Question 118: Auxiliary orthotopic liver transplant is indicated for

A. Metabolic liver disease
B. Acute fulminant liver failure for any cause (Correct Answer)
C. Drug induced hepatic failure
D. As a standby procedure until finding a suitable donor

Explanation: ***Acute fulminant liver failure for any cause*** - **Auxiliary orthotopic liver transplant (AOLT)** is primarily indicated in acute fulminant liver failure because it allows for the potential regeneration of the native liver while providing immediate liver support. - This technique preserves the **native liver**, which can recover and take over function if the underlying cause is reversible, allowing for eventual withdrawal of immunosuppression. *Metabolic liver disease* - For **metabolic liver diseases**, the primary goal is often to replace the diseased liver with a healthy one to correct the metabolic defect, making **orthotopic liver transplantation (OLT)** the standard. - In most metabolic liver diseases, the native liver is permanently dysfunctional and not expected to recover significant function, rendering AOLT less beneficial. *Drug induced hepatic failure* - While drug-induced hepatic failure can be a form of acute liver failure, the scope of the option "Acute fulminant liver failure for any cause" is broader and more accurately encapsulates the primary indication for AOLT. - If the native liver has sustained irreversible damage from drugs, a full **orthotopic liver transplant** would be more appropriate than an auxiliary approach. *As a standby procedure until finding a suitable donor* - AOLT is a definitive treatment strategy aimed at liver support and potential native liver recovery, not a temporary measure to bridge to another transplant or donor. - The concept of a "standby procedure" until a donor is found typically refers to urgent **orthotopic liver transplantation** listings or temporary support like extracorporeal devices, not AOLT.

Question 119: Which of the following is true regarding extended criteria donors for liver transplantation?

A. Donors with well-controlled diabetes mellitus
B. Hepatitis C antibody positive donors
C. Donors with significant uncontrolled comorbidities
D. Donors aged >60 years with no significant comorbidities (Correct Answer)

Explanation: ***Donors aged >60 years with no significant comorbidities*** - **Advanced donor age** is a key characteristic of an extended criteria donor (ECD), especially when coupled with other factors like **ischemic time** or comorbidities. - While age alone might not prohibit donation, it puts the donor liver into the ECD category, requiring careful recipient selection and possibly increasing the risk of **post-transplant complications**. *Donors with well-controlled diabetes mellitus* - **Well-controlled diabetes mellitus** in a donor does not automatically classify them as an extended criteria donor, if there are no other significant associated comorbidities or organ damage. - The focus is generally on signs of significant end-organ damage or poorly controlled disease that could impact graft function. *Hepatitis C antibody positive donors* - **Hepatitis C antibody positive donors** are traditionally considered extended criteria donors and remain classified as such. - However, with the advent of highly effective **direct-acting antiviral (DAA) therapies**, HCV-positive organs can now be safely transplanted into both HCV-positive and HCV-negative recipients with excellent outcomes. - While still technically ECD, the clinical significance has diminished significantly with modern treatment availability, making **donor age >60 years** the more universally recognized ECD criterion in current practice. *Donors with significant uncontrolled comorbidities* - **Significant uncontrolled comorbidities** would generally render a donor **unsuitable for donation**, rather than classify them as an extended criteria donor. - Extended criteria typically refer to factors that increase risk but are still acceptable under specific circumstances, whereas uncontrolled comorbidities often pose too high a risk for successful transplantation.

Question 120: Renal transplantation is most commonly done in?

A. Horseshoe kidney
B. Chronic glomerulonephritis (Correct Answer)
C. Bilateral staghorn calculus
D. Oxalosis

Explanation: ***Chronic glomerulonephritis*** - **Chronic glomerulonephritis** is one of the **major causes of end-stage renal disease (ESRD)** requiring renal transplantation, accounting for approximately **10-15% of transplants**. - It leads to progressive destruction of the glomeruli, resulting in irreversible loss of kidney function. - **Note:** In current practice, diabetic nephropathy and hypertensive nephrosclerosis are more common causes of ESRD, but among the options listed, chronic glomerulonephritis is the most significant indication for transplantation. *Horseshoe kidney* - A **horseshoe kidney** is a **congenital anatomical anomaly** where the kidneys are fused, usually at their lower poles. - While it can increase the risk of certain renal conditions like stones, infections, or hydronephrosis, it is **not a primary cause of ESRD** requiring transplantation. - Horseshoe kidney itself is not an indication for transplantation. *Bilateral staghorn calculus* - **Bilateral staghorn calculi** are large, branching kidney stones that can fill the renal pelvis and calyces. - While they can cause significant kidney damage, infection, and obstruction, they are **managed surgically** (percutaneous nephrolithotomy, ureteroscopy) and **rarely progress to ESRD** requiring transplantation if treated appropriately. - They represent a treatable condition rather than a primary transplant indication. *Oxalosis* - **Primary hyperoxaluria (oxalosis)** is a **rare genetic disorder** characterized by excessive oxalate production and deposition in kidneys and other organs. - Although it can lead to ESRD and requires combined **liver-kidney transplantation**, it is a **much less common** indication compared to chronic glomerulonephritis. - Accounts for <1% of transplant cases.

Question 121: What is safe maximum time for storage of heart?

A. 2 hours
B. 4 hours
C. 8 hours
D. 6 hours (Correct Answer)

Explanation: ***6 hours*** - The **ischemic time** for a donor heart before transplantation is ideally kept under **4-6 hours** to minimize damage and ensure successful engraftment. - **6 hours represents the absolute maximum** safe cold ischemic time, though shorter durations (closer to 4 hours) are associated with better outcomes. - Prolonged cold ischemic time significantly increases the risk of **primary graft dysfunction** and reduces long-term survival. *2 hours* - While a shorter ischemic time is always preferable, 2 hours is often not logistically feasible given the complexities of **organ retrieval** and **transportation**. - Many heart transplants are successfully performed with an ischemic time longer than 2 hours without major complications. - This would be an ideal but impractical limit in most real-world scenarios. *4 hours* - Although **4 hours** is the recommended optimal limit and many guidelines suggest this as the target, the question asks for the **maximum** safe time. - Most centers aim for under 4 hours, but can extend to 6 hours with acceptable outcomes for carefully selected donors and recipients. - The precise limit depends on various factors including the **donor's age and health**, and the preservation solution used. *8 hours* - An ischemic time of **8 hours** for a donor heart is generally considered too long and would result in a very high risk of **irreversible myocardial damage** and poor graft function. - This duration would lead to significantly increased rates of **primary graft failure** and mortality. - Beyond 6 hours, the risk of complications increases exponentially.

Question 122: Graft Survival in first 48 hours depends on

A. Plasma imbibition (Correct Answer)
B. Amount of Saline in graft
C. Connection between donor and recipient capillaries
D. Ingrowth of capillaries in donor tissue

Explanation: ***Plasma imbibition*** - In the initial 24-48 hours post-grafting, the graft survives primarily through **plasma imbibition**, absorbing nutrients and oxygen directly from the recipient bed fluids without established blood vessels. - This process is crucial for the survival of superficial cells until revascularization begins. *Amount of Saline in graft* - While initial hydration of the graft with saline is important during the procedure, it does not sustain graft viability for the entire 48-hour period. - The saline provides temporary turgor and moisture but doesn't offer the continuous nutrient supply required for cell survival. *Connection between donor and recipient capillaries* - The formation of direct capillary connections, known as **inosculation**, typically starts occurring after 24-48 hours, not within the first 48 hours for the primary survival mechanism. - This process is part of sustained revascularization and not the immediate survival mechanism. *Ingrowth of capillaries in donor tissue* - The actual ingrowth of new capillaries (neovascularization) into the graft tissue is a more delayed process, starting after the initial several days and continuing over weeks. - This is a long-term revascularization process, not the mechanism ensuring immediate survival.

Question 123: Which animal's heart has been used for transplantation in humans?

A. Rabbit
B. Sheep
C. Pig (Correct Answer)
D. Horse

Explanation: ***Pig*** - **Pig hearts** and heart valves have been successfully used in **xenotransplantation** due to their physiological similarities to human hearts. - Recent advances in **genetic modification** have reduced the risk of rejection, making pig organs viable for human transplantation. *Rabbit* - Rabbit hearts are significantly smaller and anatomically distinct from human hearts, making them unsuitable for whole heart transplantation. - While rabbits are used in research, their organs lack the necessary size and physiological compatibility for human organ replacement. *Sheep* - Sheep hearts have been used in some research for cardiovascular device testing, but not for whole organ transplantation in humans. - Their heart size and physiology are not as closely matched to humans as pigs for xenotransplantation purposes. *Horse* - Horse hearts are considerably larger and structurally different from human hearts, posing significant anatomical and physiological challenges for transplantation. - There is no clinical or research precedent for horse heart transplantation into humans.

Question 124: All are indications of liver transplantation except:

A. Primary sclerosing cholangitis
B. Fulminant hepatitis
C. Alcoholic cirrhosis
D. Primary biliary cirrhosis
E. Hepatic adenomas (Correct Answer)

Explanation: ***Hepatic adenomas*** - **Hepatic adenomas** are benign liver tumors that generally do not require liver transplantation unless they are **very large**, symptomatic, or show signs of **malignant transformation** or rupture, which are rare indications compared to other severe liver diseases. - Management usually involves **surgical resection** or close monitoring, not transplantation. *Primary sclerosing cholangitis* - **Primary sclerosing cholangitis (PSC)** is a chronic cholestatic liver disease that often progresses to **cirrhosis** and liver failure, making it a common indication for liver transplantation. - It also carries an increased risk of **cholangiocarcinoma**, an indication for transplant if diagnosed early under specific criteria. *Fulminant hepatitis* - **Fulminant hepatitis** (acute liver failure) involves severe, rapid onset liver dysfunction with **encephalopathy** and coagulopathy in individuals without pre-existing liver disease. - It is a **life-threatening condition** that often necessitates urgent liver transplantation. *Alcoholic cirrhosis* - **Alcoholic cirrhosis** is a leading cause of end-stage liver disease and is a common indication for liver transplantation, often after a period of **abstinence** from alcohol. - Transplantation is considered when the liver damage is irreversible and life-threatening, and the patient meets specific criteria, including a commitment to sobriety.

Question 125: Which of the following diseases is appropriately treated with combined heart-lung transplantation?

A. End-stage emphysema
B. Idiopathic dilated cardiomyopathy with long-standing secondary pulmonary hypertension (Correct Answer)
C. Primary pulmonary hypertension
D. Cystic fibrosis

Explanation: ***Idiopathic dilated cardiomyopathy with long-standing secondary pulmonary hypertension*** - In cases of severe **idiopathic dilated cardiomyopathy**, the failing left ventricle can lead to **long-standing secondary pulmonary hypertension**. - This persistent high pressure in the pulmonary circulation results in **irreversible damage** to the pulmonary vasculature, creating fixed pulmonary vascular resistance. - When the pulmonary hypertension becomes fixed and irreversible, isolated heart transplantation would fail as the new heart would face the same elevated pressures, necessitating **combined heart-lung transplantation**. *End-stage emphysema* - **End-stage emphysema** primarily affects the lungs, causing destruction of alveolar walls and airflow obstruction. - While a **bilateral lung transplant** is the standard treatment for severe emphysema, the heart is typically not primarily affected to the extent that it would require combined transplantation. *Primary pulmonary hypertension* - **Primary pulmonary hypertension** is a disease of the pulmonary arteries, where blood vessels in the lungs become narrowed, stiff, or destroyed. - In most cases, **bilateral lung transplantation** alone is sufficient, as the new lungs provide healthy pulmonary vasculature. - While combined heart-lung transplantation may be considered in severe cases with established irreversible right ventricular failure, the more definitive indication is when secondary pulmonary hypertension is caused by primary cardiac disease (as in option A). *Cystic fibrosis* - **Cystic fibrosis** is a genetic disorder that predominantly causes severe lung disease due to thick, sticky mucus buildup. - It primarily necessitates a **bilateral lung transplant** to replace the diseased lungs; the heart is generally not directly affected to the point of requiring a combined transplant.

Question 126: A graft that has been derived from another species of a different genetic disposition is also known as a:

A. Allograft
B. Isograft
C. Heterograft (Correct Answer)
D. Homograft

Explanation: ***Heterograft*** - A **heterograft**, also known as a **xenograft**, is a tissue graft transplanted between individuals of **different species**. - These grafts often face significant **immune rejection** due to the genetic disparity between the donor and recipient species. *Allograft* - An allograft is a transplant between two genetically **non-identical individuals of the same species**. - While they are from the same species, **immune responses** are still common due to genetic differences. *Isograft* - An isograft is a transplant between **genetically identical individuals**, such as **monozygotic (identical) twins**. - These grafts typically have the **lowest risk of immune rejection** because the host immune system recognizes them as "self." *Homograft* - The term **homograft** is often used interchangeably with **allograft**, referring to a graft from a **different individual of the same species**. - It is not specifically used to describe grafts between **different species**.

Question 127: Dr. Christiaan Barnard performed the 1st heart transplant in the year -

A. 1962
B. 1965
C. 1969
D. 1967 (Correct Answer)

Explanation: ***1967*** - Dr. Christiaan Barnard performed the **first human heart transplant** on December 3, 1967, at Groote Schuur Hospital in Cape Town, South Africa. - The recipient, Louis Washkansky, lived for 18 days after the surgery. *1962* - While significant advancements in medicine occurred in 1962, the **first heart transplant** had not yet been performed. - This year saw the approval of the **measles vaccine** and the publication of Rachel Carson's "Silent Spring," but not the seminal heart transplant. *1965* - The year 1965 was a period of continued research and experimentation in organ transplantation, but the **first successful human heart transplant** took place later. - Prior to 1967, xenotransplantation experiments in humans involving animal hearts were attempted, but a human-to-human transplant was still pending. *1969* - By 1969, **several hundred heart transplants** had already been performed worldwide following Barnard's pioneering surgery. - Dr. Denton Cooley performed the **first implantation of a total artificial heart** in a human in 1969, indicating that heart transplantation was already established.

Question 128: In discussing the treatment of a 42-year-old man with severe liver cirrhosis, the possibility of heterotopic transplantation is considered. Which statement about heterotopic liver transplantation is TRUE?

A. It is preferable to orthotopic liver transplantation.
B. It is rarely associated with long-term survival.
C. It implies removal of the recipient's liver.
D. It should be done in the iliac vessels. (Correct Answer)

Explanation: ***It should be done in the iliac vessels.*** - **Heterotopic liver transplantation** involves placing the donor liver in an ectopic location (typically in the right lower abdomen or pelvis) while the native liver remains in situ. - Vascular anastomosis is commonly performed using the **iliac vessels** (external or common iliac artery and vein) or infrarenal IVC and aorta for blood supply to the graft. - This is a **largely historical procedure** that has been mostly abandoned due to technical complexity, high complication rates, and poor long-term outcomes compared to orthotopic transplantation. *It is preferable to orthotopic liver transplantation.* - **Orthotopic liver transplantation (OLT)**, where the diseased liver is completely removed and replaced, is the **gold standard** for end-stage liver disease. - OLT provides superior long-term outcomes, complete removal of the diseased organ, and eliminates competition between native and donor liver function. - Heterotopic transplantation is **not preferable** and has been largely abandoned in modern practice. *It is rarely associated with long-term survival.* - This statement has historical validity—heterotopic liver transplantation was indeed associated with **poor long-term outcomes**, which is a major reason the procedure was largely discontinued. - Complications included vascular thrombosis, competition between native and donor liver, portal hypertension, and technical difficulties. - However, in the context of this question, the statement about iliac vessels is more specifically correct regarding the technical aspect of the procedure. *It implies removal of the recipient's liver.* - **Incorrect**—the defining feature of **heterotopic transplantation** is that the **native liver is left in place**. - Removal of the recipient's liver is characteristic of **orthotopic liver transplantation**, where the diseased organ is excised and replaced in the same anatomical location.

Question 129: All of the following are absolute contraindications for renal transplantation except:

A. Active infection
B. Active malignancy
C. Active drug abuse
D. Reduced life expectancy (Correct Answer)

Explanation: ***Reduced life expectancy*** - While a significantly reduced life expectancy due to certain **comorbidities** may influence the decision to transplant, it is not an absolute, but rather a relative, contraindication, as individual cases vary. - Ethical considerations and the potential for improved quality of life may still support transplantation in some cases, even with a **limited prognosis**. *Active infection* - An **active systemic infection** is an absolute contraindication due to the high risk of severe complications, including sepsis and infection of the transplanted organ, especially with immunosuppression. - The patient must be free of active infection before transplantation to ensure the safety and success of the procedure. *Active malignancy* - The presence of an **active malignancy** is an absolute contraindication because immunosuppressive therapy post-transplant can accelerate cancer progression and metastasis. - Patients typically require a **disease-free interval** (e.g., 2-5 years) after cancer treatment before being considered for transplantation. *Active drug abuse* - **Active illicit drug abuse** is an absolute contraindication due to concerns about adherence to the complex post-transplant medical regimen, potential for infections, and overall poor health outcomes. - Successful transplantation requires strict adherence to medication schedules and follow-up, which is jeopardized by **active substance use**.

Question 130: In orthotopic liver transplantation, which is the best way to achieve bile drainage in the donor liver

A. Donor bile duct with recipient bile duct or Roux-en-Y choledochojejunostomy (Correct Answer)
B. Donor bile duct with jejunum of recipient
C. Donor bile duct with duodenum of recipient
D. External drainage for a few days followed by choledochojejunostomy

Explanation: ***Donor bile duct with recipient bile duct or Roux en Y choledochojejunostomy*** - The most common and preferred method for bile drainage in **orthotopic liver transplantation** is a **duct-to-duct anastomosis** between the donor and recipient bile ducts. - If a primary duct-to-duct anastomosis is not feasible due to size mismatch, damage, or other reasons, a **Roux-en-Y choledochojejunostomy** is performed, which involves connecting the donor bile duct to a Roux limb of the jejunum. *External drainage for few days followed by choledochojejunostomy* - **External bile drainage** is generally avoided in liver transplantation due to increased risks of **infection** and complications like **bile leaks**. - It does not provide a definitive long-term solution for bile flow and necessitates a secondary, more complex surgical procedure for permanent drainage. *Donor bile duct with jejunum of recipient* - Connecting the donor bile duct directly to the jejunum (without a Roux-en-Y limb) would expose the biliary tree to **intestinal contents**, increasing the risk of **ascending cholangitis**. - The Roux-en-Y configuration is crucial to prevent reflux of food and bacteria into the biliary system, which is not achieved by a simple choledochojejunostomy. *Donor bile duct with duodenum of recipient* - Anastomosing the donor bile duct directly to the **duodenum** significantly increases the risk of **reflux of duodenal contents**, including digestive enzymes and bacteria, into the biliary system. - This reflux can lead to severe and recurrent **cholangitis**, stricture formation, and potential graft failure due to chronic inflammation and infection.

Question 131: What is a xenograft?

A. Graft from 1 species to other species (Correct Answer)
B. Graft from sister to brother
C. Graft from father to other child
D. Graft from 1 twin to other twin

Explanation: ***Graft from 1 species to other species*** - A **xenograft**, also known as a **heterograft**, is defined as the transplantation of organs or tissues from one species to another. - Examples include using **porcine (pig)** heart valves in human patients or transplanting baboon hearts into human infants, though the latter is rarely done now due to ethical issues and immunological rejection. *Graft from sister to brother* - This describes an **allograft**, also known as a **homograft**, which is a transplant between genetically different individuals of the same species. - While genetically related, a sister and brother are not genetically identical, thus requiring some degree of **immunosuppression** to prevent rejection. *Graft from father to other child* - This is also an **allograft** or **homograft**, as it involves transplantation between genetically distinct individuals of the same species. - The degree of genetic match would be moderate, similar to a sibling transplant but with potentially more **HLA mismatches**. *Graft from 1 twin to other twin* - This is an **isograft**, also known as an **isogenic graft**, and refers to a transplant between genetically identical individuals, such as identical twins. - Such grafts typically do not elicit an immune response, as the donor and recipient share the exact same **MHC (HLA)** antigens.

Question 132: Grafts transferred between different species are called

A. Homograft
B. Xenograft (Correct Answer)
C. Isograft
D. Allograft

Explanation: ***Xenograft*** - A **xenograft** refers to the transplantation of organs or tissues between **different species**. - For example, using a **pig heart valve** in a human is a xenograft. *Homograft* - A **homograft** (also known as an allograft) involves tissue transplantation between genetically **non-identical individuals of the same species**. - For instance, a kidney transplant from one human to another unrelated human is a homograft. *Isograft* - An **isograft** is a rare type of transplant where tissue is transferred between **genetically identical individuals** (e.g., identical twins). - Since the individuals are genetically identical, there is no immune rejection. *Allograft* - **Allograft** is synonymous with **homograft**, referring to tissue transplantation between genetically **non-identical individuals of the same species**. - It is the most common type of human-to-human transplant.

Question 133: Which of the following is an indication of auxiliary partial orthotopic liver transplantation?

A. As a standby procedure till a suitable donor is found
B. Metabolic liver disease (Correct Answer)
C. Drug induced hepatic failure
D. All irreversible causes of fulminant liver failure

Explanation: ***Metabolic liver disease*** - **Auxiliary partial orthotopic liver transplantation (APOLT)** is indicated for metabolic liver diseases to provide the necessary enzyme or protein function while potentially allowing the native liver to regenerate. - This procedure involves transplanting a portion of a healthy liver and leaving a portion of the diseased native liver in place. This is especially useful in conditions like **Crigler-Najjar syndrome** or **urea cycle disorders**. *As a standby procedure till a suitable donor is found* - While temporary support can be crucial in acute liver failure, APOLT is a complex surgical procedure, not a simple standby. - **Bridge to transplant** often involves less invasive measures like extracorporeal liver assist devices rather than a partial transplant. *Drug induced hepatic failure* - Drug-induced hepatic failure, if reversible, typically managed with supportive care, and the native liver may recover. - While severe cases might require transplantation, APOLT is generally reserved for conditions requiring ongoing metabolic support where the native liver may eventually recover some function. *All irreversible causes of fulminant liver failure* - For irreversible **fulminant liver failure**, a **full orthotopic liver transplantation** is usually required because the entire native liver needs to be replaced due to extensive and irreversible damage. - APOLT aims to allow the native liver to recover, which is unlikely in cases of irreversible fulminant failure, making a complete replacement necessary.

Question 134: The type of graft best suited for renal transplantation is:

A. Xenograft
B. Autograft
C. Allograft
D. Isograft (Correct Answer)

Explanation: ***Isograft*** - An **isograft** is a transplant between **genetically identical individuals** (e.g., identical twins), leading to no immune rejection. - In renal transplantation, an isograft is ideal as it eliminates the need for **immunosuppressive drugs** and their associated side effects. *Xenograft* - A **xenograft** involves transplantation between **different species** (e.g., pig to human). - Xenografts face significant challenges due to **hyperacute rejection** caused by pre-existing natural antibodies. *Autograft* - An **autograft** is a transplant from one part of the body to another in the **same individual**. - While there is no immune rejection, it is not applicable for renal transplantation as the recipient's own kidneys are diseased. *Allograft* - An **allograft** is a transplant between **genetically different individuals of the same species**. - While common in renal transplantation, allografts still require **lifelong immunosuppression** to prevent rejection, distinguishing them from the ideal isograft.

Question 135: The advantage of bladder drainage over enteric drainage after pancreatic transplantation is better monitoring of:

A. Amylase levels (Correct Answer)
B. Glucose levels
C. Electrolyte levels
D. HBA1C levels

Explanation: ***Amylase levels*** - Bladder drainage allows for direct monitoring of **urinary amylase levels**, which serves as a sensitive indicator of pancreatic allograft rejection. A drop in urine amylase activity can quickly signal graft dysfunction or rejection. - This direct measurement in urine is not possible with enteric drainage, where pancreatic enzymes are diverted into the intestines. *Glucose levels* - **Blood glucose levels** are monitored similarly regardless of the drainage type. Both bladder and enteric drainage aim to normalize blood glucose by providing insulin-producing cells. - While pancreatic transplantation aims to normalize glucose, its monitoring is systemic and not specific to the drainage method. *Electrolyte levels* - Monitoring **serum electrolyte levels** is important in all transplant patients, but it is not a specific advantage of bladder drainage over enteric drainage. - Bladder drainage can, in some cases, lead to metabolic complications (e.g., metabolic acidosis due to bicarbonate loss), but this is a potential downside, not an advantage for monitoring per se. *HBA1C levels* - **HbA1c levels** reflect long-term glycemic control (over 2-3 months) and are monitored in both bladder and enteric drained recipients to assess overall success of the transplant in managing diabetes. - HbA1c is a chronic marker, while the advantage of bladder drainage lies in acute monitoring of graft function using amylase.

Question 136: If mother is donating the kidney to her son, this is an example of:-

A. Autograft
B. Allograft (Correct Answer)
C. Isograft
D. Xenograft

Explanation: ***Correct: Allograft*** - An **allograft** involves the transplantation of organs or tissues between **genetically different individuals of the same species** - In this scenario, a mother donating a kidney to her son is a classic example, as they are genetically distinct (share approximately 50% DNA) but belong to the same human species - This is the **most common type of transplant** performed in clinical practice *Incorrect: Autograft* - An **autograft** involves transplanting tissues or organs from one part of the body to another in the **same individual** - Examples include skin grafts from a patient's thigh to an injured area on their arm, or using saphenous vein for coronary artery bypass grafting - This does not apply to mother-son transplantation as two different individuals are involved *Incorrect: Isograft* - An **isograft** refers to a transplant between **genetically identical individuals**, such as monozygotic (identical) twins - The mother and son are not genetically identical (they share only ~50% of their DNA), thus precluding an isograft - Isografts have minimal risk of rejection due to genetic identity *Incorrect: Xenograft* - A **xenograft** is a transplant of organs or tissues **from one species to another** - Examples include transplanting a pig heart valve into a human or using bovine pericardium - Mother and son are both humans (same species), so this is not a xenograft

Question 137: Graft used from an identical twin is called as?

A. Allograft
B. Isograft (Correct Answer)
C. Autograft
D. Xenograft

Explanation: ***Isograft*** - An **isograft**, also known as a **syngeneic graft**, involves tissue transfer between **genetically identical** individuals, such as monozygotic (identical) twins. - Due to identical genetic makeup, there is **minimal to no immune rejection**, making it the most successful type of transplant. *Allograft* - An **allograft** involves tissue transfer between **genetically non-identical individuals** of the **same species**. - While common, allografts carry a significant risk of **immune rejection** and require **immunosuppressive therapy**. *Autograft* - An **autograft** is a transplant where tissue is taken from **one part of the patient's own body** and transferred to another part. - Since the tissue is from the same individual, there is **no risk of immune rejection**. *Xenograft* - A **xenograft** involves tissue transfer between **different species**, such as from a pig to a human. - Xenografts face the **highest risk of hyperacute immune rejection** due to significant genetic differences.

Question 138: Dr. Christiaan Barnard is associated with?

A. Hair transplant
B. Renal transplantation
C. Liver transplant
D. Heart transplant (Correct Answer)

Explanation: ***Heart transplant*** - **Dr. Christiaan Barnard** performed the **first successful human-to-human heart transplant** on December 3, 1967. - This pioneering surgery cemented his place in medical history and opened new avenues for treating end-stage heart disease. *Hair transplant* - While a significant medical procedure, hair transplantation is primarily associated with dermatological and plastic surgery, not Dr. Christiaan Barnard. - The first successful hair transplant was performed by **Dr. Norman Orentreich** in 1952. *Renal transplantation* - The first successful human organ transplant was a **kidney transplant** performed by **Dr. Joseph Murray** in 1954, for which he received the Nobel Prize. - Although a groundbreaking procedure, it predates Barnard's work and is attributed to different surgical teams. *Liver transplant* - The first successful **liver transplant** was performed by **Dr. Thomas Starzl** in 1967, the same year as Barnard's heart transplant. - While both were monumental achievements in transplantation, they involved different organs and different surgeons.

Question 139: What is the primary indication for kidney transplantation?

A. End-stage renal disease (Correct Answer)
B. Acute kidney injury
C. Polycystic kidney disease
D. Chronic pyelonephritis

Explanation: ***End-stage renal disease*** - Kidney transplantation is primarily indicated for patients with **end-stage renal disease (ESRD)**, as it offers the best chance for long-term survival and improved quality of life compared to dialysis. - ESRD is the final stage of chronic kidney disease, where the kidneys have permanently failed and are no longer able to filter waste products from the blood adequately. *Acute kidney injury* - **Acute kidney injury (AKI)** is a sudden and often reversible loss of kidney function, which is typically managed with supportive care or temporary dialysis, not transplantation. - AKI is different from chronic kidney failure and may resolve with appropriate treatment of the underlying cause. *Polycystic kidney disease* - While **polycystic kidney disease (PKD)** can lead to ESRD, it is the resulting ESRD, not PKD itself, that is the direct indication for transplantation. - PKD is a **genetic disorder** causing fluid-filled cysts to grow in the kidneys, eventually impairing kidney function. *Chronic pyelonephritis* - **Chronic pyelonephritis** is a severe bacterial infection of the kidneys, which can cause scarring and lead to chronic kidney disease or ESRD over time. - Similar to PKD, it is the progression to **ESRD**, rather than the infection itself, that necessitates kidney transplantation.

Question 140: During a kidney transplant, which anatomical landmark is crucial for the correct positioning of the renal artery?

A. External iliac vessels (Correct Answer)
B. Aortic bifurcation
C. Superior mesenteric artery
D. Inferior mesenteric artery

Explanation: ***External iliac vessels*** - The **external iliac artery** is the primary vascular landmark for kidney transplantation and serves as the recipient vessel for anastomosis of the donor renal artery. - In renal transplantation, the donor renal artery is typically anastomosed **end-to-side** to the recipient's external iliac artery, while the renal vein is connected to the external iliac vein. - The transplanted kidney is positioned in the **iliac fossa**, and the external iliac vessels provide the essential vascular supply with adequate blood flow and appropriate vessel caliber for anastomosis. - This is the **standard surgical technique** for renal transplantation in adults. *Aortic bifurcation* - The **aortic bifurcation** is where the abdominal aorta divides into the right and left common iliac arteries at approximately the **L4 vertebral level**. - While it is an important vascular landmark, it is located **too proximal** and too high in the abdomen for the typical transplant site in the iliac fossa. - Direct anastomosis to the aorta is rarely performed and would be technically more challenging. *Superior mesenteric artery* - The **superior mesenteric artery (SMA)** is a major branch of the abdominal aorta that supplies blood to the midgut structures. - It is **not relevant** to kidney transplant surgery, as it is located too high in the abdomen and supplies the intestines, not the pelvic region where transplants are performed. *Inferior mesenteric artery* - The **inferior mesenteric artery (IMA)** arises from the aorta and supplies the hindgut (descending colon, sigmoid, and upper rectum). - Like the SMA, it is **not a landmark** for renal transplantation and has no role in the vascular anastomosis required for kidney transplant surgery.

Question 141: A patient has undergone kidney transplantation. What is the most critical concern in the early postoperative period that can lead to graft loss?

A. Graft rejection (Correct Answer)
B. Infection
C. Delayed graft function
D. Vascular thrombosis

Explanation: ***Graft rejection*** - **Graft rejection** is the most critical concern that can lead to graft loss in the postoperative period, as the recipient's immune system recognizes the transplanted kidney as foreign tissue and mounts an immune response. - **Hyperacute rejection** (rare with modern crossmatching) occurs within minutes to hours; **acute rejection** typically occurs within the first 3-6 months and requires immediate immunosuppressive therapy. - Uncontrolled rejection leads to irreversible graft damage and loss, making immunosuppression monitoring critical. *Infection* - **Infection** is a major complication due to immunosuppression and can be life-threatening, but is generally manageable with antimicrobial therapy. - While serious, infections do not directly cause graft loss in the same manner as immunologic rejection, though severe infections may require reducing immunosuppression. *Delayed graft function* - **Delayed graft function (DGF)** occurs in 20-40% of deceased donor transplants, requiring dialysis in the first week post-transplant. - While DGF increases acute rejection risk and affects long-term outcomes, it often resolves spontaneously and doesn't represent an immediate immunologic threat to the graft. *Vascular thrombosis* - **Vascular thrombosis** (arterial or venous) is a surgical emergency occurring in 1-5% of cases, typically within the first 48 hours. - While it causes immediate graft loss if not recognized promptly, it is less common than rejection episodes overall, and represents a technical rather than immunologic complication.

Question 142: In lung transplant candidate evaluation, which factor is considered most fundamental in determining transplant urgency and potential benefit?

A. Severity of underlying lung disease (Correct Answer)
B. Current functional status
C. Potential for rehabilitation
D. Patient's socioeconomic status

Explanation: ***Severity of underlying lung disease*** - This factor is paramount because it dictates the **degree of physiologic impairment** and the **rate of disease progression**, directly influencing the **urgency of transplantation** to prevent irreversible organ damage or death. - The severity of the disease also determines the **potential for meaningful clinical benefit** post-transplant, as patients with advanced disease are more likely to experience improved quality of life and survival. *Current functional status* - While important for assessing a patient's immediate capabilities and predicting post-transplant recovery, functional status is often a **consequence of the underlying disease severity**. - It provides a snapshot of the patient's current condition but doesn't inherently predict the **future trajectory or urgency** of the need for transplant as directly as disease severity does. *Potential for rehabilitation* - This refers to the patient's capacity to benefit from physical therapy and other interventions after surgery, which is crucial for **successful recovery and long-term outcomes**. - However, the ability to rehabilitate is a **determinant of transplant suitability**, not the primary factor for identifying the **initial need or urgency** for the transplant itself. *Patient's socioeconomic status* - Socioeconomic status can influence access to care, adherence to medical regimens, and the availability of support systems, all of which are important for **post-transplant success**. - It is an **ethical consideration** and a factor in holistic patient care, but it does not directly determine the **medical necessity or urgency** of a lung transplant.

Question 143: What type of graft is represented by the scenario of a mother donating a kidney to her son?

A. Isograft
B. Allograft (Correct Answer)
C. Autograft
D. Xenograft

Explanation: ***Allograft (Correct Answer)*** - An **allograft** (also called a homograft) is a graft of tissue or an organ transplanted between two genetically different individuals of the same species. - In this scenario, a mother donating a kidney to her son represents transplantation between two humans (same species) who are genetically related but not genetically identical. - This is the classic example of an **allograft** - the most common type of transplant in clinical practice. *Incorrect: Isograft* - An **isograft** (also called a syngeneic graft) is a special type of allograft where the donor and recipient are genetically identical, such as monozygotic (identical) twins. - A mother and son share approximately 50% of their genes but are not genetically identical, so this does not qualify as an isograft. - Isografts have the advantage of no rejection risk due to genetic identity. *Incorrect: Autograft* - An **autograft** is a graft of tissue from one site to another site within the same individual's body. - Examples include skin grafts from thigh to burn areas, or saphenous vein grafts for coronary artery bypass. - Since this scenario involves two different individuals (mother and son), it cannot be an autograft. *Incorrect: Xenograft* - A **xenograft** (also called a heterograft) is a graft transplanted between members of different species. - Examples include porcine (pig) heart valves used in humans, or temporary porcine skin grafts for burn patients. - Since both mother and son are humans (same species - *Homo sapiens*), this is not a xenograft.

Question 144: What is the purpose of the Milan criteria?

A. Selecting patients for heart transplantation
B. Selecting patients for Liver transplantation (Correct Answer)
C. Selecting patients for Lung transplantation
D. Selecting patients for Kidney transplantation

Explanation: ***Selecting patients for Liver transplantation*** - The **Milan criteria** are specifically used to determine which patients with **hepatocellular carcinoma (HCC)** are eligible for **liver transplantation**. - These criteria define tumor size and number limits (e.g., a single lesion ≤ 5 cm or up to 3 lesions with no lesion > 3 cm) to predict post-transplant survival. *Selecting patients for Lung transplantation* - **Lung transplantation** eligibility is typically guided by criteria related to lung disease severity, such as the **Lung Allocation Score (LAS)**, not the Milan criteria. - The primary aim is to assess the risk of death without transplantation versus the potential benefit of a transplant. *Selecting patients for Kidney transplantation* - **Kidney transplantation** selection is based on factors like **end-stage renal disease**, overall health status, and absence of significant co-morbidities, primarily using the **Kidney Allocation System (KAS)**. - Eligibility does not involve tumor-specific criteria like those in the Milan criteria. *Selecting patients for heart transplantation* - Selection for **heart transplantation** involves evaluating patients with **end-stage heart failure** who have limited treatment options and a high risk of mortality, often using criteria like MELD or UNOS scores, not the Milan criteria. - Factors like functional status, pulmonary vascular resistance, and co-morbidities are key considerations.

Question 145: Who first performed liver transplantation?

A. Christian Barnard
B. Starzl (Correct Answer)
C. Carrel
D. Huggins

Explanation: ***Starzl*** - **Thomas E. Starzl** performed the first human liver transplant in **1963** and the first successful long-term liver transplant in **1967**. - He is widely recognized as the **father of modern transplantation** for his pioneering work in liver transplantation and immunosuppression. *Huggins* - **Charles Brenton Huggins** was a Nobel Prize-winning physician known for his work on the hormonal treatment of **prostate cancer**. - His contributions were primarily in **oncology** and endocrinology, not liver transplantation. *Carrel* - **Alexis Carrel** was a French surgeon and biologist who won the Nobel Prize for his work on **vascular suturing** and organ transplantation techniques in the early 20th century. - While he laid foundational work for transplantation, he did not perform the first liver transplant. *Christian Barnard* - **Christian Barnard** was a South African cardiac surgeon who performed the **world's first human-to-human heart transplant** in **1967**. - His pioneering work was in cardiac surgery, not liver transplantation.

Question 146: Which of the following is NOT an indication for liver transplantation?

A. Sclerosing cholangitis
B. Cirrhosis
C. Biliary atresia
D. Hepatitis A (Correct Answer)

Explanation: ***Hepatitis A*** - **Hepatitis A** is typically an **acute, self-limiting viral infection** of the liver, and the vast majority of patients recover completely without chronic liver damage or the need for transplantation. - While rare cases of **fulminant hepatic failure** due to Hepatitis A can occur, requiring transplantation, it is not a routine indication for transplantation in its usual course. *Biliary atresia* - **Biliary atresia** is a common indication for **pediatric liver transplantation**, as it causes progressive destruction of the bile ducts leading to cholestasis and cirrhosis. - If initial surgical interventions like the **Kasai procedure** fail, liver transplantation becomes necessary to survive. *Sclerosing cholangitis* - **Primary sclerosing cholangitis (PSC)** is a chronic, progressive cholestatic liver disease characterized by inflammation, fibrosis, and stricturing of the bile ducts. - This leads to **cirrhosis, liver failure, and an increased risk of cholangiocarcinoma**, making liver transplantation a definitive treatment. *Cirrhosis* - **Cirrhosis** from various etiologies (e.g., chronic hepatitis B/C, alcoholic liver disease, non-alcoholic steatohepatitis) is the **most common indication for liver transplantation** worldwide. - Patients with **decompensated cirrhosis** (e.g., ascites, encephalopathy, variceal bleeding) and those with **hepatocellular carcinoma** within Milan criteria are primary candidates for transplantation.

Question 147: What type of graft is used in transplantation between identical twins?

A. Isograft (Correct Answer)
B. Allograft
C. Autograft
D. Xenograft

Explanation: ***Isograft*** - An **isograft** refers to a transplant of tissue between two **genetically identical** individuals. - This type of graft is successful because the immune system of the recipient recognizes the donor tissue as "self," preventing **rejection**. *Allograft* - An **allograft** involves transplantation of tissues or organs between two **genetically dissimilar** individuals of the same species. - While common, allografts require **immunosuppressive therapy** to prevent rejection, which is not necessary between identical twins. *Autograft* - An **autograft** is a transplant where tissue is taken from one part of an individual's body and transplanted to another part of the **same individual**. - This is used when a patient's own tissue is needed, such as in **skin grafts** or **coronary artery bypass grafting (CABG)**. *Xenograft* - A **xenograft** is a tissue or organ transplant between individuals of **different species**. - These grafts face significant challenges due to severe immune rejection and are typically used in specific situations like **heart valve replacements** from pigs or cows.

Question 148: If a mother is donating a kidney to her son, what type of graft is this an example of?

A. Isograft (graft between genetically identical individuals)
B. Autograft (graft from one part of the body to another in the same individual)
C. Allograft (graft from a genetically non-identical member of the same species) (Correct Answer)
D. Xenograft (graft from a member of one species to a member of another species)

Explanation: ***Allograft (graft from a genetically non-identical member of the same species)*** - An **allograft** involves the transplantation of organs or tissues between **genetically non-identical individuals of the same species**, such as a mother donating a kidney to her son. - While genetically related, a mother and son are not genetically identical, leading to the need for **immunosuppression** to prevent rejection. *Isograft (graft between genetically identical individuals)* - An **isograft** occurs between **genetically identical individuals**, such as identical twins, where there is no need for immunosuppression. - A mother and son are not genetically identical, making this option incorrect. *Autograft (graft from one part of the body to another in the same individual)* - An **autograft** is a transplant where **tissue is moved from one site to another within the same individual**, for example, a skin graft from a patient's thigh to their burned arm. - This scenario involves two different individuals, so autograft is not applicable. *Xenograft (graft from a member of one species to a member of another species)* - A **xenograft** involves transplantation of organs or tissues between **different species**, such as a pig heart valve transplanted into a human. - This case involves two humans, making xenograft an incorrect choice.

Question 149: Which of the following statements about heart transplantation is false?

A. High pulmonary arterial resistance is a contraindication
B. It is only orthotopic and not heterotopic (Correct Answer)
C. Immunosuppression is started preoperatively
D. A beating heart cadaver/donor is not always needed.

Explanation: ***It is only orthotopic and not heterotopic*** - This statement is **FALSE**, making it the correct answer to this question asking for the false statement. - While **orthotopic transplantation** (replacing the recipient's heart with the donor heart in its normal anatomical position) is the overwhelmingly predominant method, **heterotopic transplantation** (leaving the recipient's heart in place and implanting the donor heart as an auxiliary "piggyback" pump) has been performed as an alternative technique. - Heterotopic transplantation, though rarely used in modern practice, was described and performed in select cases, particularly when the donor heart is undersized or when severe pulmonary hypertension is present. Therefore, the claim that heart transplantation is "only orthotopic" is incorrect. *Immunosuppression is started preoperatively* - This statement is **TRUE**. - **Immunosuppressive therapy** is typically initiated intraoperatively or in some protocols may begin preoperatively to prevent hyperacute and acute rejection. - Induction immunosuppression aims to suppress the recipient's immune response before it can react to the transplanted organ, improving early graft survival. *High pulmonary arterial resistance is a contraindication* - This statement is **TRUE**. - **Fixed pulmonary hypertension** with elevated pulmonary vascular resistance (PVR >4-5 Wood units or transpulmonary gradient >15 mmHg unresponsive to vasodilators) is a **contraindication** for isolated heart transplantation. - The donor right ventricle may not be able to pump against high pulmonary pressures, leading to acute right heart failure. - Such patients may require combined heart-lung transplantation or medical optimization to reduce pulmonary vascular resistance before transplantation can be considered. *A beating heart cadaver/donor is not always needed* - This statement is considered **TRUE**, though with important caveats. - Traditionally, heart transplantation has relied almost exclusively on **beating-heart donors** (brain-dead donors with maintained cardiac function) to ensure organ viability. - The statement acknowledges that in rare circumstances or with advanced preservation techniques, the absolute requirement for a beating heart might be questioned, though in practical terms beating-heart donation remains the standard for heart transplantation.

Question 150: Which solid organ is considered to have the lowest risk of rejection during transplantation?

A. Pancreas
B. Kidney
C. Heart
D. Liver (Correct Answer)

Explanation: ***Liver*** - The liver has a unique immunologic environment, often referred to as **immunologic privilege**, which contributes to its lower rates of rejection compared to other transplanted solid organs. - It produces various **immunosuppressive factors** and has a high capacity for regeneration and repair, adapting more readily to the recipient's immune system. - The liver's **dual blood supply** (hepatic artery and portal vein) and tolerogenic properties make it the most immunologically privileged solid organ. *Pancreas* - **Pancreas transplantation** carries a high risk of rejection, with rejection rates significantly higher than liver transplantation. - Pancreatic tissue is highly **immunogenic** due to its endocrine and exocrine functions, requiring aggressive immunosuppression. - Often transplanted with kidney in diabetic patients, and rejection episodes are common. *Kidney* - Kidney transplantation is common, but it carries a significant risk of both **acute and chronic rejection**, requiring lifelong immunosuppression. - The kidney expresses various **MHC antigens** that are readily recognized by the recipient's immune system, making it more immunogenic than the liver. *Heart* - **Heart transplantation** is associated with a high risk of rejection due to the rich vascularity and immunogenicity of cardiac tissue. - It often requires aggressive immunosuppressive regimens to prevent both **acute cellular rejection** and **antibody-mediated rejection**.

Question 151: Solution currently used for liver preservation for transplantation is?

A. IGL-1 solution
B. Ross Marshall Citrate solution
C. University of Wisconsin (UW) solution (Correct Answer)
D. Kyoto ET solution

Explanation: ***University of Wisconsin (UW) solution*** - The **University of Wisconsin (UW) solution** is widely considered the gold standard for **organ preservation**, particularly for liver transplantation, due to its superior ability to extend cold ischemia time. - It contains a unique blend of components, including **lactobionate, raffinose, and hydroxyethyl starch**, which help to minimize cellular swelling, prevent free radical injury, and maintain cellular integrity during cold storage. *IGL-1 solution* - **IGL-1** is a more recent preservation solution designed to be used with **machine perfusion** systems. - While showing promise, it is **not yet as universally adopted** as UW solution for static cold storage of livers. *Ross Marshall Citrate solution* - The **Ross Marshall Citrate solution** was an older solution primarily used for **kidney preservation**. - It has been largely **superseded by newer solutions** with improved efficacy for liver and other organ preservation. *Kyoto ET solution* - **Kyoto ET solution** is another preservation solution primarily used in **Japan**, particularly for **kidney and pancreas preservation**. - While effective for those organs, it is **not the most commonly used** or preferred solution for liver preservation globally.

Question 152: Which of the following is an indication for lung transplantation?

A. COPD
B. Alpha-1 antitrypsin deficiency
C. Cystic fibrosis and bronchiectasis
D. All of the options (Correct Answer)

Explanation: ***All of the options*** - **COPD**, **Alpha-1 antitrypsin deficiency**, and **Cystic fibrosis** with **bronchiectasis** are all common indications for lung transplantation when medical management fails and the patient meets other criteria. - Lung transplantation is considered for patients with **end-stage lung disease** who have a high risk of death within 1-2 years without transplantation, and who have no significant comorbidities. *COPD* - While many patients with **COPD** manage with medical therapy, those with severe disease, frequent exacerbations, and **declining lung function** despite maximal treatment can be candidates for lung transplantation. - **End-stage COPD** is a significant cause of morbidity and mortality, making transplantation a viable option for selected patients. *Alpha-1 antitrypsin deficiency* - This genetic disorder primarily affects the lungs, leading to **early-onset emphysema** and **bronchiectasis**, particularly in non-smokers. - When the lung damage progresses to a severe and life-threatening stage, **lung transplantation** becomes a treatment option. *Cystic fibrosis and bronchiectasis* - **Cystic fibrosis** often leads to severe, progressive **bronchiectasis** and chronic lung infections, resulting in **end-stage lung disease**. - For these patients, especially those with intractable daily symptoms and **declining respiratory function**, lung transplantation can significantly improve quality of life and survival.

Question 153: Transplant of a kidney from a mother to a son is an example of:

A. Autograft
B. Allograft (Correct Answer)
C. Isograft
D. Xenograft

Explanation: ***Allograft*** - An **allograft** involves the transplantation of organs or tissues between genetically non-identical individuals of the **same species**, such as between a mother and her son. - While they are related, they are not genetically identical, necessitating methods to prevent **graft rejection**. *Autograft* - An autograft involves transplanting tissues or organs **within the same individual**, for example, skin graft from one part of the body to another. - This scenario describes a transplant between two different individuals (mother and son). *Isograft* - An isograft (or syngeneic graft) is a transplant between **genetically identical individuals**, such as identical twins. - A mother and a son are not genetically identical, so this term does not apply. *Xenograft* - A xenograft is a transplant of organs or tissues between individuals of **different species**, such as from a pig to a human. - This scenario involves a transplant between two humans, who are of the same species.

Question 154: What is the term used for transplantation of tissue from one part of a patient's body to another part of the same patient's body?

A. Autograft (Correct Answer)
B. Allograft
C. Isograft
D. Xenograft

Explanation: ***Autograft*** - An **autograft** refers to the transplantation of tissue from one part of an individual's body to another part of the **same individual's body**. - This type of transplant has the lowest risk of **immune rejection** as the tissue is genetically identical to the recipient's body. *Allograft* - An **allograft** involves the transplantation of tissue between two genetically distinct individuals of the **same species**. - While often successful, allografts carry a significant risk of **immune rejection**, necessitating immunosuppressive therapy. *Isograft* - An **isograft** is a transplant between genetically identical individuals, such as **monozygotic (identical) twins**. - Like autografts, isografts have a minimal risk of immune rejection due to their shared genetic makeup. *Xenograft* - A **xenograft** involves the transplantation of tissue between individuals of **different species**. - This type of transplant carries the highest risk of **immune rejection** and often requires extensive genetic modification of the donor tissue or aggressive immunosuppression.

Question 155: Which type of graft has the least chance of recipient failure in transplantation?

A. Allograft
B. Isograft (Correct Answer)
C. Xenograft
D. Autograft

Explanation: ***Isograft*** - An **isograft** is a transplant between two **genetically identical individuals** (e.g., identical twins). - Due to **100% HLA matching**, there is **no immunological rejection**, resulting in the highest success rate in organ transplantation. - In the context of **transplant immunology** and organ transplantation between individuals, isografts represent the ideal scenario with minimal failure risk. *Allograft* - An **allograft** is a transplant between genetically non-identical individuals of the **same species**. - Requires **lifelong immunosuppressive therapy** to prevent acute and chronic rejection. - Most common type of clinical transplantation but carries significant risk of recipient failure due to immune-mediated rejection. *Xenograft* - A **xenograft** is a transplant between individuals of **different species** (e.g., pig valve to human). - Elicits **hyperacute, acute, and chronic rejection** responses due to major histocompatibility differences. - Has the **highest failure rate** among graft types even with aggressive immunosuppression. *Autograft* - An **autograft** involves transplanting tissue from **one site to another within the same individual** (e.g., skin graft, vein graft in CABG). - While autografts also have **zero immunological rejection risk**, they are typically classified under tissue grafts rather than organ transplantation. - In the traditional classification of **transplant types between individuals**, isograft is considered the gold standard with least rejection risk.

Question 156: Which of the following is category 3 in the Maastricht classification of donation after cardiac death?

A. Awaiting cardiac arrest (Correct Answer)
B. Patient found deceased upon arrival
C. Attempts at resuscitation after cardiac arrest
D. Cardiac arrest following brain death declaration

Explanation: ***Awaiting cardiac arrest*** - This category denotes patients who are anticipated to have a **cardiac arrest** and are considered for organ donation after the cessation of circulatory function. - These individuals are typically in an **intensive care setting**, where withdrawal of life support is planned, leading to eventual cardiac death. *Patient found deceased upon arrival* - This describes individuals who have suffered **unwitnessed cardiac arrest** and are pronounced dead upon the arrival of medical personnel. - Organ viability for donation is often compromised due to the **unknown downtime** and lack of controlled conditions. *Attempts at resuscitation after cardiac arrest* - This category includes patients for whom **resuscitation efforts** were initiated following cardiac arrest but were ultimately unsuccessful. - Organ donation in this context requires assessment of the impact of resuscitation on **organ perfusion** and viability. *Cardiac arrest following brain death declaration* - This scenario describes donation after **neurological determination of death** (brain death), not cardiac death. - In brain death, the heart may still be beating with full circulatory support, and organ procurement occurs while **circulation is maintained**.

Question 157: What is the method of delivery for islet cell transplantation in diabetes mellitus?

A. Thigh
B. Pelvis
C. Forearm muscles
D. Infused into the portal vein (Correct Answer)

Explanation: ***Infused into the portal vein*** - Islet cells are infused into the **portal vein**, which carries them to the liver, where they engraft and begin producing insulin. - The **liver** provides a rich blood supply and an immunosuppressive environment favorable for islet survival and function. *Pelvis* - While other cell therapies might be delivered to the pelvis, it is not the standard site for **islet cell transplantation**. - The pelvis lacks the specific microenvironment and blood flow dynamics optimal for islet engraftment and function. *Thigh* - The thigh is not a typical site for **islet cell transplantation** due to its less favorable vascularization and tissue environment compared to the liver. - Delivering islets to the thigh would likely result in poorer survival and integration of the transplanted cells. *Forearm muscles* - **Forearm muscles** are not the preferred location for islet cell transplantation due to inadequate blood supply and an unsuitable immunological environment. - This site would not optimize cell survival or insulin secretion.

Question 158: All of the following are indications for liver transplantation, except for which of the following?

A. Hepatocellular Carcinoma
B. Biliary atresia
C. Cirrhosis
D. Alcoholic Hepatitis (Correct Answer)

Explanation: ***Alcoholic Hepatitis*** - Traditionally, **active alcoholic hepatitis with ongoing alcohol use** is a contraindication to liver transplantation. - Patients must demonstrate a sustained period of **abstinence** (typically 6 months minimum) and commitment to sobriety before being considered for transplant. - **Active alcohol use** poses risks of recidivism, non-compliance, and disease recurrence post-transplant. - Note: Some specialized centers now consider early transplant for severe alcoholic hepatitis in highly selected cases, but this remains controversial and not standard practice. *Hepatocellular Carcinoma* - **Hepatocellular carcinoma (HCC)** meeting specific criteria (e.g., **Milan criteria**: single lesion ≤5 cm or up to 3 lesions each ≤3 cm, no vascular invasion) is a well-established indication for liver transplantation. - Transplantation offers the best chance for cure by removing both the tumor and the underlying cirrhotic liver. *Cirrhosis* - **Decompensated cirrhosis** is the most common indication for liver transplantation, regardless of etiology (viral, autoimmune, metabolic, alcoholic after abstinence). - Complications like refractory ascites, hepatic encephalopathy, variceal bleeding, and hepatorenal syndrome indicate need for transplant evaluation. *Biliary Atresia* - **Biliary atresia** is the most common indication for pediatric liver transplantation. - This congenital condition involves obstruction or absence of extrahepatic bile ducts, leading to progressive cholestasis, cirrhosis, and liver failure if untreated.

Question 159: Liver transplant for which of the following conditions will require a duct-to-jejunal anastomosis rather than a duct-to-duct anastomosis?

A. Alagille syndrome
B. Liver cirrhosis
C. Primary biliary cholangitis
D. Primary sclerosing cholangitis (Correct Answer)

Explanation: ***Primary sclerosing cholangitis*** - **Primary sclerosing cholangitis (PSC)** is characterized by **inflammation and scarring of the bile ducts**, leading to strictures and impaired bile flow. - Due to the widespread nature of the disease and the potential for residual diseased ducts in the recipient, a **duct-to-jejunal anastomosis (Roux-en-Y hepaticojejunostomy)** is preferred to ensure optimal drainage and avoid complications like cholangitis and anastomotic strictures at the native duct. *Alagille syndrome* - **Alagille syndrome** is a genetic disorder causing **bile duct paucity and cholestasis**. - While it affects the bile ducts, the native large bile duct in the recipient is often suitable for a **duct-to-duct anastomosis** without significant risk of recurrent disease-related strictures. *Liver cirrhosis* - **Cirrhosis** from most causes (e.g., viral hepatitis, alcohol) primarily affects the **liver parenchyma**, not the bile ducts directly. - In such cases, the native bile duct is usually healthy, allowing for a straightforward **duct-to-duct anastomosis**. *Primary biliary cholangitis* - **Primary biliary cholangitis (PBC)** is an autoimmune disease primarily affecting the **small intrahepatic bile ducts**. - The larger extrahepatic bile ducts are typically spared and healthy, making a **duct-to-duct anastomosis** the standard and preferred method for bile drainage after transplant.

Question 160: Which of the following is the most appropriate term for a graft when the donor and recipient are identical twins?

A. Xenograft
B. Allograft
C. Isograft (Correct Answer)
D. Autograft

Explanation: ***Isograft*** - An **isograft** refers to a transplant where the donor and recipient are **genetically identical**, such as in the case of **identical twins**. - Due to their identical genetic makeup, there is typically **no immune rejection** of the graft, as the recipient's immune system recognizes the donor's tissues as "self." *Xenograft* - A **xenograft** involves grafting tissue from a donor of **one species to a recipient of another species**, such as porcine heart valves transplanted into humans. - These grafts often face significant **immune rejection** due to the large genetic differences between species. *Allograft* - An **allograft** is a transplant between **two genetically non-identical individuals of the same species**, such as an organ transplant between unrelated humans. - These grafts require **immunosuppressive therapy** to prevent rejection, as the recipient's immune system will recognize the donor's tissue as foreign. *Autograft* - An **autograft** involves transplanting tissue from **one part of an individual's body to another part of the same individual's body**, such as a skin graft from the thigh to the arm. - Since the tissue comes from the same individual, there is **no risk of immune rejection**.

Practice by Chapter

Immunology of Transplantation

Practice Questions

Immunosuppression

Practice Questions

Organ Procurement

Practice Questions

Kidney Transplantation

Practice Questions

Liver Transplantation

Practice Questions

Pancreas Transplantation

Practice Questions

Heart Transplantation

Practice Questions

Lung Transplantation

Practice Questions

Small Bowel Transplantation

Practice Questions

Complications of Transplantation

Practice Questions

Transplantation in Special Populations

Practice Questions

Ethical Issues in Transplantation

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free

Transplant Surgery — MCQs

Transplant Surgery — MCQs

On this page